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INFORMATIVE CENSORING IN TRANSPLANTATION STATISTICS
by Natalie Dawn Staplin
Observations are informatively censored when there is dependence between the time
to the event of interest and time to censoring. When considering the time to death of
patients on the waiting list for a transplant, particularly a liver transplant, patients that
are removed for transplantation are potentially informatively censored, as generally the
most ill patients are transplanted. If this censoring is assumed to be non-informative then
any inferences may be misleading.
The existing methods in the literature that account for informative censoring are ap-
plied to data to assess their suitability for the liver transplantation setting. As the amount
of dependence between the time to failure and time to censoring variables cannot be identi-
ed from the observed data, estimators that give bounds on the marginal survival function
for a given range of dependence values are considered. However, the bounds are too wide to
be of use in practice. Sensitivity analyses are also reviewed as these allow us to assess how
inferences are aected by assuming diering amounts of dependence and whether meth-
ods that account for informative censoring are necessary. Of the other methods considered
IPCW estimators were found to be the most useful in practice.
Sensitivity analyses for parametric models are less computationally intensive than those
for Cox models, although they are not suitable for all sets of data. Therefore, we develop
a sensitivity analysis for piecewise exponential models that is still quick to apply. These
models are exible enough to be suitable for a wide range of baseline hazards. The
sensitivity analysis suggests that for the liver transplantation setting the inferences about
time to failure are sensitive to informative censoring. A simulation study is carried out
that shows that the sensitivity analysis is accurate in many situations, although not when
there is a large proportion of censoring in the data set.
Finally, a method to calculate the survival benet of liver transplantation is adapted
to make it more suitable for UK data. This method calculates the expected change in
post-transplant mortality relative to waiting list mortality. It uses IPCW methods to
account for the informative censoring encountered when estimating waiting list mortality
to ensure the estimated survival benet is as accurate as possible.
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Introduction
Survival analysis methods are often used in the analysis of medical data, both designed
clinical trials and observational studies, as the event of interest may not be completely
observed. This could be because individuals drop out of a study, experience a dierent
event that means it is no longer possible to observe the event of interest, or the event of
interest has not been observed by the end of the study. Any individual for whom the event
of interest is not observed is censored at the time that they are removed from the study.
Kalbeisch and Prentice (2002) and Collett (2003) both give detailed introductions to the
analysis of data with censored observations, some of which is summarised in this section.
The time from a given origin to the event of interest is represented by the random
variable, T and the time from the same origin to censoring is represented by C. The time
to event is often referred to as time to failure in the literature. A value of interest in most
survival analysis applications is the marginal survival function of T, ST(t) = P(T > t).
This could be either the overall survival function or the survival function for a particular
individual. The factors that aect the survival time are also usually of interest, so where
possible any methods used should allow for the inclusion of covariates. Using suitable
models, the eect of any prognostic factors on the survival time can be estimated.
In this thesis, we shall consider the case where both T and C are continuous. Therefore,
we will not be looking at Type I censoring, where the censoring time of each individual is
xed in advance.
Due to the censoring, a value of T for each individual may not be observed. This
means some assumption about the association between T and C needs to be made before
ST(t) or any model parameters can be estimated. The standard assumption used in
survival analysis methods is that of non-informative censoring. This means that T and
C are independently distributed, so as described in Kalbeisch and Prentice (2002), the
conditional hazard function satises
hC(tjT;T > t) = hC(tjT > t); (1.1)
1where
hC(t) = lim
t!0

P(t  C < t + tjC  t)
t

is the hazard function for censored observations. This means censored observations pro-
vide only the information that the true survival time exceeds the survival time and no
information about the subsequent survival time. This assumption is suitable for some
types of censoring, as long as the censoring occurs randomly. For example, when individ-
uals are censored because they are still at risk at the end of the study, it is reasonable to
assume that this type of censoring is non-informative. Another example of non-informative
censoring occurs when individuals who are removed from the study when they experience
events unrelated to the event of interest, such as being run over by a bus.
However, there are other types of censoring where this assumption may be questioned
and models that allow for dependence between T and C need to be used. There are many
issues that are raised when tting these types of models which will be discussed in the
following section.
1.1 Informative Censoring
If it assumed that there is dependence between T and C and the conditional hazard
function for C does not satisfy (1.1), then the censoring is called informative. One possible
cause of informative censoring is that the factors that control time to censoring are also
associated with time to event.
There are several situations that have been identied where censoring is likely to be
informative. According to Lagakos (1979), these are
1. when individuals drop out of a clinical trial for reasons that could be related to the
therapy,
2. when individuals are removed from a clinical trial by design and no longer followed
for survival time if they experience a specic critical event, and
3. when individuals in a study experience a failure from a cause of secondary interest
which censors the failure time from the cause of primary interest.
The type of drop-out in situation 1 can generally not be avoided even if measures are put
in place to minimize the number of patients who leave a study before the end. In situation
2, the specic critical event is dened by those designing the study, such as the spread of
disease past a given threshold. So, the dierence between situations 2 and 3 is that the
censoring event in situation 2 can be avoided by using dierent study designs whereas the
2censoring event in situation 3 is unavoidable. Situation 3 here is known as the problem of
competing risks which is considered in more detail in Section 1.1.1.
The standard methods used to analyse censored data are based on the assumption
of non-informative censoring and may not be robust to the assumption of informative
censoring. In the non-informative censoring case, we assume that those who are censored
are representative of the individuals who are at risk at the time of censoring. If there is
a positive association between time to event and time to censoring then those who are
censored would have a smaller expected survival time. This could lead to the standard
methods overestimating the survival function. Conversely, a negative correlation between
time to event and time to censoring could lead to underestimation of the survival function
when using standard methods. The robustness of the standard methods would also be
aected by the proportion of observations that are informatively censored. It is found
in Fisher and Kanarek (1974) using simulated data that the more informative censoring
there is in a data set, the stronger the eect of informative censoring on the underlying
survival function. This means that the standard methods would generally be more biased
as the amount of informative censoring in a data set increases.
One possible way of incorporating informative censoring into a model is to use a bivari-
ate distribution for (T,C) that has independence of T and C as a special case. However, it
is not possible to test which bivariate distribution should be used in a particular applica-
tion due to identiability issues. The implications of these issues are discussed in Section
1.1.2.
1.1.1 Competing risks framework
It is possible to use a competing risks framework when we have censored data, this is
described in Crowder (2001), which is where the denitions given in this section are taken
from. In a competing risks framework, there are m possible event types that could be
observed. Here, the situation where only one event type can be observed for each individual
is considered. Therefore, for the ith individual in the data set, the observed data are the
event time Yi and the event type J.
The overall hazard function at time t is
h(t) = lim
t!0

P[t  T < t + tjT  t]
t

:
To model the competing risks, the sub-hazard function
h(j;t) = lim
t!0

P[t  T < t + t;J = jjT  t]
t

; j = 1;:::;m;
is used. This is the hazard rate for event type j at time t, in the presence of all the other
3types of event. The sub-hazard functions are related to the overall hazard function as
h(t) =
m X
j=1
h(j;t):
The literature that uses this framework often denes latent event times for each type
of event, denoted  Y1;:::;  Ym. The actual observation time is given by
Y = min( Y1;:::;  Ym);
and the corresponding event type is J so that Y =  YJ.
It is often the marginal distribution of one of the latent event times that is of interest.
Generally, it is the marginal hazard functions
hj(t) = lim
t!0

P[t   Yj < t + tj Yj  t]
t

; j = 1;:::;m;
that are considered, which are the hazard rates for event type j at time t in the absence
of any other event types. These marginal hazard functions cannot be identied from the
observed data.
The usual strong assumption that is made is that  Y1;:::;  Ym are statistically indepen-
dent. This means that the marginal hazard functions now equal the sub-hazard functions
and are therefore identiable. But the assumption used to achieve this is untestable.
The situation that is being considered here can be set up using the competing risks
framework described here. In this case, there are only two competing events, with latent
event times  Y1 = T and  Y2 = C. The event time that is of interest is T, and the marginal
distribution of this variable is what needs to be estimated. The observed data will be
Y = min(T;C) and J which denotes the event type. However, as there are only two types
of event, it usual that an indicator variable  = I(Y = T) is recorded instead of J.
1.1.2 Identiability issues
It has already been mentioned in Section 1.1.1 that the marginal distributions of the latent
event times of m competing risks are not identiable. This is because there is insucient
information in the observed data to be able to identify the joint distribution of the latent
event times  Y1;:::;  Ym. This was rst discussed in Cox (1959), who considered the case
with just two random variables that follow a general independent risks model. The random
variables  Y1 and  Y2 are independently distributed with continuous distribution functions
F1(t) and F2(t). Cox (1959) stated that \no data of the present type can be inconsistent
with [the general independent risks] model".
Tsiatis (1975) considers the general case where there are m competing risks acting
on the system. It is shown that for any given joint survivor function where there is
4dependence between the variables, a dierent joint survivor function can be identied
where the variables are independent. Both of these survivor functions give the same
observable functions so it is not possible to distinguish between them.
Crowder (1991) extends the result above to show that each independent risks model has
a class of satellite dependent models with the same observable functions. It is also shown
that this class can be further broken down into sets with the same marginal functions. If
it were possible to have unlimited observation of Y = min(T;C) and the corresponding
indicator along with unlimited observation of T and C then we would be able to identify
the subclass. If this subclass did not contain the independent risks models then at least it
can be identied that there are not independent risks. However, for the medical examples
of interest, this unlimited observation is not feasible.
Therefore, in general it is not possible to construct a statistical test for non-informative
censoring with the alternative being informative censoring for the situation that is being
considered here.
These problems of non-identiability also have implications for any informative censor-
ing models tted. One of the most popular approaches is to specify a bivariate distribution
for (T;C) for which independence of T and C is a special case. The parameters will no
longer be unidentiable, as long as each point in the parameter space of this joint distri-
bution has a corresponding distinct distribution for the observed data (Y;). However,
due to the lack of information in the observed data, any joint distribution assumed for
(T;C) cannot be veried using a statistical test.
1.2 Liver Transplantation
Much of the methodology developed in this thesis will be illustrated using data on liver
transplantation candidates and recipients. Accordingly, in this section, an outline of rele-
vant aspects of liver transplantation is given.
Liver transplantation is used as treatment for patients with end-stage liver disease
(ESLD). In the UK, to receive a liver transplant, a candidate must normally be registered
with NHS Blood and Transplant (NHSBT) and meet certain criteria as set out in Sec-
tion 1.2.2. NHSBT are also responsible for the allocation of donor organs which is done
according to the policy described in Section 1.2.3.
There has been an increase in the number of patients waiting for a liver transplant
despite measures introduced with the intention of making a larger number of donor organs
available. These include the use of extended criteria donors (ECD) that would have previ-
ously been rejected and split livers, so that one organ can be used to provide transplants
for both an adult patient and a paediatric patient. Because of the short fall between the
5number of donor organs and the number of patients on the waiting list for a transplant,
it is important that any allocation policy should aim to maximise the utility of the organ
whilst reducing the mortality of those on the waiting list. However, it is stated in Neu-
berger et al. (2008) that this may not be possible because \those who are very sick and
thus at greatest risk of death may have a worse outcome and will use more resources".
There has been much discussion lately of the most appropriate method of allocating
donor organs to transplant candidates. Freeman et al. (2009) compare the current centre-
based policy UK policy, which is described in Section 1.2.3, and the patient-based US
policy for allocating donor liver grafts. Neuberger et al. (2008) discuss the current UK
policy but do say that in the long-term the aim is \to develop a model of allocation based
on the greatest transplant benet which would take into account both the likelihood of
dying without a transplant as well as the likelihood of dying following a transplant". An
allocation policy that is based on the idea of the greatest survival benet from transplan-
tation is discussed in Schaubel (2009a). There will be more discussion of survival benet
and an associated allocation policy in Section 1.2.6. There has also been a call for more
transparency in the allocation policy in the UK by Elisabeth Buggins, Chair of the former
Organ Donation Taskforce for Department of Health, in an independent report to clarify
the rules on organ transplants for both NHS patients and non-UK EU residents.
If a policy that is based on statistical models is implemented, such as the allocation
policy based on survival benet, then the models of waiting list and post-transplant mor-
tality used will need to be as accurate as possible. This is why methods that facilitate the
implementation of good models are particularly useful, and this is part of the motivation
behind the research carried out here.
1.2.1 United Kingdom model for End-Stage Liver Disease
A model to predict the severity of a patient's ESLD for the US was developed in Weisner
et al. (2001), known as the model for end-stage liver disease or MELD. It uses three mea-
surements: serum creatinine at time of registration, serum bilirubin at time of registration
and the international normalized ratio (INR), which gives results of blood clotting tests.
This model gives a score that reects the measured level of liver dysfunction using the
formula
MELD =9:57log(creatinine(mg=dL)) + 3:78log(bilirubin(mg=dL))
+ 11:2log(INR) + 6:43: (1.2)
This score has also been found to be a signicant predictor of mortality on the waiting
list for a liver transplant.
6A similar UK model for end-stage liver disease (UKELD) is described in Barber et al.
(2007). Using an analysis of 1103 patients, the formula
UKELD =5f1:5log(INR) + 0:3log(creatinine(mol=L))
+ 0:6log(bilirubin(mol=L))   13log(Na(mmol=L)) + 70g (1.3)
was developed. It uses the same components as the MELD score as well as an additional
component, serum sodium at time of registration. A UKELD score of greater than 49,
calculated using (1.3), predicts a greater than 9% 1-year mortality. As a patient's UKELD
score increases, their 1-year mortality will also increase. Patients with a UKELD score
below 49 have a 1-year mortality of less than 9%.
The formula for the UKELD score has since been revised as is now given by
UKELD =5:395log(INR) + 1:485log(creatinine(mol=L))
+ 3:130log(bilirubin(mol=L))   81:565log(Na(mmol=L)) + 435 (1.4)
as detailed in Barber et al. (2011). However, we use (1.3) to calculate the UKELD scores
used in all the analyses in this thesis as the updated formula was not available at the time
that we carried out the analyses. To assess whether our results are likely to be greatly
aected by the use of the original UKELD score, in Section 1.2.5 we compare the values
given by (1.3) and (1.4) for the data set used in this thesis.
1.2.2 Selection criteria for transplant waiting list
Patients who require a liver transplant are either registered for a super-urgent transplant
or an elective transplant. The criteria for registration as a super-urgent transplantation
are detailed in the Protocols and Guidelines for Adults Undergoing Deceased Donor Liver
Transplantation in the UK, which is available on the NHSBT website
(http://www.nhsbt.nhs.uk/index.asp). These are not considered here as these patients will
not be included in any statistical models as they will always remain the top priority for
any donor organ that becomes available.
Also detailed in the Protocols and Guidelines for Adults Undergoing Deceased Donor
Liver Transplantation in the UK are the criteria for patients to be put on the waiting list
for an elective transplant. To be accepted for an elective liver transplant, the candidate
must have a projected 5-year survival after transplantation of at least 50%. Also, adult
patients awaiting a rst liver transplant must meet at least one of the following four
criteria:
 Chronic liver disease or failure (UKELD score of 49 or greater)
 Hepatocellular carcinoma
7 A variant syndrome
 Have been accepted through the National Appeals Panel
There are additional criteria for patients to be registered on the waiting list for an elective
transplant other than a UKELD score of 49 or greater as the UKELD score does not always
reect the need for a liver transplant. For patients with hepatocellular carcinoma, the
severity of this disease is not measured by the UKELD score so they need to be considered
separately. The UKELD score does not incorporate quality of life, so any patients that
need to receive a transplant to improve their quality of life must be considered separately.
1.2.3 Current allocation policy for donor organs
The current UK allocation policy for donor livers is summarised in Figure 1.1. The
owchart shows the order in which patients are considered when allocating a donor liver.
Figure 1.1: Flowchart showing the order of priority when allocating donor livers in the
UK. (IFALD = Intestinal Failure Associated Liver Disease)
Patients that are registered on the list for a super-urgent transplant are given the
highest priority. Organs are oered to super-urgent patients in the local area rst before
8being oered to super-urgent patients nationally. These patients are prioritised by the
time spent on the super-urgent list. So, if there are several patients on the list, the organ
will be given to the blood group compatible patient who has waited the longest.
If there are no suitable super-urgent patients or patients with intestinal failure associ-
ated liver disease on the list, then a decision needs to be made whether to split the liver
to maximise the use of the donor organ. Generally, a donor liver is considered for splitting
if the donor
 is less than 40 years old,
 weighs at least 50 kg and
 has been in intensive care for less than 5 days.
Once a decision has been made about splitting the liver, the organ will then pass to a
unit, usually starting with the unit that covers the area where the organ is being retrieved.
It is then the choice of the clinicians at this unit if there are any suitable patients registered
at that unit and which of these patients the organ should be oered to. If there are no
suitable patients at that unit, then the organ will be oered to another unit and so on in
an agreed sequence until a suitable patient is found.
1.2.4 Issues arising when modelling survival of candidates on the waiting
list for a liver transplant
The survival of adult patients on the waiting list for an elective liver transplant is of
interest here. For obvious reasons, death on the waiting list will only be observed for a
small subset of patients as the majority will be removed for transplantation and those
with a deteriorating condition are likely to be removed from the list before death.
Therefore, a large amount of censoring will be observed in this situation. Those who
are removed to receive a liver transplant are potentially informatively censored. The same
can be said of those removed due to deteriorating condition. This is reasonable as patients
who are removed for these reasons are generally the most sick on the list. They would have
a higher risk of death and therefore a lower expected survival time than those who remain
on the waiting list. This means that the estimated survival function may lie above the true
survival function if such censoring is assumed to non-informative. Therefore the estimated
probability of survival time at time t may be larger than the true survival probability at
time t, or the the estimated survival function may overestimate the true survival function.
However, if a patient is removed from the list during the study for other reasons or
because they were still active on the waiting list at the end of the study, then it will be
assumed that this censoring is non-informative. This is a reasonable assumption for these
patients as the censoring process is acting randomly here.
91.2.5 Liver Registration data set
A data set has been provided by NHSBT to illustrate the methods developed in this
thesis. It is important to note that this data set is being used to motivate and illustrate
the statistical methods and the results quoted should not be regarded as being denitive
for guiding clinical practice. The data set contains data on all adult patients who were
registered for an elective liver transplant between 1 January 2000 and 31 December 2008,
which is 4594 rows of data. There were 203 patients that had multiple lines of data as they
were re-registered for a liver transplant during this period. For example, they could have
received a donor organ which later failed and were then put back on the waiting list for
a transplant. The two registrations are then treated as two separate observations. This
information was taken from the UK Transplant Registry (UKTR) on 7 April 2009. The
date of registration on the waiting list is given along with the date of removal from the
waiting list, and details of whether this removal was due to death, transplantation or for
other reasons.
Some preliminary investigations of the data found that 39 patients were recorded as
have been transplanted a few days before their time of registration or on the date of
their registration. It was found that these patients received their transplant before their
registration details were sent to NHSBT and entered into the UKTR. Therefore, these
patients are removed from the data used here, as their time from registration to time of
transplant would be recorded as non-positive. There were also two patients who were
recorded as being registered on the list and being removed from the list on the same date,
as well as three patients who were recorded as being registered on the list on the same
day that they died. These ve patients were also removed from the data set as they would
have had an observation time of zero. This means that there were 4550 rows of data used
in the analyses here.
Many covariates are also included in the data set, the details of which are given in
Tables 1.1 to 1.9. Some of the earlier registrations in this data set do not have all the
covariates recorded as the data collected at time of registration changed over the period
under consideration.
10Variable Name Description and Details
RECIP ID Unique patient number
UNIT Anonymised transplant centre (Levels: A (n=260), B (n=725), C
(n=586), D (n=410), E (n=1109), F (n=1033), G (n=417))
ENDSTAT Code denoting the current or nal state of a registration (Levels: A
Active (n=165), S Suspended (n=2), T Transplanted (n=3498), R
Removed (n=451), D Died (n=478))
ADATE ON Date of rst active record per registration
SDATE ON Date of rst suspended record per registration
R DATE Date of removal from the transplant list
TX DATE Date of liver transplant
D DATE Date of death
RUN DATE Date registration dataset run (7 April 2009)
REG AGE Age at time of registration (Range: 17-78 years, Mean: 51.8 years)
LIV DIS Primary liver disease at time of registration (See Table 1.3)
PD CAT Primary liver disease grouped at time of registration (See Table 1.4)
PRIM COD Primary cause of death (See Table 1.5)
RCOD GRP Primary cause of death grouped (See Table 1.6)
RHEIGHT Height at time of registration (Range: 62-205 cm, Mean: 169.75 cm,
208 missing)
RWEIGHT Weight at time of registration (Range: 30-178 kg, Mean: 76.44 kg,
80 missing)
RSEX Sex (Levels: 1 Male (n=2881), 2 Female (n=1713))
RBG Blood group (Levels: 0 O (n=2053), 1 A (n=1831), 2 B (n=532), 3
AB (n=178))
RETHNIC Ethnicity (Levels: 1 White (n=4077), 2 Asian or Asian-British
(n=332), 3 Black or Black-British (n=103), 4 Chinese/Oriental
(n=34), 7 Other (n=48))
LIVER Completeness of liver transplanted (Levels: 0 Whole (n=3239), 1
Reduced (n=6), 2 Split (n=253), 1096 missing)
CREAT REG Serum creatinine at time of registration (Range: 7.6-400 mol/l,
Mean: 98.1 mol/l, 1875 missing)
INR REG INR at time of registration (Range: 1-12, Mean: 1.5, 1902 missing)
BILIRUBIN REG Serum bilirubin at time of registration (Range: 1-1270 mol/l, Mean:
98.7 mol/l, 1871 missing)
SODIUM REG Serum sodium at time of registration (Range: 105-150 mmol/l, Mean:
135.9 mmol/l, 1887 missing)
UKELD REG UKELD score at time of registration (Range: 38-83.2, Mean: 55.5,
1924 missing)
Table 1.1: The variables applicable to all patients in the Liver Registration data set and
giving details about the variables. For continuous variables the range and mean are given
and for factorial variables the levels of the factor and the number of observations at each
level are given. The number of observations missing the covariate value is also noted.
11Variable Name Description and Details
COF Cause of graft failure (See Table 1.7)
FAILDATE Date of graft failure
CREAT TX Serum creatinine at time of transplant (Range: 27-400 mol/l,
Mean: 101.1 mol/l, 1 missing)
INR TX INR at time of transplant (Range: 1-18, Mean: 1.5, 161 miss-
ing)
BILIRUBIN TX Serum bilirubin at time of transplant (Range: 2-1151 mol/l,
Mean: 96.4 mol/l, 11 missing)
SODIUM TX Serum sodium at time of transplant (Range: 112-150 mmol/l,
Mean: 136.2, 5 missing)
UKELD TX UKELD score at time of transplant (Range: 40.7-86.5, Mean:
55.0, 173 missing)
DSEX Donor sex (Levels: 1 Male (n=1835), 2 Female (n=1663))
DWEIGHT Donor weight at time of donation (Range: 22-140 kg, Mean:
74.3 kg, 6 missing)
DHEIGHT Donor height at time of donation (Range: 52-208 cm, Mean:
170.7 cm, 34 missing)
DONOR TYPE Donor type (Levels: 1 Deceased Heartbeating (n=3321), 2 De-
ceased Non-Heartbeating (n=177))
DBG Donor blood group (Levels: 0 O (n=1511), 1 A (n=1498), 2 B
(n=384), 3 AB (n=105))
DCOD Donor cause of death (See Table 1.8)
DCOD GRP Donor cause of death grouped (See Table 1.9)
DETHNIC Donor ethnicity (Levels: 1 White (n=3332), 2 Asian or Asian-
British (n=47), 3 Black or Black-British (n=35), 4 Chi-
nese/Oriental (n=8), 6 Mixed (n=15), 7 Other (n=10), 9 Un-
known (n=51))
DAGE Donor age at time of donation (Range: 5-85 years, Mean: 44.8
years, 12 missing)
Table 1.2: The variables in the Liver Registration data set that are applicable only to
patients who are transplanted. Details of these variables given, for continuous variables
these are the range and mean and for factorial variables these are the levels of the fac-
tors and the number of observations with each level of the factor. Also the numbers of
applicable patients who are missing values for these variables are given.
12Code Primary liver disease Code Primary liver disease
410 Chronic liver failure cause 442 Hepatocellular carcinoma -
unknown cirrhotic
411 Primary biliary cirrhosis 443 Cholangiocarcinoma
412 Autoimmune chronic active liver 445 Secondary hepatic malignancy
disease 447 Other primary hepatic
413 Hepatitis B cirrhosis malignancy, please specify
414 Primary sclerosing cholangitis 448 Benign liver tumour
415 Alpha-1-antitrypsin deciency 450 Other metabolic liver disease,
416 Budd-Chiari syndrome please specify
(not code 27) 451 Cystic brosis
417 Cryptogenic cirrhosis 460 Polycystic liver disease
418 Secondary biliary cirrhosis 461 Hereditary haemochromatosis
419 Alcoholic liver disease 462 Glycogen storage disease
420 Biliary atresia 471 Acute rejection
421 Congenital hepatic brosis 472 Chronic rejection
422 Wilson's Disease 473 Primary non-function
423 Congenital biliary disease 474 Acute vascular occlusion
424 Hepatitis C cirrhosis (artery plus vein)
425 Paediatric cholestatic liver 475 Non-thrombotic infarction
disease, please specify 476 Ductopenic rejection
426 Non-alcoholic fatty liver disease 477 Recurrent disease
430 Acute hepatic failure - 478 Biliary complications
serologically indeterminate 479 Hepatic artery thrombosis
434 Acute hepatic failure - 480 Early graft dysfunction
Wilson's disease 482 Acute vascular occlusion -
436 Acute hepatic failure - HBV artery and venous
437 Acute Hepatic Failure - 498 Other, please specify
paracetamol hepatotoxicity 499 Unknown
438 Acute Hepatic Failure - other
drug toxicity
888 Not reported
439 Acute Hepatic Failure - other
441 Hepatocellular carcinoma - non-
cirrhotic
Table 1.3: The codes used for dierent liver diseases
13Level Primary liver disease group
1 Primary biliary cirrhosis (PBC) (liv dis=411, n=580)
2 Primary sclerosing cholangitis (PSC) (liv dis=414, n=434)
3 Alcoholic liver disease (ALD) (liv dis=419, n=1142)
4 Auto-immune + cryptogenic disease (AID) (liv dis=412,417, n=523)
5 Hepatitis C cirrhosis (HCV) (liv dis=424, n=686)
6 Hepatitis B cirrhosis (HBV) (liv dis=413, n=162)
7 Cancers (liv dis= 441,442,443,444,445,447, n=208)
8 Metabolic liver disease (liv dis=415,422,426,434,450,456,461,462,466,
467,468, n=196)
9 Other liver diseases (liv dis=410,416,418,420,421,423,425,427,448,451,
453,455,460,484,486,498,499,888, n=489)
10 Acute hepatic failure (liv dis=428,430,435,436,437,438,439,471,472,473,
475,476,477,478,479,480,481,482,474,432, n=130)
Table 1.4: The groupings of the primary liver diseases given in Table 1.3
14Cause of death Cause of death Cause of death
0 Recipient still alive 532 Pulmonary infection 563 Bone marrow depression
500 Cause of death (viral) 564 Cachexia
uncertain 533 Pulmonary infection 566 Lymphoid malignant
511 Myocardial ischaemia (fungal) disease possibly induced by
and infarction 534 Infections elsewhere immunosuppressive therapy
512 Hyperkalaemia (except viral 567 Lymphoid malignant disease
513 Haemorrhagic hepatitis) not induced by
pericarditis 535 Septicaemia immunosuppressive therapy
514 Other causes of cardiac 536 Tuberculosis (lung) 568 Malignant disease:
failure 537 Tuberculosis lymphoproliferative disorders
515 Sudden unexplained (elsewhere) 569 Dementia
cardiac death 538 Generalized viral 570 Sclerosing (or adhesive)
516 Hypertensive cardiac infection peritoneal disease
failure 539 Peritonitis 571 Perforation of peptic ulcer
517 Hypokalaemia 541 Liver - due to 572 Perforation of colon
518 Fluid overload hepatitis B virus 573 Non-lymphoid malignant
519 Elevated
PVR/pulmonary
542 Liver - other viral
hepatitis
disease possibly induced by
immunosuppressive therapy
hypertension 543 Liver - drug toxicity 574 Non-lymphoid malignant
520 Airway dehiscence 544 Cirrhosis - not viral disease not induced by
521 Pulmonary embolus 545 Cystic liver disease immunosuppressive therapy
522 Cerebro-vascular 546 Liver failure - cause 575 Early graft dysfunction
accident unknown 576 Cardiac tamponade
523 Gastro-intestinal 547 Renal failure 577 ARDS
haemorrhage 548 Recurrent primary 578 Respiratory failure
524 Haemorrhage disease - benign 579 Multi-system failure
from graft site 549 Recurrent primary 581 Accident related to treatment
525 Haemorrhage from disease - malignant 582 Accident unrelated to
vascular access or 551 Patient refused treatment
dialysis circuit further treatment 590 Donor organ failure
526 Haemorrhage from 552 Suicide 595 Other identied cause of
ruptured vascular 553 Therapy ceased for death
aneurysm any other reason 598 Other identied cause of
527 Haemorrhage from 554 ESRF treatment death
surgery withdrawn for 599 Unknown
528 Other haemorrhage medical reasons 888 Cause of death not requested
529 Mesenteric infarction 561 Uraemia caused by
530 Pulmonary infection graft failure
(protozoal) 562 Pancreatitis
531 Pulmonary infection
(bacterial)
Table 1.5: The codes for the primary cause of death for patients on the waiting list for a
liver transplant
15Code(s) Cause of death group Code(s) Cause of death group
500 Cause of death uncertain 561 Uraemia caused by
511 Myocardial ischaemia and graft failure
infarction 562 Pancreatitis
512 Hyperkalaemia 563 Bone marrow depression
513-518 Cardiac - miscellaneous 564 Cachexia
519 Elevated PVR 566-567 Lymphoma
520 Tracheal dehiscence 569 Dementia
521 Pulmonary embolus 570 Sclerosing (or adhesive)
522 Cerebro-vascular accident peritoneal disease
523 Gastro-intestinal 571 Perforation of peptic ulcer
haemorrhage 572 Perforation of colon
524-528 Haemorrhage - 573-574 Non-lymphoid malignant
miscellaneous disease
529 Mesenteric infarction 575 Early graft dysfunction
530-533 Pulmonary infection 576 Cardiac tamponade
534,536-539 Infection - miscellaneous 577 Ards
535 Septicaemia 578 Respiratory failure
541-546 Liver disease 579 Multi-system failure
547 Renal Failure (not kidney 581 Accident related to
recipients) treatment
548 Recurrent primary disease
- benign
582 Accident unrelated to
treatment
549 Recurrent primary disease 590 Donor organ failure
- malignant 595,598 Other identied cause of
551 Patient refused further death
treatment 599 Unknown
552 Suicide
553 Therapy ceased for any
other reason
Table 1.6: The grouped causes of death for patients on the waiting list for a liver transplant
Code Cause of graft failure Code Cause of graft failure
0 Graft still functioning 470 Recurrent disease
410 Acute rejection 480 Biliary complications
420 Chronic rejection 490 Recip. died, graft still
430 Primary non-functioning functioning at T.O.D.
440 Acute vascular occlusion 495 Other
441 Vascular occlusion 498 Other, please specify
450 Non-thrombotic infarction 499 Unknown
460 Ductopenic rejection
Table 1.7: The codes for causes of graft failure
16Code Cause of death Code Cause of death
0 Living donor 51 Pneumonia
10 Intracranial haemorrhage 52 Asthma
11 Intracranial thrombosis 53 Respiratory failure
12 Brain tumour 54 Carbon monoxide poisoning
13 Hypoxic brain damage - all
causes
59 Respiratory - type unclassied
(inc smoke inhalation)
19 Intracranial - type unclassied 60 Cancer (other than brain
(CVA) tumour)
20 Trauma RTA - car 70 Meningitis
21 Trauma RTA - motorbike 71 Septicaemia
22 Trauma RTA - pushbike 72 Infections - type unclassied
23 Trauma RTA - pedestrian 73 Acute blood loss/hypovolaemia
29 Trauma RTA - unknown type 74 Liver failure (not self poisoning)
30 Other trauma - known or 75 Renal failure
suspected suicide 76 Multi-organ failure
31 Other trauma - accident 77 Sudden Infant Death Syndrome
39 Other trauma - unknown cause (SIDS)
40 Cardiac arrest 80 Alcohol poisoning
41 Myocardial infarction 81 Paracetamol overdose
42 Aneurysm 82 Other drug overdose
43 Ischaemic heart disease 85 Self poisoning - type unclassied
44 Congestive heart failure 88 Not reported
45 Pulmonary embolism 90 Other identied cause of death
49 Cardiovascular - type 98 Other identied cause of death
unclassied 99 Unknown
50 Chronic pulmonary disease
Table 1.8: The codes for donor cause of death
Code Donor cause of death group
0 Live
10-11,19 CVA
12,13,40-45,49,50-54,59,60 Miscellaneous
70-77,80-82,85,88,90,98,99 Miscellaneous (continued)
20-23,29 RTA
30,31,39 Other trauma
Table 1.9: The donor cause of death groups
17Initial data analysis
In this section, some initial data analysis on the Liver Registration data set is carried
out assuming all the censoring in the data set is non-informative. Firstly, Kaplan-Meier
estimates of the survival functions for time to death and time to censoring are obtained.
Then the signicant variables for both time to death and time to censoring are identied.
Figures 1.2 and 1.3 are plots of the Kaplan-Meier estimates of the survival functions
for time to death and time to censoring respectively. The estimated median time to death
is 1194 days and the estimated median time to censoring is 97 days. This shows that
patients who are censored tend to spend less time on the list than those who die while on
the waiting list.
Figure 1.2: The Kaplan-Meier estimate of the survival function for time to failure
Tables 1.10 and 1.11 contain the results of Cox proportional hazards models for time to
death and time to censoring for the Liver Registration data set. The general proportional
hazards model is given by
hi(t) = exp(1x1i + 2x2i + ::: + pxpi)h0(t);
where  is the vector of parameters of the explanatory variables x1;x2;:::;xp included
in the model and h0(t) is the baseline hazard function. When tting the proportional
hazards model proposed by Cox (1972), no assumptions are made about the baseline
hazard function and only  is estimated. The variables that are signicant for time to
death under the Cox proportional hazards model are
 UKELD score at time of registration,
18Figure 1.3: The Kaplan-Meier estimate of the survival function for time to censoring
 primary liver disease category,
 age at time of registration,
 ethnicity,
 serum sodium at time of registration and
 INR at time of registration.
The variables that are signicant for time to censoring under the Cox proportional hazards
model are
 UKELD score at time of registration,
 primary liver disease category,
 height at time of registration and
 blood group.
Parametric survival models will also be used in some of the methods reviewed in Chap-
ter 3 so the exponential proportional hazards model is also tted to the Liver Registration
data set. This model has the form
hi(t) = exp( + 1x1i + 2x2i + ::: + pxpi);
where  is the intercept parameter. The results of the exponential proportional hazards
model for time to death and time to censoring are given in 1.12 and 1.13 respectively. The
19variables that are signicant for time to death under the exponential proportional hazards
model are
 UKELD score at time of registration,
 primary liver disease category,
 age at time of registration and
 ethnicity.
The variables that are signicant for time to censoring under the exponential proportional
hazards model are
 UKELD score at time of registration,
 primary liver disease category,
 height at time of registration and
 blood group.
The results from the Cox proportional hazards models and exponential proportional
hazards models are similar, as the models being tted are both variations of the general
proportional hazards model. The main dierence is that the Cox proportional hazards
model for time to death includes serum sodium and INR at time of registration as well.
This suggests that some changes should be made to the UKELD score as these two variables
are components of the UKELD score. But, as discussed in Section 1.2.1, we are using the
original UKELD score which has since been revised, so this is not too surprising.
The four main covariates for time to death, UKELD score, age, primary liver disease
category and ethnicity were examined, and it was found that only 2650 rows of data had
full information for these covariates. If the two additional covariates that are signicant
for time to censoring, height and blood group, are also examined, then only 2605 rows of
data had full covariate information. We will ignore any observations that do not have full
covariate information. There are other methods of dealing with missing data that would
be preferable but the aim here is to deal with the issue of informative censoring.
UKELD Score
As discussed in Section 1.2.1, the UKELD score used in our analyses is calculated using
(1.3). However, this UKELD score has since been revised and is now given by (1.4). To
asses how much change this causes in the UKELD score, the original value from (1.3)
and the revised value from (1.4) are plotted against each other for each individual in the
20Parameter Estimate Standard p-value Hazard
Error Ratio
UKELD score 0.25126 0.01868 < :0001 1.286
PLD - PBC -0.04365 0.34301 0.8987 0.957
PLD - PSC -0.60813 0.38124 0.1107 0.544
PLD - ALD -0.13828 0.32027 0.1864 0.871
PLD - AID 0.17176 0.33786 0.6112 1.187
PLD - HCV 0.59734 0.33487 0.0745 1.817
PLD - HBV 0.02856 0.50702 0.9551 1.029
PLD - Cancer -1.09539 0.77467 0.1574 0.334
PLD - Metabolic 0.95969 0.36540 0.0086 2.611
PLD - Other 0.47124 0.34028 0.1661 1.602
PLD - Acute 0
Age 0.02946 0.00587 < :0001 1.030
Ethnicity - White 1.26645 1.00791 0.2089 3.548
Ethnicity - Asian 0.34320 1.04198 0.7419 1.409
Ethnicity - Black 1.25277 1.09829 0.2540 3.500
Ethnicity - Chinese -0.41759 1.43131 0.7705 0.659
Ethnicity - Other 0
Serum Sodium 0.06060 0.01644 0.0002 1.062
INR -0.22431 0.09654 0.0202 0.799
Table 1.10: Results for Cox model for time to death tted to the Liver Registration data
set assuming non-informative censoring
21Parameter Estimate Standard p-value Hazard
Error Ratio
UKELD score 0.02680 0.00471 < :0001 1.027
PLD - PBC -0.05982 0.14472 0.6793 0.942
PLD - PSC -0.03346 0.14420 0.8165 0.967
PLD - ALD -0.24277 0.13282 0.0676 0.784
PLD - AID -0.15159 0.14348 0.2907 0.859
PLD - HCV 0.08462 0.13807 0.5399 1.088
PLD - HBV 0.05300 0.17830 0.7663 1.054
PLD - Cancer 0.46530 0.15586 0.0028 1.592
PLD - Metabolic -0.04300 0.16682 0.7966 0.958
PLD - Other -0.32864 0.14746 0.0258 0.720
PLD - Acute 0
Height 0.00953 0.00252 0.0002 1.010
Blood Group - O -0.58504 0.11535 < :0001 0.557
Blood Group - A -0.24982 0.11493 0.0297 0.779
Blood Group - B -0.21245 0.12788 0.0967 0.809
Blood Group - AB 0
Table 1.11: Results for Cox model for time to censoring tted to the Liver Registration
data set assuming non-informative censoring
22Parameter Estimate Standard p-value Hazard
Error Ratio
Intercept -19.9758 1.2216 < 0:0001 2  10 9
UKELD score 0.1854 0.0091 < :0001 1.204
PLD - PBC -0.1346 0.3389 0.6913 0.874
PLD - PSC -0.6234 0.3789 0.0999 0.536
PLD - ALD -0.3441 0.3100 0.2671 0.709
PLD - AID 0.0113 0.3308 0.9727 1.011
PLD - HCV 0.4000 0.3263 0.2204 1.492
PLD - HBV 0.0276 0.5065 0.9566 1.028
PLD - Cancer -1.4751 0.7661 0.0542 0.229
PLD - Metabolic 0.6556 0.3554 0.0650 1.926
PLD - Other 0.3188 0.3368 0.3439 1.375
PLD - Acute 0
Age 0.0287 0.0059 < 0:0001 1.029
Ethnicity - White 1.1834 1.0082 0.2405 3.265
Ethnicity - Asian 0.2172 1.0445 0.8353 1.243
Ethnicity - Black 0.9603 1.1196 0.3910 2.612
Ethnicity - Chinese -0.5219 1.4282 0.7148 0.593
Ethnicity - Other 0
Table 1.12: Results for an exponential proportional hazards model for time to death tted
to the Liver Registration data set assuming non-informative censoring
23Parameter Estimate Standard p-value Hazard
Error Ratio
Intercept -8.1525 0.5266 < 0:0001 0.0003
UKELD score 0.0312 0.0047 < 0:0001 1.032
PLD - PBC -0.0115 0.1451 0.9368 0.989
PLD - PSC 0.0080 0.1447 0.9557 1.008
PLD - ALD -0.2159 0.1334 0.1056 0.806
PLD - AID -0.1179 0.1440 0.4129 0.889
PLD - HCV 0.1354 0.1387 0.3288 1.145
PLD - HBV 0.1004 0.1786 0.5741 1.106
PLD - Cancer 0.5487 0.1564 0.0004 1.731
PLD - Metabolic -0.0114 0.1675 0.9460 0.989
PLD - Other -0.3300 0.1485 0.0262 0.719
PLD - Acute 0
Height 0.0108 0.0025 < 0:0001 1.011
Blood Group - O -0.6175 0.1158 < 0:0001 0.539
Blood Group - A -0.2588 0.1156 0.0251 0.772
Blood Group - B -0.2077 0.1287 0.1066 0.812
Blood Group - AB 0
Table 1.13: Results for an exponential proportional hazards model for time to censoring
tted to the Liver Registration data set assuming non-informative censoring
24Liver Registration data set. This scatterplot can be seen in Figure 1.4. We can see that
apart from a few individuals, the original UKELD score and the revised UKELD score are
almost identical. Therefore our results should not be greatly aected by the use of the
original UKELD score rather than the revised UKELD score.
Figure 1.4: Scatterplot comparing the values of the original UKELD score given by (1.3)
with the values of the revised UKELD score given by (1.4) for all individuals in the Liver
Registration data set for whom the necessary component values are available.
1.2.6 Survival benet
An important concept for the analysis of transplantation data is that of survival benet.
This quanties the dierence in survival between patients who received a transplant and
similar patients who remained on the waiting list. From this it is possible to identify the
patients who benet most from liver transplantation and those that should remain on the
waiting list at the present time. This approach was introduced in the USA by Merion
et al. (2005), and subsequently there have been many analyses that use the concept of
survival benet.
The majority of the analyses use the covariate-adjusted hazard ratio for transplantation
compared to not receiving a transplant to quantify the survival benet of liver transplan-
tation. Merion et al. (2005) use a time-dependent Cox regression model to calculate this
hazard ratio. However, all the later analyses use the method of sequential stratication,
introduced in Schaubel et al. (2006), which has been shown to give parameter estimates
which can be more easily interpreted. As stated in Schaubel et al. (2008), sequential
stratication is an \extension of Cox regression for evaluating time-dependent treatments
25in the presence of time-dependent patient characteristics". This method creates a stratum
each time a patient is transplanted and compares their survival with that of similar candi-
dates who were active on the waiting list at the time. The experience from each stratum
is aggregated to estimate the regression parameters using a Cox model.
The method is extended to deal with issues specic to liver transplantation, such as
dependent censoring, in Schaubel et al. (2009b). This is covered in more detail in Chapter
6 where the method is applied to the Liver Registration data set. The contributions of
each patient are weighted by the inverse of the probability of remaining untransplanted to
account for the under-representation due to dependent censoring. This is one application
of the well-established method known as inverse probability of censoring weighting (IPCW)
which was introduced in Robins and Rotnitzky (1992) and is explained in more detail in
Section 3.1.
It was established that overall, liver transplantation gives a signicant survival benet.
However, patients have dierent severities of disease, as indicated by the MELD score,
which is given in (1.2). The MELD score quanties the level of organ dysfunction. A high
MELD score indicates a high level of organ dysfunction. It has been shown by Merion et
al. (2005) that survival benet is not distributed evenly across subgroups of MELD scores.
Those with high MELD scores have the greatest survival benet from liver transplantation.
In comparison, patients with fairly low MELD scores have a higher mortality risk post-
transplant compared to remaining on the waiting list, and so they have a negative survival
benet from liver transplantation.
Donor factors should also be considered when computing the survival benet as they
eect the post-transplant mortality of recipients. The Donor Risk Index(DRI) can be used
to measure the quality of the donor organ. Schaubel et al. (2008) carried out an analysis
to compute the survival benet for dierent levels of MELD scores and DRI. The patients
with the highest MELD scores still receive a signicant survival benet, irrespective of
the quality of the organ received. Those patients with a low MELD score who receive a
high DRI liver have a signicantly higher mortality risk than comparable patients who
remain on the waiting list and possibly receive a better quality liver later. These results
are especially worrying when the current organ allocation policy in the USA is considered.
Patients with low MELD scores are generally given high DRI livers, so that the best
quality organs can be given to the patients deemed to be the sickest. As shown by Volk et
al. (2008), this has led to a small but signicant decrease in the post-transplant survival
of patients with low MELD scores.
More recently, analyses of the survival benet for patients with specic diagnoses have
been carried out in Lucey et al. (2009). Also the eect of individual components of the
MELD score on survival benet is computed in Sharma et al. (2009).
26Using survival benet to allocate donor livers One of the recent developments
in the survival benet literature is the application of survival benet to the allocation
of deceased-donor livers. This was rst presented in Schaubel et al. (2009a). Here the
denition of survival benet is dierent from that given in the papers considered previously.
This is to allow individual patients to be ranked in order of priority for a donor organ
according to a benet score. The benet score is the candidate's 5-year mean lifetime with
a transplant(from the organ under consideration) minus their 5-year mean lifetime without
a transplant. An individual's 5-year mean lifetime is the area under the individual's
survival curve out to 5 years, where the survival curve is found using a Cox model. In
this approach, waiting list survival and post-transplant survival are modelled separately.
Post-transplant survival is modelled using covariate-adjusted Cox regression. The model
for waiting list survival is based on the sequential stratication approach. However, the
paper giving the exact details of this method is yet to be published.
There have also been several articles that provide a critical analysis of the proposal
to use survival benet for donor liver allocation. The need for a high level of accuracy
in the estimation of both pre- and post-transplant survival is highlighted by Kim and
Kramers (2008). Some ethical questions are raised in Asrani et al. (2009); is it fair to
give all patients with a certain diagnosis a lower priority just because a few will have a
severe recurrence of the disease? Asrani at al. (2009) also discuss the limitations of the
analyses that have been carried out so far. As all the analyses have been carried out on
observational data, it is highly likely that there is a selection bias present in the data.
This is because there are many factors that aect the matching of patients with donor
organs that cannot be quantied in statistical modelling. Therefore even if an allocation
policy that uses statistical models is implemented to assist with the selection of patients
to be transplanted with a particular donor organ, the nal decision on the suitability of a
patient must belong to the clinicians.
1.3 Outline of Thesis
Chapters 2 and 3 provide a review of the methods in the literature that have been suggested
to incorporate informative censoring into models. The most relevant methods are applied
to the Liver Registration data set so that the results from the contrasting methods can
be compared. Chapter 2 looks at estimators of the survival function that are used to give
bounds on the possible values of the estimated survival function assuming informative
censoring. The estimators in this chapter are some of the rst estimators presented in the
literature to allow for informative censoring. As the estimators in Chapter 2 give bounds
27that are too wide to be of practical use, we review some of the more recent methods from
the literature in Chapter 3. These can be split into two categories: estimators that use
models of the censoring process and sensitivity analyses. The most popular of the methods
in the former category is reweighting the estimators, particularly inverse probability of
censoring weighted estimators. There are sensitivity analyses presented in Chapter 3 for
both the Cox model and parametric survival models. These methods estimate the change
in the parameter estimates in the model if informative censoring is assumed instead of non-
informative censoring. The methods that use parametric models are less computationally
intensive but lack the exibility of the methods that use the Cox model.
Chapters 4 and 5 show the development of a new sensitivity analysis methodology that
can generally be applied to any situation where there is potentially informative censoring.
It uses piecewise exponential models, which means the method is computationally simple
but more exible than the method that uses standard parametric models. It is an extension
of one of the sensitivity analysis methods detailed in Chapter 3. The derivation of the
method is shown in Chapter 4, along with its application to the Liver Registration data
set. A simulation study is carried out to test the accuracy of this new methodology and
this is detailed in Chapter 5. This allows us to identify the situations where the sensitivity
analysis is least accurate. An extension of the sensitivity analysis is presented to try and
overcome these identied limitations.
Finally, in Chapter 6, a method that is of interest to NHSBT is detailed, that allows the
survival benet of groups of patients of interest to be calculated by comparing survival on
the waiting list with survival after transplantation. This method has already been applied
to US data, but we suggest some changes to the method and then apply it to the Liver
Registration data set. The method overcomes any potentially informative censoring in the
data set by using inverse probability of censoring weighted estimators, which are described
in Chapter 3. There will also be a concluding chapter that summarises the main ndings
and shortcomings of this work and also describes further work that could be carried out.
28Chapter 2
Bounds on the Marginal Survival
Function under Informative
Censoring
The rst approaches that account for potentially informative censoring in data sets derive
estimators that are extensions of the Kaplan-Meier estimator. Because of this they cannot
incorporate covariates unless the variables have a very simple structure. Generally these
estimators are used to provide bounds on the marginal survival function. These bounds
tend to be quite wide despite eorts to derive tighter bounds.
Here a review of these methods is presented, in the order that they were published,
so that it is possible to see the improvements in the methods. The estimators that are
considered suitable are applied to the Liver Registration data set so that results obtained
using the dierent methods can be contrasted. As this is a review chapter, all the methods
discussed can be found in the literature and are presented here in consistent notation.
Unless otherwise stated, the original work in this chapter is the application of the methods
to the Liver Registration data set.
The estimators here use a variety of assumptions about the conditional distribution of
the failure time variable given the censoring time variable to make the joint distribution
of the two variables identiable. These range from non-parametric methods to using a
copula to specify the joint distribution of the variables. A section on copulas is included,
detailing some of the more common forms used.
2.1 Measuring Dependence between Variables
When estimators are being compared, it is important that they assume the same amount of
dependence between the time to censoring and time to failure variables so that meaningful
29comparisons can be made. As the estimators use dierent parameters to control the
dependence then, where possible, the relationship between these parameters and a widely
used measure of dependence between two variables should be established. The measure of
dependence that has been chosen for this is Kendall's  which is a measure of concordance.
The denition presented here is taken from Nelsen (1999). A pair of random variables are
said to be concordant if large values of one variable are associated with large values of
the other variable, and small values of one are associated with small values of the other.
So, if there are two observations (xi;yi) and (xj;yj) from the random vector (X;Y ), then
they are concordant if xi < xj and yi < yj, or if xi > xj and yi > yj. Similarly, they are
discordant if xi < xj and yi > yj, or if xi > xj and yi < yj. If xi = xj or yi = yj, then the
pair is neither concordant nor discordant.
To be able to express the concordance measure, rstly a concordance function, Q, needs
to be dened. This is the dierence of the probability of concordance and the probability
of discordance between two vectors (X1;Y1) and (X2;Y2) with joint distribution functions
H1 and H2, but common margins. So,
Q(H1;H2) = P[(X1   X2)(Y1   Y2) > 0]   P[(X1   X2)(Y1   Y2) < 0]: (2.1)
The population version of Kendall's  for random vectors (X1;Y1) and (X2;Y2), is the
concordance function Q, given in (2.1), but assuming the same joint distribution function
H for each of the random vectors. So,  can be expressed as
 = Q(H;H) = 4
ZZ
<2
H(x;y)dH(x;y)   1;
as shown in Nelson (1999).
So that sensible values of Kendall's  to be used here can be established, the relation-
ship between this and the parameter , which we introduce in Section 3.3, will be found.
The parameter  is used here because the sensitivity analysis that uses this parameter is
considered in detail in Chapter 4, so a sensible range of values for  is established. We nd
that  = =2 when using an approximation to the joint density function. When tting the
model that incorporates informative censoring to the Liver Registration data set, the 95%
condence interval obtained for  is (0.1388,0.4163), so  = 0:2 will be used as the upper
limit for Kendall's  here. However, the dependence assumption that was used to obtain
this interval for  cannot be checked so it is possible that a larger value of Kendall's 
should be used.
For some of the estimators presented here it is not possible to relate their parameter
directly to Kendall's . In these cases a parameter value that gives an estimator with
the same median value as an estimator for which the parameter can be directly related to
Kendall's  is chosen.
302.2 Fisher-Kanarek Estimator
Fisher and Kanarek (1974) present a non-parametric method that estimates the survival
function without consideration of covariates. The method allows for both informative
and non-informative censoring within the same data set. In the case of no informative
censoring the Kaplan-Meier estimate of the survival curve results.
The following model presented is non-parametric with the exception of the parameter
 which either expands or contracts the residual lifetime after informative censoring. The
assumption of the dependence between survival time T and informative censoring time CI
used is
P(T > tjCI = c < t) = P(T > c + (t   c)jCI > c + (t   c)): (2.2)
If  > 1, then it is the patients with a poorer prognosis who are censored, and  < 1 means
it is the patients with a favourable prognosis who drop out. If  = 1 then censoring has
no eect on expected survival and corresponds to the independent censoring case. This
means the Kaplan-Meier estimate will be appropriate.
As there are three possible times that can be observed for each of the i = 1;2;:::;n
individuals, there are three variables:
 ~ T, the survival time if it is less than the censoring time, which has survival function
P(~ T > t) = S ~ T(t)
 CI, the censoring time that shall be considered informative, where individuals are
lost to follow-up, which has survival function P(CI > t) = SCI(t), and
 CE, the censoring time that will be considered independent of failure time, such as
end of study censoring, which has survival function P(CE > t) = SCE(t).
The survival function S(t) of the \true" survival time T is the function that will
be estimated here. The survival time, T, will be equal to ~ T if ~ T  CI, otherwise the
assumption in (2.2) is used. This means that S(t) is related to S ~ T(t) and SCI(t) by the
following relationship
S(t) = P(T > tjCI > t)P(CI > t)
+
Z t
0
P(T > t0jCI = t0)P(T > tjT > t0;CI = t0)dP(CI  t0)
= S ~ T(t)SCI(t) +
Z t
0
S ~ T(t0 + (t   t0))d( SCI(t0)): (2.3)
So to estimate the survival function S(t), estimates of S ~ T(t) and SCI(t) need to be obtained
and then substituted into (2.3).
31The data observed are Yi = min(~ Ti;CIi;CEi) and the indicator functions
i; ~ T =
8
<
:
1; if ~ Ti < min(CIi;CEi)
0; otherwise
i;CI =
8
<
:
1; if CIi  ~ Ti;CIi < CEi
0; otherwise
and
i;CE =
8
<
:
1; if CEi < min(~ Ti;CIi)
0; otherwise:
Let Y(i) be the corresponding order statistics and (i); ~ T, (i);CI and (i);CE the indicator
functions relating to these order statistics. The maximum likelihood estimates of S ~ T(t),
SCI(t) and SCE(t) are then given by
^ S ~ T(t) =
Y
i=1;2;:::;k

n   i
n   i + 1
(i); ~ T
where Y(k)  t < Y(k+1)
^ SCI(t) =
Y
i=1;2;:::;k

n   i
n   i + 1
(i);CI
where Y(k)  t < Y(k+1)
and ^ SCE(t) =
Y
i=1;2;:::;k

n   i
n   i + 1
(i);CE
where Y(k)  t < Y(k+1): (2.4)
So the maximum likelihood estimate of S(t) is given by
^ S(t) = ^ S ~ T(t)^ SCI(t) +
Z t
0
^ S ~ T(t0 + (t   t0))d( ^ SCI(t0)) (2.5)
where ^ S ~ T(t) and ^ SCI(t) are the product-limit estimates dened in (2.4).
As the data give no information about the value of , assumed values of  should be
used. These can be used to see how robust the assumption of non-informative censoring
is. If a large value of  is used, then the true marginal survival distribution should lie
somewhere in the region between the Fisher-Kanarek estimator and the Kaplan-Meier
estimator. However, this is not guaranteed as this method does not provide true bounds
on the marginal survival function.
2.3 Peterson Bounds on the Survival Function
Methods that give denite bounds on the survival function are now considered, but these
methods only allow for one type of censoring. So even if we have end of study censoring,
it has to be treated as possibly informative censoring in these methods.
32Peterson (1976) gives bounds for a joint survival function G(t1;t2) = P(T > t1;C > t2)
and the marginal survival functions ST(t) and SC(t). The estimated survival function of
the variable T is of interest, so the bounds for the marginal survival function ST(t) are
obtained. These are given by
S
T(t) + S
C(t)  ST(t)  S
T(t) + (1   p1) (2.6)
where
S
T(t) = P(T > t;T < C);
S
C(t) = P(C > t;C < T)
and 1   p1 = 1   P(T < C) = P(C < T):
The observed data are Yi = min(Ti;Ci) and i = I(Yi = Ti) for i = 1;2;:::;n. The
empirical estimators of the marginal survival functions are used as they are consistent
estimators, where
^ S
T(t) =
1
n
n X
i=1
I[Yi  t;i = 1]
and ^ S
C(t) =
1
n
n X
i=1
I[Yi  t;i = 0]:
The empirical estimator of (1   p1) is also used, which is given by
1   ^ p1 =
1
n
n X
i=1
I[i = 0]:
If these terms are substituted into (2.6) then consistent estimators of the bounds for ST(t)
can be obtained. After a little algebra they become
1
n
n X
i=1
I[Yi  t]  ST(t) 
1
n
n X
i=1
I[Yi  t] +
1
n
n X
i=1
I[Yi < t;i = 0]: (2.7)
2.4 Slud-Rubinstein Bounds on the Survival Function
Slud and Rubinstein (1983) also derive bounds for the survival function ST(t) but their
bounds can be tighter than those given by Peterson (1976). They make a nonparametric
assumption on the joint density f(t;c) of (T;C),
lim
!0
P(t < T < t +  jT > t;C  t)
P(t < T < t +  jT > t;C > t)
= (t) (2.8)
where (:) is a known function of t. This means that (t) is the amount that the conditional
death hazard at time t diers by, according to whether the individual is censored before
33or after t. So  = 1, corresponds to the independence assumption. If (t) > 1 for all t,
then there is positive dependence between T and C and similarly if  is always below 1,
then there is negative dependence between failure and censoring.
If we assume that (:) is known, then there is a consistent estimator of the marginal sur-
vival function ST(t) which generalises the Kaplan-Meier estimator. Again Yi = min(Ti;Ci)
and i = I(Yi = Ti) for i = 1;2;:::;n are observed. Let Y(1)  :::  Y(d) be the ordered
failure times, when there are d observations with i = 1. Let the number of observations
censored between Y(j) and Y(j+1) be cj, with c0 censored before the rst failure time. The
number of individuals with Yi  Y(j) is dened to be nj.
The product-limit estimator for ST(t) proposed in Slud and Rubinstein (1983) is
^ S(t) =
1
n
8
<
:
n(t) +
d(t) 1 X
k=0
ck
d(t) Y
i=k+1
ni   1
ni + i   1
9
=
;
; (2.9)
where
n(t) =
X
i
I(Yi  t); d(t) =
X
i
I(Yi  t;i = 1) and i = (Y(i)):
After some algebra, this becomes
^ S(t) =
d(t) Y
i=1
ni   1
ni + i   1
+
1
n
d(t) X
k=1
(k   1)
d(t) Y
i=k
ni   1
ni + i   1
: (2.10)
When (:) = 1, ^ S is exactly the Kaplan-Meier estimator.
From (2.9), we see that for xed t, ^ S(t) is a decreasing function of , so as  increases,
the value of ^ S at time t decreases. Bounds for the function (:), as dened as in (2.8),
can be assumed and if the true value of the function does lie between the bounds 1(:)
and 2(:), then for suciently large samples
^ S2(t)  S(t)  ^ S1(t): (2.11)
This can be used to give bounds on the survival function which are tighter than those
given in Peterson (1976), which correspond to (2.11) with 1 = 0 and 2 = 1. However,
as there is no information available on the value of  from the observed data, it is not
possible to identify whether the bounds assumed contain the true value of . This limits
the usefulness of this method in a practical setting.
2.5 Klein-Moeschberger Bounds on the Survival Function
Klein and Moeschberger (1988) also present bounds on the survival function ST(t) that are
tighter than those of Peterson (1976). However they make a dierent assumption about the
34dependence between the failure and censoring times. As previously, the marginal survival
functions of T and C are ST(t) and SC(t) respectively. The joint survival function of T
and C, G(t1;t2) = P(T > t1;C > t2) is expressed as
G(t1;t2) =
(
1
ST(t1)
 1
+

1
SC(t2)
 1
  1
)  1
 1
(2.12)
for   1. This model for the joint distribution of T and C was rst introduced in Clayton
(1978) to model association in bivariate lifetimes. It is also used to model bivariate survival
data in Oakes (1982). The model in (2.12) can be interpreted in terms of the hazard
functions
hT(tjC = c) = lim
!0

P(t  T < t + jC = c;T  t)


and
hT(tjC > c) = lim
!0

P(t  T < t + jC > c;T  t)


:
Using (2.12), we obtain
hT(tjC = c) = hT(tjC > c): (2.13)
This means that for  > 1, the hazard rate of death, if censoring happens at time c, is the
hazard rate of death if censoring had not occurred multiplied by . So the hazard rate if
censoring does occur will be greater than the hazard rate if censoring does not occur, as it
has been accelerated by a factor of . Therefore this only allows for positive dependence
between T and C. This is not a problem for the data set under consideration here, as it
is suspected that the dependence between T and C is positive.
Klein and Moeschberger (1988) show that  = ( 1)=(+1). Since   1,  can only
take values between 0 and 1.
If T and C have joint survival function (2.12), then the observed value Y = min(T;C)
has survival function
F(t) =
(
1
ST(t)
 1
+

1
SC(t)
 1
  1
)  1
 1
:
This is a reasonable choice for the joint distribution function of T and C as it is used to
model bivariate survival data in Oakes (1982). It is also related to the Clayton copula
function given in Table 2.1, which seems to be a reasonable choice of copula family, as we
will discuss in Section 2.10.1. The marginal distribution function of T is also required,
which is dened as
Q1(t) = P(Y < t;T < C):
These functions are estimated directly from the observed data, Yi = min(Ti;Ci) and
i = I(Yi = Ti) for i = 1;2;:::;n, using
^ F(t) =
n X
i=1
I(Yi  t)
n
and ^ Q1(t) =
n X
i=1
I(Yi  t;i = 1)
n
:
35Then, if  is known and the underlying joint survival of (T;C) is given by (2.12), a
consistent estimator of ST(t), given in Klein and Moeschberger (1988), is ^ S(t) where
^ S(t) =
8
> > > > > > > > <
> > > > > > > > :
(
1 + (   1)
Z t
0
d ^ Q1(u)
[ ^ F(u)]
)  1
 1
if  > 1
exp
"
 
Z t
0
d ^ Q1(u)
^ F(u)
#
if  = 1.
(2.14)
Upper and lower bounds on ST(t) can be found by letting  ! 1+ and  ! 1
respectively. This gives an upper bound which corresponds to independence between T
and C and a lower bound which is the same as that of both Peterson (1976) and Slud and
Rubinstein (1983). So,
F(t)  ST(t)  exp

 
Z t
0
F 1(u)dQ1(u)

:
It is possible to set up tighter bounds on the survival function using the same method
as Slud and Rubinstein (1983). A possible range of values for , (1;2) is specied. If the
sample size is suciently large and 1    2, then ^ S1(t)  S(t)  ^ S2(t).
2.6 Applying Methods to Liver Registration
Dataset
Firstly, the Fisher-Kanarek estimator is tted to the Liver Registration data set. As
it is believed that the transplant candidates with the poorest prognosis that are being
censored, then it is assumed that  is greater than 1 when obtaining an estimate of the
survival function. More specically,  = 3 is chosen. This is the value of  that gives
the estimator the same median value as the Klein-Moeschberger estimator for this data
set with Kendall's  = 0:2. The estimate for the independent case ( = 1), which is
the Kaplan-Meier estimate of the survival function, is also obtained to see how close the
other estimates are. These are given in Figure 2.1. From this we see that as  increases,
the estimate of the survival function decreases more quickly. This is expected as we are
adjusting for patients who survive for progressively shorter times after censoring. Also,
there can be a rather large dierence between the Fisher-Kanarek estimate of the survival
function and the Kaplan-Meier estimate.
Drawbacks of this method When the largest observation time in a data set, t, is
censored, the Kaplan-Meier estimate of the survival function cannot be dened beyond
this time. As stated in Kaplan and Meier (1958), the estimated survival function beyond
36Figure 2.1: Plot of Fisher-Kanarek estimators of the marginal survival function for T for
 = 1and3
time t will lie somewhere between ^ S(t) and 0, but it is not possible to dene it any
more precisely. However, Fisher and Kanarek have disregarded this when presenting their
estimates of the survival function. In their simulated data set, they observed 44 deaths
with times between .01 and .58, 34 non-informative censoring times between .01 and .67
and 22 informative censoring times between .03 and .72. Therefore, their last observation
must be censored. So, the product-limit estimate of S ~ T should not be dened beyond .72.
Fisher and Kanarek do not explicitly state that they assume a value for S ~ T beyond this
time, but they present estimates of S(t) up until time 1 when  > 1. This means that
they must have dened S ~ T beyond .72 so that the integral in (2.5) can be evaluated.
In the Liver Registration data set, the last observation is a censored one at time 1265.
This means that here S ~ T should not be dened beyond this time. However, we assume
that beyond time 1265, S ~ T remains at the same value that it has at time 1265. This is
why we observe the strange behaviour of the Fisher-Kanarek estimator at around time
400 in Figure 2.1. It is for this reason that use of this estimator is not recommended.
The Slud-Rubinstein bounds for the survival function estimate for the Liver Registration
data set are shown in Figure 2.2. A range of values for  were chosen, with the upper
and lower bounds being  = 0 and  = 1 respectively. As these are the same as the
Peterson bounds on the survival function, it was not necessary to produce a separate plot
for these bounds. We chose  = 2:7 as this gives an estimator with the same median as
the Klein-Moeschberger estimator with  = 0:2. The estimator with  = 1 is included as
this is the same as the Kaplan-Meier estimator and can be used for comparison. We see
37that the Peterson bounds are extremely wide and the Slud-Rubinstein bounds can indeed
be an improvement on these. However, depending on our condence about the bounds on
the value of , the Slud-Rubinstein bounds may still be wide and so are of little practical
value.
Figure 2.2: Plot of Slud-Rubinstein bounds on the marginal survival function for T and a
Slud-Rubinstein estimator of the marginal survival function for T with  = 2:7.
Figure 2.3 shows the Klein-Moeschberger bounds for the survival function for the
Liver Registration data set. Estimators for values of  between 1 and 1 are presented.
So, the lower bound is the same as that for Peterson and Slud-Rubinstein but the upper
bound corresponds to the assumption of independence. Therefore, the Klein-Moeschberger
bounds are not as wide as those of Peterson. It also means that only positive correlation
between the failure and censoring times is considered. While this is not a problem for this
particular data set, the method may not be suitable for other data sets. The estimator
with  = 1:5 corresponds to  = 0:2.
2.7 Background on Copulas
Copulas can be used to give the dependence structure between two variables X and Y with
marginal distribution functions F and G respectively. All the denitions and information
on copulas given in this section come from Nelsen (1999). It is possible to dene either
the joint distribution function H, or the joint survival function  H. Firstly, the denition
that uses the joint distribution function which comes from Sklar's theorem is given.
Sklar's Theorem If we have a joint distribution function H with margins F and G, then
38Figure 2.3: Plot of Klein-Moeschberger bounds on the marginal survival function for T
and a Klein-Moeschberger estimator of the marginal survival function for T with  = 1:5.
there exists a copula C such that for all x; y in R
H(x;y) = C(F(x);G(y)): (2.15)
This means that the copula is given by
C(u;v) = H(F 1(u);G 1(v)); u;v 2 [0;1];
where F 1 and G 1 are inverses of F and G.
2.7.1 Survival copulas
A similar function  C, called a survival copula, can be dened. This gives the joint survival
function  H in terms of the marginal survival functions  F and  G. Again from Nelsen
(1999), we have
 H(x;y) =  C(  F(x);  G(y)):
This is related to the copula dened in (2.15) by
 C(u;v) = u + v   1 + C(1   u;1   v):
This relationship is obtained since
 H(x;y) = 1   F(x)   G(y) + H(x;y)
=  F(x) +  G(y)   1 + C(F(x);G(y))
=  F(x) +  G(y)   1 + C(1    F(x);1    G(y)):
392.7.2 Archimedean copulas
There is a special class of copula functions known as Archimedean copulas, dened in
Nelsen (1999), where the copula can be expressed as
C(u;v) = ' 1('(u) + '(v)); (2.16)
where ' is the generator of the copula. The most well-known one parameter families of
Archimedean copulas are given in Table 2.1.
Name C(u;v) '(t)  2
Clayton max([u  + v    1] 1=;0) 1
(t    1) [ 1;1)nf0g
Gumbel-
Hougaard
exp( [( logu) + ( logv)]1=) ( logt) [1;1)
Frank  1
 log(1 +
(e u 1)(e v 1)
e  1 )  log(e t 1
e  1 ) ( 1;1)nf0g
Table 2.1: Table showing some of the most well-known families of Archimedean copulas
with their generators and corresponding copula functions as given in Nelsen (1999).
Some of the papers considered in this section refer to a gamma frailty copula, which
is given by
C(u;v) = u + v   1 +

(
1
1   u
) 1 + (
1
1   v
) 1   1
 =( 1)
;  > 0nf1g:
It is easy to see that this is the corresponding survival copula for the Clayton copula with
 =    1. However, in some papers the domain of  is restricted to (1;1] so that only
positive dependence between the variables is possible.
To visualise the dierences between the copula functions considered, the density func-
tion of the copula, c(u;v) = @2
@u@vC(u;v), for the Clayton, Frank, Gumbel-Hougaard and
gamma frailty copulas has been plotted in Figure 2.4.
2.7.3 A dependence measure for copulas
Kendall's  has already been dened as a measure of concordance and it will be used to
express the amount of dependence between time to failure and time to censoring here. It
will be shown that it can be expressed in terms of copulas, instead of the joint distribution
function. Recall that the population version of Kendall's  for random vectors (X1;Y1)
and (X2;Y2), each with joint distribution function H is
 = P[(X1   X2)(Y1   Y2) > 0]   P[(X1   X2)(Y1   Y2) < 0]:
40Figure 2.4: Joint density functions for Clayton, Frank, Gumbel-Hougaard and gamma
frailty copulas
41Let X and Y be continuous random variables with copula C, then the population version
of Kendall's  given in Nelsen (1999) is
C = Q(C;C) = 4
ZZ
I2
C(u;v)dC(u;v)   1:
where the unit square I2 is the product II where I = [0;1]. For an Archimedean copula
with generator ', this has a simpler form, given by
C = 1 + 4
Z 1
0
'(t)
'0(t)
dt:
The following theorem from Georges et. al. (2001) will be of use when using copulas
that are the corresponding survival copulas of well-known families of copulas.
Theorem The Kendall's  of the survival copula ^ C are equal to the Kendall's  of the
associated copula C
2.8 Self-consistent Estimators based on an Assumed Copula
In this section, the estimator from Zheng and Klein (1994) is presented, which they call
a self-consistent estimator based on an assumed copula. The idea of self-consistency was
rst discussed in Efron (1976), and a summary of this concept is given here.
If both the time to the event of interest T, and the time to censoring C could be
observed for every individual in a data set, then natural non-parametric estimators of the
marginal survivor functions, ST(t) and SC(t), of T and C respectively, would be
^ ST(t) =
1
n
n X
i=1
I[Ti  t] and ^ SC(t) =
1
n
n X
i=1
I[Ci  t]:
As we have censored data, these estimators need to be adapted. Let Y1;Y2;:::;Yn be the
observation times, where Yi = min(Ti;Ci). If Yi is a death time then it is known whether
Ti is smaller or greater than t. If Yi is a censored observation that is greater than or equal
to t, then it is also known that the Ti for this individual is greater than t. However, if Yi
is a censored observation that is less than t, it is not known if Ti is greater than t as it
could fall between Yi and t. So, Zheng and Klein (1994) state that the estimator for ST(t)
that comes from the concept of self-consistency given in Efron (1967) is
^ ST(t) =
1
n
8
<
:
n X
i=1
I(Yi  t) +
X
Yi<t
(1   i) ^ P[T > tjT > Yi;C = Yi]
9
=
;
: (2.17)
where i = I(Yi = Ti). A similar argument can be used when obtaining an estimator of
the marginal survival function of C, which gives
^ SC(t) =
1
n
8
<
:
n X
i=1
I(Yi  t) +
X
Yi<t
i ^ P[C > tjC > Yi;T = Yi]
9
=
;
: (2.18)
42Zheng and Klein (1994) show that when T and C are dependent with copula C, the
estimated probabilities in (2.17) and (2.18) can be written as
^ P(T > tjT > Yi;C = Yi) =
1   Cv(1   ^ ST(t);1   ^ SC(Yi))
1   Cv(1   ^ ST(Yi);1   ^ SC(Yi))
and
^ P(C > tjC > Yi;T = Yi) =
1   Cu(1   ^ ST(Yi);1   ^ SC(t))
1   Cu(1   ^ ST(Yi);1   ^ SC(Yi))
;
where
Cu(a;b) =
@C(u;v)
@u
and Cv(a;b) =
@C(u;v)
@v
;
evaluated at the point (u;v) = (a;b).
Thus the estimators in (2.17) and (2.18) become
^ ST(t) =
1
n
8
<
:
n X
i=1
I(Yi  t) +
X
Yi<t
(1   i)
1   Cv(1   ^ ST(t);1   ^ SC(Yi))
1   Cv(1   ^ ST(Yi);1   ^ SC(Yi))
9
=
;
(2.19)
and
^ SC(t) =
1
n
8
<
:
n X
i=1
I(Yi  t) +
X
Yi<t
i
1   Cu(1   ^ ST(Yi);1   ^ SC(t))
1   Cu(1   ^ ST(Yi);1   ^ SC(Yi))
9
=
;
: (2.20)
An iterative process is used to nd the self-consistent estimators ^ ST(t) and ^ SC(t). The
initial guesses ^ S0
T(t) and ^ S0
C(t) are substituted in the right-hand sides of (2.19) and (2.20)
to give ^ S1
T(t) and ^ S1
C(t). This is repeated with ^ S1
T(t) and ^ S1
C(t), and so on until the stable
points of the process are found.
This process will converge as the convergence of self-consistent estimators such as those
in (2.17) and (2.18) is established in Tsai and Crowley (1985). They found that the EM
algorithm can be set up so that it converges to estimators that have the property of self
consistency given in Efron (1967), and that convergence is guaranteed as long as the initial
estimator used in the algorithm is a step function with mass at the observed time points.
2.9 Copula-Graphic Estimators
Zheng and Klein (1995) suggest an estimator of the marginal survival function of T, ST(t),
based on an assumed copula C, known as the copula-graphic estimator. It is a step function
with jumps at the distinct event times. They also dene a similar estimator for SC(t),
the marginal survival function of C. This is a step function with jumps at the observed
censoring times, which is needed in the estimation of the copula-graphic estimator, ^ ST(t).
We observe Yi = min(Ti;Ci) and an indicator function i = I(Yi = Ti) for the ith
individual in the data set. The times t1;:::;tm are the distinct times at which individuals
43experience an event or are censored. Let t0 = 0 and ^ ST(t0) = ^ SC(t0) = 1. If the
observation at time ti is a failure time, then ^ SC(ti 1) is used instead of ^ SC(ti) when
computing our estimator, as there will be no change in value for ^ SC at time ti if the
observation is a failure time. Similarly, if at time ti there is a censored observation, let
^ ST(ti) = ^ ST(ti 1). So if i = 1, then
^ ST(ti) + ^ SC(ti 1)   1 + C
h
1   ^ ST(ti);1   ^ SC(ti 1)
i
=
1
n
n X
j=1
I(Yj > ti): (2.21)
Similarly, if i = 0, then
^ ST(ti 1) + ^ SC(ti)   1 + C
h
1   ^ ST(ti 1);1   ^ SC(ti)
i
=
1
n
n X
j=1
I(Yj > ti): (2.22)
To ensure that these estimators can handle tied observation times, if there are both
failures and censored observations at the time ti, it is assumed that the censored times
occur at time t+
i after the failure times. This is a standard assumption when there are
ties in the data, and ensures that the estimator ^ SC(t) does not have any jumps at exactly
the same time as ^ ST(t). Also any individuals that are censored at ti would be included in
the sum
Pn
j=1 I(Yj > ti) when computing ^ ST(ti). However, failures that occur at time ti
would not be included in this summation when computing ^ SC(ti).
2.9.1 Closed form copula graphic estimators
Rivest and Wells (2001) show that in certain circumstances, it is possible to obtain a
closed form of copula-graphic estimator of the marginal survival function of T, ^ ST(t).
They assume that the joint survival function  H(t;c) is given by an Archimedean copula,
which is a copula of the form given in (2.16). They present the closed form of the estimator
when there are no ties in the data. However, we extended their closed-form estimator to
data with tied observation times by assuming that if there are both failures and censored
observations at time ti, then the censored observations occur at time t+
i , just after the
failures.
So, if the joint survival function  H(t;c) can be expressed by an Archimedean copula
with generator function '(t), it can be shown that the copula-graphic estimator of the
marginal survival function of T is
^ ST(ti) = ' 1
2
4 
X
Yiti;i=1

'
ni
n

  '

ni   di
n

3
5 (2.23)
where ni is the number of individuals at risk at time ti and di is the number of observed
failures at time ti.
442.10 Applying Estimators that use an Assumed Copula to
Liver Registration Data Set
In this section, self-consistent and copula graphic estimates for the Liver Registration data
set are presented, for dierent families of copulas. Figure 2.5 shows the self-consistent
estimates based on the Gumbel-Hougaard, Frank, gamma frailty and Clayton copulas,
each with Kendall's  of 0.2. Similarly, Figure 2.6 shows the corresponding copula graphic
estimates. In Figures 2.5 and 2.6, the Kaplan-Meier estimate of the survival function is
also plotted for comparison.
In Figure 2.7 the copula graphic estimates using the Gumbel-Hougaard, Frank and
Clayton copulas are presented. However, the estimates here were obtained using the
closed forms of the estimators. This form of the estimator gives dierent results for some
of the copulas. This is because Zheng and Klein (1995) use the assumed copula to give
the joint distribution function, whereas Rivest and Wells (2001) use the assumed copula
to give the joint survival distribution. So if the corresponding survival copula for the
Archimedean family had been used, then the two estimators would be the same. As we
can see, the closed-form copula graphic estimator for the Clayton copula is the same as the
copula graphic estimator for the gamma frailty copula. This is because the gamma frailty
copula is the corresponding survival copula for the Clayton copula. For some families of
copulas, it does not matter whether the standard copula or the survival copula is used.
This is true of the Frank copula as it gives a symmetric distribution to the dependence
between the two variables.
Figure 2.5: Plot of self-consistent estimates based on dierent assumed copulas for
Kendall's  = 0:2
45Figure 2.6: Plot of copula-graphic estimates using dierent assumed copulas for Kendall's
 = 0:2
Figure 2.7: Plot of copula-graphic estimates with closed form expression using dierent
assumed copulas for Kendall's  = 0:2
46Here the estimates for a range of copula families for a given value of Kendall's  have
been plotted in each of the Figures 2.5, 2.6 and 2.7. This is so the dierences in the
estimates given by each family can be seen. However, when applying these methods to
data, a copula family that reects the suspected dependence structure should be chosen.
This is because copulas cannot to be tted to the data to see which ts best as the failure
and censoring time are not both observed for each individual.
2.10.1 Selecting copula family
Plots of the joint density functions of the Clayton, Frank, Gumbel-Hougaard and gamma
frailty copulas are given in Figure 2.4. These plots should be used to select which of the
copulas is believed to be the most appropriate for the data set under consideration. This
can be done by choosing the copula with the joint density function that seems most the
plausible for our data set.
As the copula C is used to specify the joint distribution of two variables, then the
copula density function c(u;v) = @2
@u@vC(u;v) gives the joint density function of the two
variables. So a point (u;v) on the surfaces given in the plots in Figure 2.4 corresponds to
f(x;y) where x = S 1
T (u) and y = S 1
C (v).
As generally the values of T and C observed tend to be fairly small with only a few
individuals having large observations, a copula that has higher density values for low values
of u and v should be chosen. From Figure 2.4, it can be seen that a sensible choice would be
either the Clayton copula or the gamma frailty copula. As the Clayton copula only gives
large density to very small values of u and v, the gamma frailty copula is recommended
as its density function does not have such a steep slope.
It is not possible to estimate Kendall's  so assumed values of this measure are used.
The estimators given when using these values of Kendall's  can be used as bounds for
the estimated survival function, if it is believed that the true value of Kendall's  lies in
the assumed interval. Figure 2.8 gives the bounds on the survival function for the Liver
Registration data set given by a copula-graphic estimator if Kendall's  lies between -0.2
and 0.2, assuming rstly a Clayton copula and then assuming a gamma frailty copula.
The plots in Figure 2.8 show how dierent the bounds on the marginal survival function
obtained are when using dierent copula families. When t < 200 the bounds given by the
estimators using a gamma frailty copula are tighter than those given by the estimators
that use a Clayton copula. Shortly after this time, the bounds given by the estimators
that use a gamma frailty copula become much wider than those given by the estimators
that use a Clayton copula.
47Figure 2.8: Bounds for estimated survival function given by copula-graphic estimators if
Kendall's  lies between -0.2 and 0.2, assuming a Clayton copula and a gamma frailty
copula.
2.11 Inclusion of Covariates
As the estimators considered in this chapter are extensions of the Kaplan-Meier estimator,
they share some of the limitations of this estimator. The main one here being that not
all covariates can be incorporated when using this estimator. In fact, only covariates with
simple structures like factors with only a few levels can be considered. For these variables,
an estimator for each level of the factor or for each combination of levels of several dierent
factors can be produced. But there is no way of incorporating continuous variables, and
some of the most important covariates in the data set under consideration are continuous.
In Yan (2007), it is detailed how it is possible to incorporate covariates into copulas
in two ways. Firstly, the margins can be modelled using regression models instead of just
a distribution. This means that one of the parameters of the distribution is replaced by
XT, where X is a vector of covariates and  is a vector of parameters. Similarly the
copula parameters could be replaced by XT to allow covariates to be incorporated.
However, for the estimators considered here that use an assumed copulas, it is the
marginal distributions used in the copulas that are being estimated so they cannot be
replaced by regression models. Also the value of the copula parameter is used to control
the amount of dependence between T and C so the parameter can not be replaced with
XT. So the only way of incorporating covariates in these estimators are those that were
discussed previously for the other estimators in this chapter.
482.12 Another estimator of the marginal survival function
for failure time variable
There are other estimators that are modications of the Kaplan-Meier estimator that allow
for informative censoring in a data set. One of these estimators is considered briey, but
not applied to the Liver Registration data set.
The estimator is given in Link (1989), uses a frailty model to account for informative
censoring. It is assumed that each life time T has a random variable Z associated with it,
which is called the frailty. Censoring is then only possible for a subset A of the values of
Z. It is usually assumed that censoring is possible for individuals with either high or low
frailty.
The survival function S(tjZ = z) is decreasing in Z, so the individuals that tend to
have smaller lifetimes are those with high frailties. So if it is assumed that individuals with
high frailties are those at risk of censoring and A = fzjz  ag, then there will be heavier
censoring on small observations and less censoring on larger observations than under non-
informative censoring. This means the Kaplan-Meier estimator would over estimate the
survival function S(t) if it was used here.
As before, the observed data are the observation times Y and the indicator function
 = I(Y = T). Here the ordered observation times y(i) will be used along with (i),
which is the corresponding value of the indicator function.
The Kaplan-Meier estimator can be written as
^ S(t) =
1
n
(
n X
i=1
I(y(i) > t) +
n X
i=1
(1   (i))P(T > tjY = y(i); = 0)
)
;
where
P(T > tjY = y(i); = 0) = S(t)=S(y(i)):
In the alternative frailty model, proposed in Link (1989), this probability is given by
P(T > tjY = y(i);j = 0) =
S(tjZ 2 A)
S(y(i)jZ 2 A)
:
Then a modied form of the Kaplan-Meier estimator can be obtained by using the algo-
rithm
~ S(k+1)(t) =
1
n
(
n X
i=1
I(y(i) > t) +
n X
i=1
(1   (i))
~ S(k)(tjZ 2 A)
~ S(k)(y(i)jZ 2 A)
)
;
and letting k ! 1.
This estimator is not applied to the data set under consideration for two reasons.
Firstly, as it just another extension of the Kaplan-Meier estimator then it still has all
the disadvantages associated with this estimator and so does not provide an improvement
49on any of the other estimators considered here. Secondly, and more importantly, the
assumption used here is not a realistic one for the situation being considered. For this
method, it is assumed that censoring is possible for only a subset of the individuals in the
data set. Although there are patients on the waiting list for a liver transplant that have a
greater hazard of receiving a transplant, we do not want to restrict censoring to just these
individuals. This would imply that there are patients on the waiting list who could not
receive a transplant and this is not realistic.
2.13 Discussion
The bounds that are given by the all estimators applied to the Liver Registration data set
in this chapter are not useful in a practical setting as they are too wide. The method used
in both Slud and Rubinstein (1983) and Klein and Moeschberger (1988) of assuming that
the parameter controlling the dependence lay within a restricted region gave bounds that
were tighter than those of Peterson (1976). However, even these were still too wide to be
of use. It is still possible to use the estimators with an assumed value of dependence. But
they still not of much use in a practical application as they do not allow all the important
covariates to be incorporated.
A number of dierent estimators that extend the Kaplan-Meier estimator to allow for
informative censoring have been presented here. Some of the estimators are preferable to
others. In particular, it is not as easy to specify an interpretable amount of dependence
for the Fisher-Kanarek and Slud-Rubinstein estimators as for the other estimators that
use Kendall's . However, the Fisher-Kanarek estimator does allow for non-informative
censoring as well as informative censoring, unlike the rest of the estimators which only
consider one type of censoring. This means either only the data up until the rst non-
informative censoring is used or the non-informative censoring is treated as informative
censoring. Here the latter method is used.
However, use of the Fisher-Kanarek estimator is still not recommended. This is because
when the last observation in a data set is censored we can see some strange behaviour in
the estimate of the survival function when assuming a positive dependence between T and
C. The reason for this is discussed in detail in Section 2.6.
Zheng and Klein (1994) present the results of a small simulation study that compares
the self consistent estimator and the copula-graphic estimator. A gamma frailty copula
with exponential margins is used with a value of  that gives  = 0:5. The parameters of
the exponential margins chosen give P(X < Y ) = 0:50, which equates to 50% censoring.
Also a sample size of 20 is used. They calculate the relative biases of the estimators
as the marginal distribution function FT(t) increases. The relative bias of ^ S is dened
50as (E[^ S(tp)]   p)=p at time tp where S(tp) = p. Both estimators are biased for large t,
as the size of the risk set becomes smaller. However, the self-consistent estimator has
a signicantly larger bias than the copula-graphic estimator. This behaviour is typical
for these estimators as they also carried out further simulation studies for other copulas,
association parameters and sample sizes. The results of these simulation studies are given
in Zheng (1992).
Also the copula-graphic estimator is less computationally intensive as it only requires
one pass through the data to construct the estimator. In contrast the self-consistent
estimator requires a pass through the data at each iteration. For these reasons the copula-
graphic estimator is recommended rather than the self-consistent estimator.
Although the preferred estimator that uses an assumed copula is now known, it is still
not known how it compares to the other estimators in this chapter. Also, it is not known
whether the gamma frailty copula that is recommended here gives estimators that are
closer to the true survival function than the other copulas. However, as these methods
cannot easily be used in practice due to the wide bounds found and the diculties with
incorporating covariates, it would not be particularly useful to identify the preferred esti-
mator of those detailed in this chapter. Therefore, in the following chapter, we go on to
look at more recent approaches to account for informative censoring that allow the use of
a wider variety of covariates.
5152Chapter 3
Estimation when using Regression
Models for the Censoring Process
and Sensitivity Analyses under
Informative Censoring
This chapter continues the literature review that was started in Chapter 2. The estimators
considered previously gave bounds on the estimated survival function but it was found that
these bounds were too wide to be of much use. These estimators also generally did not
allow covariates to included easily.
The methods reviewed in this chapter are of more use in practice than those in Chapter
2 and generally can easily include covariates. They can be split into two categories,
estimators that use regression models for the censoring process and sensitivity analyses.
The estimators that use regression models for the censoring process are described in
sections 3.1 and 3.2. These include one of the most popular methods in the literature on
informative censoring. These are the inverse probability of censoring weighted estimators
that are given in Section 3.1.
The sensitivity analyses in sections 3.3 to 3.6 assess the sensitivity of the results from
standard models to the assumption of informative censoring. Sensitivity analyses for both
standard parametric survival models and Cox's proportional hazards model are presented.
In Section 3.7, a sensitivity analysis for an estimator that already accounts for informative
censoring is described, that allows us to assess how biased this estimator could be if there
is dependence between T and C that is not explained by its assumed dependence structure.
As this is a review chapter, all the methods discussed can be found in the literature
and, unless otherwise stated, the original work is the application of the methods to the
53Liver Registration data set. Some of the notation used in this chapter may dier from
that in the papers referenced as we present all the methods in consistent notation.
3.1 IPCW estimators
Inverse probability of censoring weighted (IPCW) estimators were rst introduced by
Robins and Rotnitzky (1992) and Robins (1993). They have been recognised as a way to
adjust for the bias introduced by dependent censoring, for cases where the same prognostic
factors predict both time to failure and time to censoring.
This method relies on the assumption of no unmeasured confounders for censoring
or the assumption of sequential ignorability of censoring, which states that if the cause
specic hazard of censoring is conditioned on the recorded history, V(t), of a vector of
possibly time-dependent covariates,V, then it does not further depend on T,
hC(tj V(t);T;T > t) = hC(tj V(t);T > t) (3.1)
where  V(t) is dened as fV(x);0  x  tg. If all the prognostic factors are recorded in
V(t) then the IPCW estimators outlined below will adjust completely for the bias due
to dependent censoring. However, in practice, we will not be able to record all possible
prognostic factors, but if the most important factors are recorded then the use of IPCW
estimators will considerably reduce the bias caused by dependent censoring.
Another concept that is necessary to introduce is that of the data being coarsened at
random (CAR). This was introduced by Heitjan and Rubin (1991) as a generalisation of
the concept of missing at random. Censoring is just one example of how a dataset could
be coarsened. Censored data are CAR if the censoring mechanism does not depend on the
values of the outcome, although it is allowed to depend on the values of any covariates.
The CAR assumption can be expressed as
hC(tj V(T);T;T > t) = hC(tj V(t);T > t): (3.2)
This is similar to Equation 3.1, except that  V(t) has been replaced by  V(T). So CAR
implies (3.1), but (3.1) does not imply CAR.
3.1.1 Constructing IPCW estimators
The IPCW versions of the Kaplan-Meier (KM) estimator and the Cox partial likelihood
score function are given here. The construction of these types of estimators was outlined
in Robins and Finkelstein (2000), who used it to adjust for dependent censoring when
comparing two treatments in an AIDS clinical trial. IPCW estimators can be found by
weighting the contribution of each subject by the inverse of an estimate of the conditional
54probability of having remained uncensored until time t. The eect that this weighting
has on estimators will now be explained, using the KM estimator as an example. The
standard KM estimator is given by
^ S(t) =
Y
fi;Yi<tg

1  
di
ni

;
where di is the number who fail at time Yi and ni is the number at risk at time Yi. For the
IPCW KM estimator, the contributions to these two terms are weighted by the inverse
probability of remaining uncensored until time t. Then the numerator of the fraction
estimates the number of individuals who would have been observed to fail at time Yi
in the absence of any censoring. Similarly, the denominator estimates the number of
subjects at risk at time Yi in the absence of any censoring. This means that the IPCW
KM estimator gives an estimate of the survival function in the absence of censoring.
To construct the weights an estimate of the probability of remaining uncensored until
time t given ( V(T);T) is needed, where  V(T) is the recorded history of a covariate vector
up until time T. This is given by a KM estimator for time to censoring that has been
extended to include time-dependent covariates. The model for censoring that will be used
is
hC(tj V(t);T > t) = h0(t)expf0
CV(t)g; (3.3)
where h0(t) is the baseline hazard and C is a vector of parameters. A Cox proportional
hazards model will be tted to give the partial likelihood estimate ^ C. The observed values
are denoted by Y = min(T;C). Indicator values R(u) = I(Y  u) and  = I(T = Y ) are
used to identify those at risk and which observations are failures. Let t1;t2;:::;tn be the
times of the observations.
In the literature, several dierent ways of selecting the covariates to be included in V(t)
have been suggested. We consider the ways suggested in Robins and Finkelstein (2000),
Schaubel et al. (2009) and Zhang and Schaubel (2010). These are outlined in more detail
in Section 3.1.3. When we apply the method to our data set, we shall compare the IPCW
estimates given by using each of these ways.
Under CAR and model (3.3), then it is possible to derive the following KM estimator
for censoring
^ KV
i (t) =
Y
fj;tj<t;j=0g
[1   ^ h0(tj)expf^ 
0
CVi(tj)g]; (3.4)
where the Cox estimator of the baseline hazard for censoring at observation time tj is
given by
^ h0(tj) =
(1   j)
f
Pn
i=1 exp(0
CVi(tj))Ri(tj)g
:
55The estimator in (3.4) is written as ^ KV
i (t) to show that it depends on Vi(t). The usual
KM estimator of the probability of being uncensored at time t is denoted by ^ K0
i (t). This
will be equal to ^ KV
i (t) when C is the zero vector.
We can dene subject specic weights, ^ Wi(t), which will be used in the IPCW versions
of the KM estimator and Cox partial likelihood. One possible weight is ^ K0
i (t)= ^ KV
i (t) which
will be close to one for all t if and only if  V(t) does not predict the hazard of censoring at
t. So, if we do have informative censoring, ^ Wi(t) will not be close to one. Another weight
that could be used is 1= ^ KV
i (t). However, as shown in Robins (1993), using ^ K0
i (t)= ^ KV
i (t)
as the weight has important eciency advantages. These will be discussed further in
Section 3.1.2. They suggest that using 1= ^ KV(t) as the weight may be appropriate when
there is only light or moderate censoring but if there is heavy censoring, this value can
become quite large. Because of this, Robins and Finkelstein (2000) recommend using
^ K0
i (t)= ^ KV
i (t) when there is heavy censoring. From now on, ^ K0
i (t)= ^ KV
i (t) will be referred
to as a \stabilised" weight and 1= ^ KV
i (t) as an \unstabilised" weight.
Now it is possible to dene the IPCW Kaplan-Meier estimator for time to failure. It
is shown in Robins and Finkelstein (2000) that the value of this estimate at time t is
^ ST(t) =
Y
fi;ti<tg
0
@1  
i ^ Wi(ti)
nPn
k=1 Rk(ti) ^ Wk(ti)
o
1
A: (3.5)
It does not matter whether ^ K0
i (t)= ^ KV
i (t) or 1= ^ KV(t) is used for ^ Wi in (3.5) as ^ K0(t)
cancels from both the numerator and the denominator. Therefore the merits of using
stabilised weights instead of unstabilised weights only need to be considered when using
the Cox partial likelihood.
The IPCW Cox partial likelihood score for a vector of parameters T, is also derived
in Robins and Finkelstein (2000) and is given by
U(T) =
X
i
i ^ Wi(ti)
"
Zi  
Pn
j=1 Rj(ti) ^ Wj(ti)Zje0
TZj
Pn
j=1 Rj(ti) ^ Wj(ti)e0
TZj
#
(3.6)
where Z is a vector of baseline covariates to be included in the model for time to fail-
ure. When tting a model with weights like this, robust estimates of the variance of the
parameter estimates need to be used.
Weibull model for time to censoring Robins and Finkelstein (2000) only consider
a Cox model for time to censoring, but it is also possible to use a Weibull model for the
baseline hazard for censoring, where
hC0(t) = t 1;
56and the survival function for time to censoring for individual i can be estimated by
^ SCi(t) = exp
n
 exp(^ 
0
WVi(t))^ t^ 
o
(3.7)
where ^ W is obtained using the Weibull proportional hazards model. However, this does
mean that it is not easy to include time-dependent covariates in the model. So, when
using these weights to obtain IPCW estimates for the Liver Registration data set, we
will consider only time independent covariates when using a Weibull proportional hazards
model.
Again it is possible to use both \stabilised" and \unstabilised" weights to obtain IPCW
estimates. The unstabilsed weights are 1=^ SV
Ci(t) and are comparable to 1= ^ KV
i (t) used
previously. The stabilised weights require the use of ^ S0
Ci(t), which is the estimated sur-
vival function in (3.7) with Vi(t) replaced by the zero vector. The weight used is then
^ S0
Ci(t)=^ SV
Ci(t).
We expect that the IPCW estimates using a Cox model for censoring and a Weibull
model for censoring will be similar for the Liver Registration data set. This is because we
have little information on how the UKELD score changes over time in this data set. How-
ever, if more information on time-dependent covariates is available then it is recommended
that the Cox model for censoring is used, because it can easily incorporate time-dependent
covariates.
3.1.2 Stabilised weights vs. unstabilised weights
In this section, we will discuss whether the stabilised weights ^ K0
i (t)= ^ KV
i (t) or the unsta-
bilised weights 1= ^ KV
i (t) should be used when calculating IPCW estimates. The weights
being considered here are those that use Cox models for censoring as these are the weights
used in Robins (1993a), which established many of the results on the properties of the
estimators that are presented in this section.
Robins and Finkelstein (2000) recommend using ^ K0
i (t)= ^ KV
i (t) as the subject specic
weight as this gives important eciency advantages. In this context, the estimate with
the lowest variance is regarded as the most ecient. Semi-parametric variance bounds for
the semi-parametric models detailed in Section 3.1.1 are given in Robins and Rotnitzky
(1992) and Robins (1993b). These papers rely heavily on the theory of semi-parametric
eciency bounds given in Newey (1990) and Bickel at al. (1998)1.
Robins (1993a) proves that the solution ^ T to U(T) = 0 is consistent and asymptot-
ically normal when ^ K0
i (t)= ^ KV
i (t) is used for ^ W(t) in (3.6), given that (3.1) holds and the
model for time to censoring is correctly specied. The solution ^ T to U(T) = 0 remains
1The publication date of this book is after the publication of the papers by Robins (1993) and Robins
and Rotnitzky (1992) but both papers include an advance manuscript in their bibliographies.
57consistent and asymptotically normal if 1= ^ KV
i (t) is used for ^ W(t) in (3.6). However, if
^ K0
i (t)= ^ KV
i (t) is used then the estimator ^ T is asymptotically more ecient than the usual
Cox partial likelihood estimator of T, if
hC(tj V(t);T > t) = hC(t;T > t) (3.8)
and (3.1) hold, that is if there is non-informative censoring. This result suggests that we
should use an IPCW estimator with stabilised weights instead of the Cox partial likelihood
estimator of T, even when the censoring is non-informative. However, many of the results
given in this section rely on the correct specication of the Cox model for time to censoring.
We cannot be sure that the model for time to censoring used is correct and therefore use
of the usual Cox partial likelihood estimator of T is justied.
As in the liver transplantation setting being considered in this thesis it is unlikely
that (3.8) always holds, then these eciency advantages are not as important as choosing
weights that reect the situation under consideration. There will be some individuals
on the waiting list for a liver transplant who are at much greater risk of being censored
than others, so these individuals would need to be more heavily weighted. Therefore, we
recommend that the unstabilised weights should be used in the liver transplant setting
rather than the stabilised weights.
3.1.3 Models for censoring process
There are several models for time to censoring that have been suggested in the literature.
The rst model for time to censoring considered here is suggested by Robins and Finkel-
stein (2000), where only the time-dependent covariates that are signicant for both time
to failure and time to censoring are included. As the assumption of sequential ignorability
of censoring relies on all the shared prognostic factors being included in the model for time
to censoring, we recommend that this model is used unless there is a good argument for
using one of the following models.
The next model used for time to censoring includes all the baseline variables that are
to be included in the time to failure model plus time-dependent UKELD. This model was
proposed in Schaubel et al. (2009). The nal model used includes any baseline covariates
that were found to be signicant for time to censoring plus time-dependent UKELD. Use
of such a model was suggested in Zhang and Schaubel (2010).
As all these use Cox models for time to censoring, we can dene the models considered
here as
Cox model 1 which uses just time-dependent UKELD,
58Cox model 2 which uses primary liver disease category, ethnicity, age, serum sodium
at time of registration, INR at time of registration and time-dependent UKELD, and
Cox model 3 which uses primary liver disease category, ethnicity, age, serum sodium at
time of registration, INR at time of registration, height, blood group and time-dependent
UKELD.
The baseline covariates that were found to be signicant for time to censoring were all
the variables in the model for time to failure plus two additional covariates, so we are
successively adding more covariates in the models considered above.
Weibull models for time to censoring are also considered. So that they are comparable
to the models dened above, the same covariates will be used, except that time-dependent
UKELD will be replaced by the value of UKELD at the time of registration. So we dene
these models as
Weibull model 1 which uses just UKELD score at time of registration,
Weibull model 2 which uses primary liver disease category, ethnicity, age, UKELD
score at time of registration, serum sodium at time of registration and INR at time of
registration, and
Weibull model 3 which uses primary liver disease category, ethnicity, age, UKELD
score at time of registration, serum sodium at time of registration, INR at time of regis-
tration, height and blood group.
3.1.4 Application to the Liver Registration data set
Firstly, IPCW KM estimators using each of the models described in Section 3.1.3 are
tted to the Liver Registration data set. Figures 3.1, 3.2 and 3.3, compare the IPCW KM
estimators using Cox and Weibull models for censoring to the standard KM estimator of
the marginal survival function. We see that all the plots in Figures 3.1, 3.2 and 3.3 give
similar IPCW KM estimators that do not deviate greatly from the standard KM estimator.
This suggests that the potentially informative censoring in the Liver Registration data set
has little eect on the estimate of the survival function. This does not agree with the
estimates of the survival function found in Chapter 2, which suggested that even a small
amount of dependence between T and C would result in a fairly large change in the
estimate of the survival function.
One possible reason why the IPCW KM estimator does not vary greatly from the
standard KM estimator is that the dependence between T and C is not completely due
59Figure 3.1: Plots comparing IPCW KM estimators with unweighted KM estimators, using
Cox Model 1 and Weibull Model 1 for censoring respectively
Figure 3.2: Plots comparing IPCW KM estimators with unweighted KM estimators, using
Cox Model 2 and Weibull Model 2 for censoring respectively
60Figure 3.3: Plots comparing IPCW KM estimators with unweighted KM estimators, using
Cox Model 3 and Weibull Model 3 for censoring respectively
to shared prognostic factors included in the model for time to censoring. There could be
residual dependence caused by unmeasured prognostic factors. Scharfstein and Robins
(2002) and Rotnitzky et al. (2007) developed methods that allow the eect of residual de-
pendence on an estimator that assumes sequential ignorability of censoring to be assessed.
This is covered in more detail in Section 3.7. Unfortunately, the estimator considered in
Section 3.7 is not the IPCW KM estimator presented in Section 3.1.1, so the eect of
possible residual dependence on the IPCW KM estimate of the survival function cannot
be assessed.
However, this analysis using the IPCW KM estimator is fairly simplistic and does
not allow for adjustment for signicant covariates for time to failure. Therefore we t
IPCW Cox models for time to failure to the Liver Registration data set. These allow us
to assess the eect of informative censoring on individual parameter estimates and also
the estimated survival function for individuals in the data set.
Several IPCW Cox models for time to death are tted to the data set. The same
baseline covariates will be included in all the models for time for failure. These are
primary liver disease category, ethnicity, age, UKELD score at time of registration, serum
sodium at time of registration and INR at time of registration. However, dierent models
are used for to time to censoring and the corresponding IPCW estimates for each model
are presented, along with the unweighted estimates obtained by tting the standard Cox
model. The models for time to censoring that are used were discussed in Section 3.1.3.
Figures 3.4, 3.5, 3.6 and 3.7 give the point estimates and 95% condence intervals
61obtained by tting all these models using Cox models for censoring and Weibull models
for censoring using both stabilised and unstabilised weights.
Figure 3.4: Point estimates and 95% condence intervals for parameters in time to failure
model, for unweighted Cox model and IPCW Cox model using Cox models 1, 2 and 3 for
time to censoring respectively. All the weights used in IPCW estimates are stabilised.
We nd that the IPCW estimates using stabilised weights, which are shown in Figure
3.4, the point estimates are slightly dierent from the standard point estimates, but gen-
erally signicant covariates do not become non-signicant or vice versa. This is with the
exception of some of the estimates for the Chinese level of ethnicity. Under the standard
Cox model, this parameter estimate has wide bounds as there are only a small number of
individuals with this ethnicity in the data set. However the use of weights here is anal-
ogous to the use of sampling weights. This means that the number of observations with
this ethnicity is being increased so there is less uncertainty about this parameter estimate.
However, we see that for the IPCW estimates that use unstabilised weights, which
can be seen in Figure 3.5, there are more changes from the standard estimates. Several
dierent levels of the categorical variables that are signicant under the standard model,
become non-signicant. However, these changes are likely to be caused by the heavy
censoring in the data set making some of these unstabilised weights quite large.
62Figure 3.5: Point estimates and 95% condence intervals for parameters in time to failure
model, for unweighted Cox model and IPCW Cox model using Cox models 1, 2 and 3 for
time to censoring respectively. All the weights used in IPCW estimates are unstabilised.
63Figure 3.6: Point estimates and 95% condence intervals for parameters in time to failure
model, for unweighted Cox model and IPCW Cox model using Weibull models 1, 2 and 3
for time to censoring respectively. All the weights used in IPCW estimates are stabilised.
64Figure 3.7: Point estimates and 95% condence intervals for parameters in time to failure
model, for unweighted Cox model and IPCW Cox model using Weibull models 1, 2 and 3
for time to censoring respectively. All the weights used in IPCW estimates are unstabilised.
65For the covariates and factor levels that remain signicant when using an IPCW Cox
model, we will examine the changes the estimated hazard ratios. There is a slight decrease
in the point estimates of the hazard ratio for patients with metabolic liver disease when
using an IPCW Cox model. This suggests that the standard Cox model slightly overesti-
mates the hazard ratio for these patients. The hazard ratios for age, UKELD score, serum
sodium and INR all also remain signicant when using an IPCW Cox model. However,
there is very little dierence between the point estimates from the standard Cox model
and the point estimates from the IPCW Cox models.
The IPCW estimates using Weibull models for time to censoring, with both stabilised
and unstabilised weights, can be seen in Figures 3.6 and 3.7 respectively. The results in
these two gures are very similar, suggesting that when using a Weibull proportionals
hazards model for time to censoring it does not matter whether stabilised or unstabilised
weights are used. The changes from the standard estimates are also similar to those
observed in Figure 3.5, with some levels of categorical variables that were signicant
becoming non-signicant.
Again, we examine the changes in the estimated hazard ratios for the covariates and
factor levels that remain signicant when using an IPCW Cox model. The results are very
similar to those for the IPCW estimates given in Figure 3.5. There is slight decrease in the
estimated hazard ratio for patients with metabolic liver disease, suggesting the standard
Cox model slightly overestimates the hazard ratio for these patients. The hazard ratios
for age, UKELD score, serum sodium and INR remain signicant, with the exception of a
couple of the estimated hazard ratios for serum sodium. Again there is very little change
in the point estimates for these covariates.
Figures 3.4 to 3.7 show the eects of inverse probability of censoring weighting on the
parameter estimates of the Cox model. We will now look at the eects that these changes
in the parameter estimates can have on the survival functions for individuals in the data
set.
Figure 3.8 compares the estimated survival function under the standard Cox model
with the estimated survival function under the IPCW Cox model for the individual who
had the largest observed value of ^ IPCW0
T xi   ^ 00
T xi. The weights used for the IPCW
estimates were unstabilised weights using Cox model 1 for time to censoring. We can
see that there is a large dierence between the two estimated survival functions. The
estimated survival function under the standard model, shown by the solid line in Figure
3.8 does not fall below 0.9, whereas the estimated survival function under the IPCW Cox
model, shown by the dashed line, has a median survival time of approximately 1200 days.
The analyses carried out in this section show that using an IPCW version of the KM
estimate of the survival function has little eect on the value of the estimated survival
66Figure 3.8: Plot comparing the estimated survival function under the standard Cox model
with the estimated survival function under the IPCW Cox model for the individual that
has the largest observed value of ^ IPCW0
T xi   ^ 00
T xi. The weights used are unstabilised
weights using Cox model 1 for time to censoring.
67function. However, if an IPCW Cox model is used, which allows for adjustment for
signicant covariates, then there can be a large eect on the estimated survival function
for some individuals in the data set.
3.1.5 Other weighted estimators
A similar weighted KM estimator is derived in Satten et al. (2001), but using Aalen's
additive hazard model instead of the proportional hazards model when calculating ^ KV
i (t).
Aalen's model is more exible than the proportional hazards model as the regression
coecients for the p covariates, C1(t);:::;Cp(t), are allowed to change continuously
over time. So, Aalen's model has hazard function
hC(tj Vi(t)) =
p X
k=1
Ck(t)Vik(t);
where Vik(t) is the value of the kth covariate for the ith individual at time t and Vi0(t) = 1.
Also the cumulative hazard function of Aalen's model can be written as
H(tj Vi(t)) =
Z t
0
hC(uj Vi(u))du
=
p X
k=0
Vik(t)
Z t
0
Ck(u)du
=
p X
k=0
Vik(t)BCk(t); (3.9)
where BCk(t) is the cumulative regression coecient for the kth covariate. It is easier to
estimate the cumulative regression coecients than the regression coecients, and Aalen
(1989) uses a least-squares-like estimator of BC(t) = (BC0(t);:::;BCp(t)),
^ BC(t) =
n X
i=1
I(Yi  t)(1   i)A 1(Yi)Vi(Yi) (3.10)
where
A(t) =
n X
i=1
I(Yi  t)Vi(t)V0
i(t):
The estimator in (3.10) can be substituted into (3.9), so that an estimator for HC(tj Vi(t))
is
^ HC(tj Vi(t)) =
n X
j=1
I(Yj  t)(1   j)Vi(Yj)A 1(Yj)Vj(Yj); t  Yi;
and this can be used to obtain an estimate for KV
i (t) as
^ KV
i (t) =
Y
st
[1   dHC(sj Vi(s))]:
68There are two possible problems that can arise when using Aalen's additive hazard
model, which is why it is not generally used in practical situations. The hazard estimates
may be negative and the estimator involves inverting a matrix that may not have full rank.
However, Satten et al. (2001) show that neither of these problems occur when estimating
KV
i (t).
3.2 Other estimators that use models for the censoring pro-
cess
There are several other estimators that use models for the censoring process when there
is informative censoring in a data set. Wu and Carroll (1988) use a linear random ef-
fects model, Wu and Bailey (1989) use a conditional linear model and Schlucter (1992)
uses a log-normal survival model that is an extension of the linear random-eects model.
However, these papers consider a dierent situation to the one being considered here. We
want to estimate the marginal survival function of the failure time variable when there is
informative censoring, whereas these papers estimate and compare the rate of change of a
continuous variable measuring physiological function or disease status, when patients that
discontinue from the study are considered to be informatively censored.
Koziol-Green estimators There is also a class of models in Braekers and Veraverbeke
(2001, 2003, 2005, 2008) known as Koziol-Green models, where a censoring variable is
assumed to have a hazard function that is proportional to the hazard function of the
failure time variable. This means that the relationship between the survival functions for
the two variables is
SC(t) = ST(t)
for some  > 0. This assumption is used in Braekers and Veraverbeke (2001,2003) and they
refer to the censoring variable as an informative censoring variable. However, they also
assume that the censoring variable is independent of the failure time variable. Therefore,
this censoring variable is not truly informative. The term \partially informative censor-
ing" used in Braekers and Veraverbeke (2005) is preferred when referring to this type of
censoring.
Braekers and Veraverbeke (2008) consider a Koziol-Green type model when there is
also dependence between the failure time and censoring variables. This is the situation
that is of interest here. They use a copula function (see Section 2.7) to specify the joint
distribution function of T and C. The copula-graphic estimators from Zheng and Klein
(1995), which were considered in Section 2.9, are extended to the xed design regression
case. This is useful as it allows the incorporation of covariates, but is still not applicable
69to the situation being considered here, as in the xed design regression case, observations
only occur at the xed design points x1;:::;xn. This means that covariates can only take
the predened values x1;x2;:::;xn.
3.3 Siannis (2004) and Siannis et al. (2005) Sensitivity
Analyses
The methods that will now be considered allow the sensitivity of parameter estimates to
informative censoring to be assessed. Firstly, sensitivity analyses for parametric survival
models will be considered. One such approach is given in Siannis (2004) and Siannis et al.
(2005). They use the same assumption about the conditional distribution of C given T to
obtain equations for sensitivity analyses using parametric marginal distributions for T and
C. Siannis et al. (2005) give the method for the simplest case where there is only one type
of censoring in the data set and use exponential marginal distributions in their example.
Siannis (2004) gives an extended version of the sensitivity analysis that allows for non-
informative censoring as well as one type of informative censoring. It is necessary to use
this extended version when applying the sensitivity analysis to the Liver Registration as we
have non-informative end-of-study censoring as well as potentially informative censoring.
The method used to derive the sensitivity analysis equations in this section will be given
in more detail in Chapter 4, where the sensitivity analysis is extended to incorporate
piecewise parametric models. In this section, we will only cover enough of the derivation
of the method in the simplest case where there are only scalar parameters to illustrate
how the sensitivity analysis equations were obtained. Weibull marginal distributions are
used when applying this method to the Liver Registration data set.
The marginal density functions of T and C are given by fT(t;) and fC(c;), where
 is the parameter of interest and  will be treated as a nuisance parameter. This means
there will also be corresponding hazard and survival functions for both T and C. The
score and information functions for the marginal density functions are also required, for
fT(t;) these are dened by
sT(t;) =
@
@
logfT(t;) and i = VarTfsT(T;)g:
We can dene sC(c;) and i similarly. The C variable here relates only to the potentially
informative censoring as no parametric form is assumed for the non-informative censor-
ing. As both informative censoring and non-informative censoring could be observed, the
indicator variable Zi = I(Yi = Ci) is required as well as i = I(Yi = Ti).
The assumption that is used in Siannis (2004) and Siannis et al. (2005) to make the
joint distribution of T and C identiable is that the conditional distribution of C given T
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fC(cjt;;;) = fC(c; + i 1=2
 B(t;)); (3.11)
that is it has the same distribution as the marginal distribution of C but with the parameter
dependent on T = t. The dependence is determined by  and B(t;), where  is a
correlation coecient and B(t;) is a bias function. The conditional density function in
(3.11) can be approximated by
fC(cjt;;;) ' fC(c;)
h
1 + i 1=2
 sC(c;)B(t;)
i
: (3.12)
Let `(;), be the log-likelihood function when T and C are dependent as outlined
above in Section 4.1. Then
`(;) =
n X
i=1
n
i logK1(ti) + Zi(1   i)logK2(ti)
+ (1   i)(1   Zi)logK3(ti)
o
; (3.13)
where
K1(ti) =
Z 1
ti
fT;C(ti;u)du
K2(ti) =
Z 1
ti
fT;C(u;ti)du
and K3(ti) =
Z 1
ti
Z 1
ti
fT;C(t;c)dtdc: (3.14)
These can be thought of as the likelihood contributions for each of the three types of
observations that may occur in each interval. The joint density function fT;C(t;c) is given
by fT(t)fC(cjt;;;) using the approximation of fC(cjt;;;) given in (3.12). When
the forms of the contributions in (3.14) using this form of the joint density function are
substituted in (3.13), then the log-likelihood becomes
`(;) ' `0(;)   i 1=2

n X
i=1
n
iB(ti;)
@
@
HC(ti;)
+ (1   i)(1   Zi)
@
@
HC(ti;)(ti;)
  Zi(1   i)sC(ti;)(ti;)
o
; (3.15)
where
(ti;) =
Z 1
ti
B(u;)fT(u;)du
ST(ti;)
:
For a xed value of , ^  is the value that maximises (3.15). The rst term in (3.15),
`0(;), is the log-likelihood under the assumption that T and C are independent. This
log likelihood is used to nd the maximum likelihood estimates (MLEs), ^ 0 and ^ 0.
71The aim of this method is to approximate the value of ^    ^ 0, which is done by
rearranging Taylor expansions of the score functions
r0(^ 0) =
@
@
`0(;)
 
 
^ 0
and r(^ ) =
@
@
`(;)
 
 
^ 
: (3.16)
The score functions given in (3.16) are expanded about  and set equal to zero to give
r0(^ 0) ' r0()   (^ 0   )i() = 0
r(^ ) ' r()   (^    )i() = 0 (3.17)
where
i() =  
@2
@2`0(;):
Rearranging the two equations in (3.17) gives
(^    ^ 0)i() ' r()   r0():
So, an approximation of the dierence between the parameter estimates is given by
^    ^ 0 ' i 1=2
 (i()) 1
n X
i=1
n
Zi(1   i)sC(ti;)
@(ti;)
@
  (1   Zi)(1   i)
@HC(ti;)
@
@(ti;)
@
  i
@HC(ti;)
@
@B(ti;)
@
o
(3.18)
We can see that in (3.18) there are parameter estimates on the LHS of the approximation
and parameters on the RHS. This is a consequence of rearranging the Taylor expansions of
the score functions, which are given in (3.17). So when the sensitivity analysis is applied,
the parameters on the RHS of (3.18) must be replaced by estimated values.
Before the sensitivity analysis can be applied a form of the bias function B(t;) needs
to be chosen. A detailed explanation of the bias function chosen is given in Section 4.2.1.
The bias function we use is the same as the one used in Siannis et al. (2005). The
expression in (3.18) can also be simplied by assuming a proportional hazards structure.
This is discussed in Section 4.2.2 and the same structure is used in Siannis et al. (2005).
After these changes, the expression in (3.18) becomes
^    ^ 0 ' i() 1
n X
i=1

HT(ti;)HC(ti;)   Zi(1   i)HT(ti;)
	
; (3.19)
where
i() =
n X
i=1
HT(ti;):
72Siannis et al. (2005) include covariates in the sensitivity analysis by replacing  and
 by the linear predictors w(x) = 0x and z(x) = 0x. They derive an expression for
the sensitivity analysis that approximates the dierence between the vectors of parameter
estimates ^  and ^ 0. The vector ^  maximises the log-likelihood
`(;) ' `0(;)   i
 1=2

n X
i=1
n
iB(ti;;x)
@
@
HC(ti;;x)
+ (1   i)(1   Zi)
@
@
HC(ti;;x)(ti;;x)
  Zi(1   i)sC(ti;;x)(ti;;x)
o
; (3.20)
where
(ti;;x) =
Z 1
ti
B(u;;x)fT(u;;x)du
ST(ti;;x)
:
The log-likelihood in (3.20) is the log-likelihood in (3.15) that has been extended to allow
the inclusion of covariates and vectors of parameters. Similarly ^ 0 is the vector of param-
eter estimates that maximises `0(;). We shall express ^    ^ 0 using slightly dierent
notation to Siannis et al. (2005). The equation
^    ^ 0 ' i(;x)
 1(r()   r0()); (3.21)
is found by rearranging vectorised versions of the Taylor expansions in (3.17). The kth
component of r()   r0() is
n X
i=1
xik

HT(ti;;xi)HC(ti;;xi)   Zi(1   i)HT(ti;;xi)
	
: (3.22)
The information matrix is now i(;x), where the (k;l)th element is given by
 
@
@k
@
@l
`0(;;x) = xikxilHT(ti;;xi)
However, Siannis et al. (2005) did not use (3.21) when applying the sensitivity analysis
to data. Instead they performed the sensitivity analysis on w(x) rather than . However,
when applying the sensitivity analysis to the Liver Registration data set we shall the
perform the sensitivity analysis for  as well as that for w(x).
The sensitivity analysis equation for performing the sensitivity analysis equation on
w(x) is now derived. The quantity of interest is now ^ w(x)   ^ w0(x) where ^ w(x) is
the estimated linear predictor using the vector ^  that maximises the log-likelihood in
(3.20). Similarly ^ w0(x) is the estimated linear predictor using the vector ^ 0 that maximises
`0(;). The linear predictors w(x) and z(x) are treated as scalar quantities so the
73sensitivity analysis can be found by replacing  and  in (3.18) by w(x) and z(x). The
sensitivity analysis equation becomes
^ w(x)   ^ w0(x) ' i(w(x))
 1
n X
i=1

HT(ti;w(x))HC(ti;z(x))
  Zi(1   i)HT(ti;w(x))
	
; (3.23)
where
i(w(x)) =  
@
@w(x)
`0(w(x);z(x)) =
n X
i=1
HT(ti;w(x)):
We can see that (3.23) only applies to the covariate vector x, so to estimate the change
in linear predictors for all individuals in the data set, all observed covariate vectors must
be considered. This dependence on the covariate vector x also means that the same
covariates have to be included in both the model for time to death and the model for time
to censoring.
We can see that in (3.21) and (3.23) there is the same issue that was observed in (3.18).
There are parameter estimates on the LHS of the expressions and parameters on the RHS.
This means that the parameters need to be replaced by estimated values when applying
the sensitivity analysis.
3.3.1 Comparison with Scharfstein and Robins (2002)
In this section the assumption in (3.11) will be compared to the assumption used in
Scharfstein and Robins (2002). The aim of this is to make the interpretation of the
assumption in (3.11) easier to understand. Scharfstein and Robins (2002) assume that the
censoring process follows a proportional hazards model, so that the conditional hazard
function for C can be expressed as
hC(cjT;T > c) = hC0(c)exp(q(c;T)); (3.24)
that is the conditional hazard for C given T is the baseline hazard multiplied by a function
of T. The function q(c;T) quanties the dependence between T and C just after time c,
for those who are still at risk at time c. This \censoring bias function" determines the
way T enters the proportional hazards model for the cause-specic hazard of censoring.
So that the two assumptions can be compared, the corresponding conditional hazard
function for the conditional density function in (3.11) needs to be found. The form of
this conditional hazard function is given in Siannis et al (2005) and we shall now give the
derivation of this term. Firstly, we use that
SC(cjT;;;) =
Z 1
c
fC(cjT;;;)dc
' SC(c;)[1   i 1=2
 B(t;)
@
@
HC(c;)];
74which means that the conditional hazard can be expressed as
hC(cjT;;;) =  
@
@c
logSC(cjT;;;)
'  
@
@c

logSC(c;) + log

1   i 1=2
 B(t;)
@
@
HC(c;)

(3.25)
The approximation log(1 + x) ' x is used to simplify the second term in (3.25), so that
the conditional hazard becomes
hC(cjT;;;) '  
@
@c
logSC(c;)  
@
@c

  i 1=2
 B(t;)
@
@
HC(c;)

:
This can be rearranged to give
hC(cjT;;;) ' hC(c;)

1 + i 1=2
 B(t;)
@
@
loghC(c;)

: (3.26)
To be able to compare (3.11) with (3.24), the conditional hazard in (3.11) needs to be
expressed as a proportional hazards model, with the baseline hazard function being mul-
tiplied by some function. To do this, the approximation ex ' 1 + x is used in (3.26), so
that the conditional hazard function is now
hC(c;)exp

i 1=2
 B(T;)
@
@
loghC(c;)

: (3.27)
If (3.27) is compared with (3.24), then we can see the two hazard functions have a
similar form. The baseline hazard in (3.24), has been replaced with a parametric baseline
hazard in (3.27). Also, we see that the specication of q(c;T) in (3.24) is the same as
choosing B(T;) in (3.27). This means that B(T;) also quanties the dependence
between T and C just after time c and determines the way that T enters the proportional
hazards model for censoring.
3.3.2 Application to the Liver Registration data set
This sensitivity analysis is now applied to the Liver Registration data set. Firstly, the
sensitivity analysis will be performed on w(x) and then the sensitivity analysis for  will
be applied. Siannis et al. (2005) assumed exponential marginal models for T and C and
Siannis (2004) used Weibull marginal models for T and C. When applying this method
to the Liver Registration data set, Weibull marginal models are used as these are more
exible than exponential marginal models.
When applying the sensitivity analysis to w(x), the marginal density functions are
given by
fT(t;w(x);T) = ew(x)TtT 1 exp( ew(x)tT) and
fC(t;z(x);C) = ez(x)CtC 1 exp( ez(x)tC):
75This means that the integrated hazard functions are
HT(t;w(x);T) = ew(x)tT and
HC(t;z(x);C) = ez(x)tC: (3.28)
Here the scale parameters w(x) and z(x) are linear predictors that incorporate the follow-
ing covariates: age at registration, ethnicity, primary liver disease category and UKELD
score at registration. The same covariates need to be included in the models for time to
death and time to censoring for this sensitivity analysis.
The sensitivity analysis will be conducted on the scale parameter for T, w(x), as this
is the parameter of interest and the shape parameters, T and C, are treated as nuisance
parameters. The scale parameter for C, z(x), is also treated as a nuisance parameter. If
the integrated hazards in (3.28) are substituted into (3.23) then the sensitivity analysis
equation becomes
^ w(x)   ^ w0(x) ' 
Pn
i=1
n
ez(x)t
T+C
i   Zi(1   i)t
T
i
o
Pn
i=1 t
T
i
: (3.29)
This can be thought of as  multiplied by a sensitivity index, U. As in (3.23), we have
parameter estimates on the LHS of (3.29) and parameters on the RHS. To overcome this
issue when applying the sensitivity analysis, z(x), T and C are replaced by their estimates
from the Weibull proportional hazards model that assumes non-informative censoring. It
is found that ^ T0 = 1:03 and ^ C0 = 0:9297. The estimate for T was not found to be
signicantly dierent from one so an exponential model could be used for T, however the
estimate for C was signicantly dierent from one so the use of Weibull marginal models
is justied.
As there are many dierent combinations of the covariates in the Liver Registration
data set, ^ z0(x) takes a range of values so the sensitivity index needs to be computed over
this range. The easiest way of displaying the results is to plot U over the range of ^ z0(x),
which is shown in Figure 3.9 for  = 0:2 and 0.3. The range of values for ^ z0(x) used on the
horizontal axis in Figure 3.9 is the observed range of ^ z0(x) for the Liver Registration data
set. The largest values of ^ w(x)   ^ w0(x) are observed for patients with the largest values
of ^ z0(x). These are the patients which have the greatest hazard of censoring. We see that
for these individuals, the change in the estimated linear predictor seems large enough that
results obtained assuming non-informative censoring could be misleading. However, to be
sure of this the eect on a value of interest, such as the survival function of individuals
in the data set, should be examined. When we apply the sensitivity analysis derived in
Chapter 4 to the Liver Registration data set, this will be investigated.
The sensitivity analysis for  will now be applied to the Liver Registration data set.
Again Weibull marginal models are assumed for T and C. For simplicity, z(x) will be used
76Figure 3.9: Plot showing  times the sensitivity index, U, over the range of observed values
for ^ z0(x) for the individuals in the Liver registration data set, using  = 0:2 and 0.3.
77as the scale parameter for C, rather than the vector . This means the marginal density
functions are now given by
fT(t;;x;T) = e0xTtT 1 exp( e0xtT) and
fC(t;z(x);C) = ez(x)CtC 1 exp( ez(x)tC):
The integrated hazard functions are now
HT(t;;x;T) = e0xtT and
HC(t;z(x);C) = ez(x)tC: (3.30)
It is the vector of parameters for T, , that is of interest. So, T, C and z(x) will again
be treated as nuisance parameters. For notational simplicity, it is assumed that the same
covariate vector is used in both the model for time to death and the model for time to
censoring. However, it is not a requirement for this sensitivity analysis. Therefore, age,
ethnicity, primary liver disease category and UKELD score are used in the model for time
to death and primary liver disease category, UKELD score, height and blood group are
used in the model for time to censoring.
The sensitivity analysis equation in (3.21) will be used to carry out the sensitivity
analysis for . When substituting the integrated hazard functions in (3.30) into (3.22),
the expression for the kth component of r()   r0() becomes
n X
i=1
xik
n
e0xiez(xi)t
T+C
i   Zi(1   i)e0xit
T
i
o
: (3.31)
and the (k;l)th element of the information matrix i(;x) in (3.21) becomes
n X
i=1
xikxile0xit
T
i :
We can see that in (3.31) we have the parameter vector  as well as z(x), T and C.
These all need to be replaced with their estimates from the Weibull proportional hazards
model that assumes non-informative censoring.
Table 3.1 shows the estimated values of the components of ^    ^ 0 for  = 0:2 and  =
0:3. We see that for some covariates there are positive changes in the parameter estimates,
while others have negative changes in the parameter estimates. Positive values in Table
3.1 mean that the element of ^  for that covariate is larger than the corresponding element
of ^ 0. So, this suggests that the hazard ratio of the covariate is being underestimated by
the model assuming non-informative censoring. Conversely, negative values in Table 3.1
mean that the parameter estimate for the covariate from the model assuming informative
censoring is smaller than the corresponding parameter estimate from the model assuming
78non-informative censoring. Therefore, the sensitivity analysis is suggesting that the hazard
ratio for these covariates are overestimated by the model that assumes  = 0.
So, the sensitivity analysis for  suggests the hazard ratio for patients with hepatitis
B virus infection is being underestimated, whereas the hazard ratios for patients with
other levels of primary liver disease are being overestimated. Patients of either white or
black ethnic origin are having their hazard ratios overestimated, whereas the hazard ratios
for patients of asian or oriental ethnic origin are being underestimated. The sensitivity
analysis also suggests that the hazard ratios for UKELD score and age are being slightly
overestimated by the model that assumes non-informative censoring.
The eects that the estimated changes in Table 3.1 have on the parameter estimates
are shown in Table 3.2. The p-values of the estimates are also shown. These are all calcu-
lated using the standard errors of the estimates from the model assuming non-informative
censoring. This can be done as Siannis et al. (2005) show that
fVar(^ )g1=2 ' fVar(^ 0)g1=2 + O(2):
Only linear values of  are considered in the sensitivity analysis so the standard error of the
parameter estimate from the model assuming informative censoring can be approximated
by the standard error of the parameter estimate from the model assuming non-informative
censoring. This approximation should only be used if the value of  is fairly small.
3.4 Zhang and Heitjan (2006) Sensitivity Analysis
An alternative sensitivity analysis for parametric survival models is presented in Zhang
and Heitjan (2006). Again, the marginal density functions of T and C are given by
fT(t;) and fC(c;), where  is the parameter of interest and  will be treated as a
nuisance parameter. Non-informative censoring could also be observed but no parametric
distribution will be assumed for this type of censoring. Therefore, for simplicity we use
C to denote the informative censoring. As there are several types of censoring that can
be observed in addition to the failure time then two indicator variables are required to
distinguish between the events. These are i = I(Yi = Ti) and Zi = I(Yi = Ci). The
likelihood function that incorporates one type of informative censoring as well as non-
informative censoring is
L(;) =
n Y
i=1
Int
i(1 Zi)
1i Int
Zi(1 i)
2i Int
(1 i)(1 Zi)
3i (3.32)
79Parameter ^ 0:2   ^ 0 ^ 0:3   ^ 0
Intercept 0.5529 0.8293
PLD - PBC -0.0717 -0.1076
PLD - PSC -0.0815 -0.1223
PLD - ALD -0.0343 -0.0515
PLD - AID -0.0675 -0.1013
PLD - HCV -0.0694 -0.1040
PLD - HBV 0.1122 0.1683
PLD - Cancer -0.0675 -0.1012
PLD - Metabolic -0.00001 -0.00002
PLD - Other -0.1027 -0.1540
Ethnicity - White -0.0194 -0.0292
Ethnicity - Asian 0.0325 0.0487
Ethnicity - Black -0.0379 -0.0569
Ethnicity - Chinese 0.0721 0.1082
UKELD score -0.0046 -0.0069
Age -0.0012 -0.0018
Table 3.1: The results of the Siannis sensitivity analysis for  using Weibull marginals.
The table shows each component of the vector ^    ^ 0 for  = 0:2 and  = 0:3.
80Parameter ^ 0 p-value ^ 0:2 p-value ^ 0:3 p-value
Intercept -20.6134 < 0:001 -20.0605 < 0:001 -19.7841 < 0:001
PLD - PBC -0.2260 0.508 -0.2977 0.383 -0.3336 0.328
PLD - PSC -0.9060 0.022 -0.9875 0.013 -1.0283 0.010
PLD - ALD -0.4644 0.138 -0.4987 0.111 -0.5159 0.099
PLD - AID -0.0141 0.966 -0.0817 0.806 -0.1154 0.729
PLD - HCV 0.2715 0.409 0.2022 0.538 0.1675 0.610
PLD - HBV -0.4724 0.418 -0.3602 0.537 -0.3041 0.602
PLD - Cancer -1.4244 0.062 -1.5019 0.050 -1.5357 0.046
PLD - Metabolic 0.6656 0.063 0.6656 0.063 0.6656 0.063
PLD - Other 0.3657 0.282 0.2630 0.439 0.2117 0.534
Ethnicity - White 0.9596 0.342 0.9401 0.351 0.9304 0.356
Ethnicity - Asian -0.0369 0.972 -0.0044 0.997 0.0118 0.991
Ethnicity - Black 0.9273 0.408 0.8894 0.428 0.8704 0.438
Ethnicity - Chinese -0.7135 0.619 -0.6413 0.655 -0.6053 0.673
UKELD score 0.1943 < 0:001 0.1898 < 0:001 0.1875 < 0:001
Age 0.0308 < 0:001 0.0296 < 0:001 0.0290 < 0:001
Table 3.2: The approximate values of the vectors of parameter estimates ^ 0:2 and ^ 0:3 ob-
tained using the results of the Siannis sensitivity analysis given in Table 3.1. The parameter
estimates of the model assuming non-informative censoring are included for comparison.
The p-values of the parameter estimates are also included, they were calculated using the
standard errors of the model assuming non-informative censoring.
81where
Int1i =
Z 1
ti
fT(ti;)fCjT(ujti;;)du
Int2i =
Z 1
ti
fT(u;)fCjT(tiju;;)du and
Int3i =
Z 1
ti
Z 1
ti
fT(u;)fCjT(vju;;)dudv:
So the conditional distribution of C given T needs to be specied so that this likelihood is
well dened. As in Section 3.3 this conditional distribution is assumed to be the same as
the distribution of C but with the parameter allowed to depend on t. However in Zhang
and Heitjan (2006), t replaces i
 1=2
 B(t;) in (3.11).
To evaluate the sensitivity of an estimate of  to small departures of  from zero, the
rate at which ^  departs from ^ 0 as  varies from zero needs to be calculated. Troxel et
al. (2004) gave an index of sensitivity to non-ignorability (ISNI), which is given by
ISNI(^ ) =
@^ 
@

 
 
=0
=  

@2`
@@0
 1 @2`
@@

 
 
=0;^ 0;^ 0
(3.33)
where ` is the logarithm of the likelihood in (3.32).
As ISNI is the derivative of ^  with respect to , the value of ^  for a xed value of  is
approximately
^  ' ^ 0 + ISNI(^ ): (3.34)
When applying the sensitivity analysis described in Section 3.3, the value of ^  for a given
value of  can be approximated by
^  ' ^ 0 + U; (3.35)
so it is possible to compare the values of ISNI(^ ) and U.
Zhang and Heitjan (2006) suggest a method to assess whether ^  is sensitive to the
informative censoring. They dene the inference to be aected by informative censoring if
the estimate changes by more than 1 standard error (SE) of the parameter estimate under
the model that assumes non-informative censoring. The value of  that causes a change
of 1 SE in ^  is
 =
SE(^ 0)
ISNI(^ )
and this is considered to be the smallest value of  that causes a substantial change in
^ . They say that the plausibility of  can be checked by plotting t against a suitable
measure, where t varies over the range of observed values. A suitable measure is one for
which the plausibility is easily assessed, such as the mean or hazard function of C given T.
If the value of  is deemed to be plausible, then ^  is sensitive to the informative censoring
82in the data set. However, no criteria are given to establish whether the values of the
measure are indeed plausible or not. For example, in one application considered in Zhang
and Heitjan (2006) they say that the value of  is plausible because the hazard ratios do
not vary by more than two. However, the choice of this value seems rather arbitrary so
this method does not seem to be that useful when establishing whether ^  is sensitive to
informative censoring.
3.4.1 Application to the Liver Registration data set
Only exponential marginal models for T and C are considered in Zhang and Heitjan
(2006) and the form of ISNI is given just for the situation where there is only informative
censoring considered. As the Liver Registration data set also has some non-informative
censoring, the form of ISNI given in Zhang (2004) is used, which is
ISNI(^ ) =
(
e
^ 0
n X
i=1
ti
) 1

e ^ 0
"
n X
i=1
(1   i)(1   Zi)e^ 0ti   Zi(1   i)(1   tie^ 0)
#
(3.36)
where
e
^ 0 =
Pn
i=1 i(1   Zi)
Pn
i=1 ti
e^ 0 =
Pn
i=1 Zi(1   i)
Pn
i=1 ti
:
If (3.36) is used to calculate the ISNI for the Liver Registration data set when assum-
ing exponential marginal distributions with scalar parameters, then ISNI(^ ) =  757:72.
Zhang and Heitjan (2006) observed values of ISNI(^ ) of a similar magnitude when they
applied the sensitivity analysis to their data. This value of ISNI(^ ) can be compared to
the value of U obtained when applying the Siannis sensitivity analysis to the data set with
the same marginal distributions assumed, where
U =
Pn
i=1 e^ 0t2
i   Zi(1   iti)
Pn
i=1 ti
:
This gives U = 1:05, which gives very dierent results to ISNI. If a positive value of
 is assumed, which assumes positive dependence between T and C, then the value of
ISNI suggests there will be a very large decrease in the parameter estimate, whereas U
suggests there will be a moderate increase in the parameter estimate. The result from
the Siannis sensitivity analysis seems more realistic, as if we assume positive dependence
between T and C and those being censored have a lower expected survival, then a model
that incorporates this dependence should give a value of E(T) = e  that is lower than
under the model that assumes non-informative censoring. This means an increase in the
parameter estimate under the assumption of informative censoring is expected. Observing
83such unexpected values of ISNI(^ ) suggests that there could be an error in the method
presented in Zhang and Heitjan (2006). However, we were unable to nd any errors in the
derivation of (3.36).
The values of  that would give a change in the parameter estimate of one standard
error of ^  under the non-informative censoring model can also be computed and compared.
For the Zhang and Heitjan sensitivity analysis, this is  =  0:000028, and for the Siannis
sensitivity analysis, this is  = 0:021. While both these values are small, the  for
the Zhang and Heijtan sensitivity analysis seems unfeasibly small. However, use of this
method to determine whether ^  is sensitive to informative censoring is not recommended
as the method used to determine whether  is plausible still seems to be subjective.
Covariates are not incorporated in (3.36), although if ^ 0 and ^ 0 are replaced by ^ w0(x) =
^ 
0
0x and ^ z0(x) = ^ 0
0x then the value of ISNI can be calculated over the ranges of ^ w0(x) and
^ z0(x). The covariates included in the vector x are the same as those used when applying
the sensitivity analysis for w(x) from Siannis et al. (2005) to the Liver Registration data
set. These are recipient age, recipient ethnicity, primary liver disease category and UKELD
score. The range of values that ISNI takes when including covariates is shown in the plot
in Figure 3.10 for  = 0:2.
In Figure 3.10, we see that for some parameter combinations, the expected increase
in the parameter estimate is observed, but again this tends to have an extremely large
magnitude that does not seem feasible in reality. However, Figure 3.10 looks at all com-
binations of ^ w0(x) and ^ z0(x) for their observed ranges, when in the Liver Registration
data set only some of these combinations are observed. Figure 3.11 shows the observed
combinations of ^ w0(x) and ^ z0(x) for all the patients in the Liver Registration data set. We
can see that none of the individuals have the combination of ^ w0(x) and ^ z0(x) that gives
the largest value of ISNI. However, if the value of ISNI is calculated for each observed
combination in the Liver Registration data set, it is found that it takes values in the inter-
val (-24663436,4102221). The boundaries of this interval still have such large magnitudes
that these values do not seem realistic.
3.5 Huang and Zhang (2008) Sensitivity Analysis
The previous sections 3.3 and 3.4 considered sensitivity analyses for parametric survival
models. In this section and the following section 3.6, sensitivity analyses that use the Cox
proportional hazards model for the marginal distributions are considered.
The model presented in this section extends the copula approach of Zheng and Klein
(1994) to develop an estimation method for the bivariate proportional hazards model for
competing risks. Marginally, each one of the dependent competing risks under study is
84Figure 3.10: Plot showing  times ISNI, over the range of observed values for ^ z0(x) and
^ w0(x) for patients in the Liver Registration data set, using  = 0:2
85Figure 3.11: Scatterplot showing the observed combinations of ^ w0(x) and ^ z0(x) for all the
patients in the Liver Registration data set.
86modelled by a Cox proportional hazards model. The dependence between T and C is mod-
elled by an assumed copula function. The parameter of this copula function determines
the degree of association that is being assumed. It would be possible to use this model
to conduct a sensitivity analysis for the Cox proportional hazards model by varying the
parameter over a sensible range.
We assume that the marginal hazard functions for Ti and Ci are
hTi(tjZi;Xi) = hT0(t)exp(Z0
iT);
hCi(tjZi;Xi) = hC0(t)exp(X0
iC);
where T and C are unknown parameters, Z and X are covariate vectors and hT0(t)
and hC0(t) are unspecied baseline hazard functions. Their cumulative hazard functions
are denoted by HT0(t) and HC0(t) respectively. We denote their marginal cumulative
distributions functions by FTi(t) and FCi(t) and survival functions by STi(t) and SCi(t).
If we suppose that C(u;v;) is a copula with parameter , then the joint cumulative
distribution function of Ti and Ci is given by
Pr(Ti  t;Ci  c) = CfFTi(t);FCi(c);g
3.5.1 Fitting an extended Cox model that allows for informative cen-
soring
To develop an extended Cox model that allows for informative censoring, Huang and
Zhang (2008) use the idea of \redistribution of mass" that is used in Efron (1967) to
derive self-consistent estimators. This idea was briey explained in Section 2.8, when the
self-consistent estimators that use an assumed copula from Zheng and Klein (1994) were
reviewed, but will be included in more detail in this section.
Assume that yi, i = 1;:::;n; are sorted observation times in ascending order without
ties. If yi is a death time then it is known whether Ti is smaller or greater than t. If yi is a
censored observation time that is greater than or equal to t, then it is also known that the
Ti for this individual is greater than t. However, if yi is a censored observation that is less
than t, it is not known if Ti is greater than t as it could fall between yi and t. Therefore,
some assumption needs to be made about the probability that Ti is greater than t.
If the censoring is assumed to be non-informative then it is assumed that a censored
individual has equal chance of failure at all event times after their observed censoring time.
If there is potentially informative censoring in a dataset, then censored individuals would
no longer have equal change of failure at all event times after their observed censoring
time. One way of specifying the probability of failure at the event times after their
observed censoring time is to use a copula function, as in Zheng and Klein (1994).
87Zheng and Klein (1994) show that under the joint distribution assumption specied
by the copula C, if the subject i is censored at time yi, then for each time point yj > yi,
the probability that this subject i fails at time yj is
Pr(Ti  yjjTi  yi;Ci = yi) =
Pr(Ti  yj;Ci = yi)
Pr(Ti  yi;Ci = yi)
=
1   CvfFTi(yj);FCi(yi)g
1   CvfFTi(yi);FCi(yi)g
; (3.37)
where Cv(a;b) =
@C(u;v)
@v j(u;v)=(a;b). We denote the above conditional survival probability
by Pi(yj), so then the mass that subject i loses at time yj is
Di(yj) = Pi(yj 1)   Pi(yj): (3.38)
Similarly, all the other subjects censored before time yj lose some mass at time point yj.
So we dene an extended partial likelihood function as follows:
L
(T)
j (T) =
j Y
i=1

Pi(yj)exp(Z0
iT)
Pn
k=1 Pk(yj)exp(Z0
kT)
Di(yj)
; (3.39)
L(T)(T) =
n Y
j=1
L
(T)
j (T)
=
n Y
j=1
j Y
i=1

Pi(yj)exp(Z0
iT)
Pn
k=1 Pk(yj)exp(Z0
kT)
Di(yj)
: (3.40)
Here, L
(T)
j (T) is the likelihood function for the time point yj. So that the above equation
is well dened, we need to set Pk(yj) = 1 for k  j. For a failed subject i, set Pi(yj) = 1
for j  i, and Pi(yj) = 0 and j > i. Also for failed subjects, we do not use (3.38), instead
we set Di(yi) = 1, Di(yj) = 0 for j > i. So a failed subject contributes only one term in
this extended partial likelihood function.
When there are tied failure events, then the above equations can naturally handle them
using Breslow's method of handling ties. Also, if the pieces of mass Di(yj), i = 1;:::;j;
are viewed as the number ties at time yj, then we would obtain the form of L
(T)
j (T) in
(3.39) using Breslow's method.
As well as the extended partial likelihood for the failure events, a similar expression is
needed for the censored events. If subject i fails at time yi, then for c > yi, we have
Pr(Ci  cjCi  yi;Ti = yi) =
Pr(Ci  c;Ti = yi)
Pr(Ci  yi;Ti = yi)
=
1   CufFTi(yi);FCi(c)g
1   CufFTi(yi);FCi(yi)g
; (3.41)
where Cu(a;b) =
@C(u;v)
@u j(u;v)=(a;b). We denote the above conditional survival probability
by Qi(c), so then the mass that subject i loses at time yj is
Ui(yj) = Qi(yj 1)   Qi(yj):
88The extended partial likelihood function for censoring events is given by
L(C)(C) =
n Y
j=1
j Y
i=1

Qi(yj)exp(X0
iC)
Pn
k=1 Qk(yj)exp(X0
kC)
Ui(yj)
: (3.42)
So that the above equation well dened, we need to set Qk(yj) = 1 for k  j. For a
censored subject i, set Qi(yj) = 1 for j  i, and Qi(yj) = 0 and j > i. Also we set
Ui(yi) = 1, Ui(yj) = 0 for j > i. For an administratively censored subject i, we set
Pi(yj) = Qi(yj) = 1 for j  i, Pi(yj) = Qi(yj) = 0 for j > i and Di(yj) = Ui(yj) = 0 for
all j.
We can now estimate the parameters T and C by maximising the following extended
joint partial likelihood,
L(T;C) = L(T)(T)L(C)(C): (3.43)
Because the functions in this likelihood involve unknown quantities, then we have to carry
out the following iterative process:
1. Assuming independent censoring, t two Cox proportional hazards models to get
initial estimators ^ 
(0)
T and ^ 
0
C for T and C. Then use the Breslow method to
obtain the estimators ^ H
(0)
T0() for HT0() and ^ H
(0)
C0() for HC0(). Let m = 0.
2. For i = 1;:::;n; compute
^ S
(m)
Ti (t) = exp
n
  ^ H
(m)
T0 (t)exp(Z0
i^ 
(m)
T )
o
;
^ S
(m)
Ci (t) = exp
n
  ^ H
(m)
C0 (t)exp(X0
i^ 
(m)
C )
o
:
Then for each time point yj such that yj > yi, compute
^ P
(m)
i (yj) =
1   Cvf ^ F
(m)
Ti (yj); ^ F
(m)
Ci (yi);g
1   Cvf ^ F
(m)
Ti (yi); ^ F
(m)
Ci (yi);g
;
if subject i is censored;
^ Q
(m)
i (yj) =
1   Cuf ^ F
(m)
Ti (yi); ^ F
(m)
Ci (yj);g
1   Cuf ^ F
(m)
Ti (yi); ^ F
(m)
Ci (yi);g
;
if subject i is failed;
3. Using the above computation results and other specications as described earlier,
replace the unknown functions Pi, Qi, Di, Ui in L(T)(T) and L(C)(C) by their
estimates at step m, and then maximise the likelihood functions in (3.40) and (3.42)
with respect to T and C, respectively. The resulting estimators for T and C
are denoted by ^ 
(m+1)
T and ^ 
(m+1)
C .
894. Use ^ 
(m+1)
T , ^ 
(m+1)
C , ^ P
(m)
i (), ^ Q
(m)
i (), ^ D
(m)
i () and ^ U
(m)
i () to obtain the Breslow
estimators ^ H
(m+1)
T0 () for HT0() and ^ H
(m+1)
C0 () for HC0(), as shown below:
^ H
(m+1)
T0 (t) =
X
j:yjt
P
i:yiyj
^ D
(m)
i (yj)
Pn
k=1 ^ P
(m)
k (yj)exp(Z0
k^ 
(m+1)
T )
;
^ H
(m+1)
C0 (t) =
X
j:yjt
P
i:yiyj
^ U
(m)
i (yj)
Pn
k=1 ^ Q
(m)
k (yj)exp(X0
k^ 
(m+1)
C )
:
5. Let m = m + 1, return to Step 2, and iterate until convergence.
After convergence, we get estimators ^ T, ^ C, ^ HT0() and ^ HC0(), respectively, for T,
C, HT0() and HC0().
3.5.2 Applying sensitivity analysis to the Liver Registration dataset
Before using the method presented above to estimate the bivariate proportional hazards
model for competing risks, we tted Cox proportional hazards models for both time to
censoring and time to death assuming independent censoring. We selected covariates for
these models using a stepwise selection algorithm. We set a p-value of 0.15 as the threshold
for variables both to be entered into and stay in the model. This is larger than would
usually be used, but this is because p-values will change under the model presented here,
and we want to include any variables that might become signicant. Also we shall include
covariates that are included in the Cox proportionals hazards models for either time to
death or time to censoring, so that we are including more covariates than used in other
methods.
Table 3.3 compares the results for models for time to death under independent censor-
ing and assuming that the dependence between T and C is modelled by a Clayton copula
with Kendall's  = 0:2.
This table shows that we draw roughly the same conclusions under the two models.
All the parameter estimates remain the same sign with the exception those for serum
creatinine and patients with AIDS. However, the p-values show that both of these param-
eter estimates are not signicant under either the Cox model or the Huang-Zhang model.
There are only a small number of levels of categorical variables that have gone from be-
ing non-signicant under the model assuming independent censoring to signicant under
the Huang-Zhang model. These are for patients with AB blood group, patients of black
ethnicity, patients with alcoholic liver disease and patients with liver diseases that are not
included in any of the other main categories.
We can also examine the changes between the parameter estimates in Table 3.3 to see
whether the standard Cox proportional hazards model overestimated or underestimated
90Cox PH model Huang-Zhang model
Variable ^  s.e. p value ^  s.e. p value
Age 0.0330 0.0063 < 0:001 0.0273 0.0031 < 0:001
Height 0.0039 0.0072 0.586 0.0067 0.0039 0.091
Blood group - AB 0.5012 0.3225 0.120 0.7324 0.1359 < 0:001
Blood group - B 0.4196 0.2013 0.037 0.4314 0.0969 < 0:001
Blood group - O 0.1717 0.1311 0.190 0.0510 0.0647 0.430
Sex - Male -0.0150 0.1669 0.928 -0.0140 0.0875 0.873
Ethnicity - Black 1.0170 0.5938 0.087 0.5327 0.2666 0.046
Ethnicity - Other -0.3268 0.7815 0.676 -0.2090 0.3176 0.511
Ethnicity - White 1.0974 0.3200 0.001 0.8004 0.1360 < 0:001
INR -0.2862 0.1166 0.014 -0.1598 0.0527 0.002
Bilirubin -0.0010 0.0007 0.191 -0.0002 0.0003 0.643
Sodium 0.0918 0.0257 < 0:001 0.0654 0.0121 < 0:001
UKELD 0.2984 0.0353 < 0:001 0.2374 0.0161 < 0:001
Creatinine -0.0003 0.0012 0.771 0.0001 0.0007 0.868
PLD - AID 0.0289 0.3481 0.934 -0.0772 0.1690 0.648
PLD - ALD -0.4126 0.3363 0.220 -0.4593 0.1609 0.004
PLD - Cancer -1.1880 0.7813 0.128 -0.3808 0.2310 0.099
PLD - HBV -0.4510 0.5889 0.444 -0.4160 0.2530 0.100
PLD - HCV 0.2904 0.3457 0.401 0.1856 0.1669 0.266
PLD - Metabolic 0.8390 0.3700 0.023 0.7568 0.1848 < 0:001
PLD - Other 0.4295 0.3467 0.216 0.3359 0.1694 0.047
PLD - PBC -0.2154 0.3634 0.553 -0.2665 0.1741 0.126
PLD - PSC -1.0029 0.4063 0.014 -0.8413 0.1809 < 0:001
Table 3.3: Results from tting a standard Cox proportional hazards model and the Huang-
Zhang model using a Clayton copula with Kendall's  = 0:2
91the hazard ratios for each covariate. If there is an increase in the value of ^  from the
Cox model to the Huang-Zhang model, then the estimated hazard ratio would also in-
crease. This suggests that the hazard ratio is underestimated by the standard Cox model.
Conversely, if there is a decrease in ^  from the standard Cox model to the Huang-Zhang
model then the hazard ratio is being overestimated by the standard Cox model. The
results in Table 3.3 suggest that the standard Cox model overestimates the hazard ratio
for the following covariates and levels of factors: height, blood groups AB and B, males,
ethnicities that are not one of the main categories, INR, serum bilirubin, and patients
with cancer, hepatitis B virus or primary sclerosing cholangitis. The parameter estimates
in Table 3.3 also suggest that the standard Cox model underestimates the hazard ratio for
the following covariates and levels of factors: age, blood group O, black and white eth-
nicity, serum sodium, UKELD score and patients with alcoholic liver disease, hepatitis C
virus, metabolic liver disease, primary biliary cirrhosis or other liver diseases not included
in the main categories.
3.6 Siannis (2011) Sensitivity Analysis
The sensitivity analysis here uses a similar approach to that of Siannis (2004) and Siannis
et al. (2005) but instead of considering parametric survival models, it uses the Cox
proportional hazards model.
It is still assumed that
fCjT(cjt;;;) = fC(c; + i 1=2
 B(t;)); (3.44)
but now this function is written in terms of an unspecied baseline hazard multiplied by a
parametric function instead of a known parametric baseline hazard. The Cox proportional
hazards model assumes that
hT(t;i) = eihT0(t);
with i usually expressed as 0
Txi to incorporate the covariates in the vector xi. Therefore
the quantity of interest is now T. The hazard function for C can be expressed in a
similar form, with the corresponding vector of regression coecients denoted by C. For
simplicity, C is assumed to have the same covariate vector xi as T.
To derive a partial likelihood for the proportional hazards model when there is poten-
tially informative censoring, the competing risks set up is used. This means that T and C
are seen as two competing causes of failure with the observed time for individual i being
Yi = min(Ti;Ci). The cause of the failure, J, is also observed. As there are two competing
causes of failure, then J can take values 1 or 2. Let J = 1 denote that the observed time
is a failure time and J = 2 denote that it is a censored observation. The competing risks
92set up considers the sub-hazard function of cause j, which is dened as
h(j;t;) = lim
dt!0+
P(t  Y < t + dt;J = jjY  t;)
dt
and is the hazard of failure from cause j in the presence of all the other causes. The
sub-hazard function h(T;t;) will be the same as the marginal hazard function hT(t;) if
there is no informative censoring.
The competing risks partial likelihood,
L
p =
n Y
i=1
h(j;tijxi)
P
l2Rti h(j;tljxl)
;
where Rti is the risk set at time ti, uses sub-hazard functions instead of marginal hazard
functions like the ordinary partial likelihood. When the two causes being considered are
Tand C, each death time contributes
h(T;tjxi)
P
l2Rt h(T;tjxi)
to the likelihood, while each censored time c contributes
h(C;cjxi)
P
q2Rc h(C;cjxi)
to the likelihood. The product of the contributions from all the individuals in the data
set gives the modied partial likelihood (MPL),
LM =
nT Y
i=1
h(T;tijxi)
P
l2Rti h(T;tljxl)
nC Y
k=1
h(C;tkjxk)
P
q2Rtk h(C;tqjxq)
(3.45)
where nT is the number of deaths and nC is the number of censored observations. If the
censoring is assumed to be ignorable, then the sub-hazards in (3.45) would be equal to
the marginal hazards and it would become
Lp =
nT Y
i=1
e0
Txi
P
l2Rti e0
Txl
nC Y
k=1
e0
Cxk
P
q2Rtk e0
Cxq ;
which is the product of two ordinary partial likelihoods.
Using the assumption in (3.44), Siannis (2011) show that a rst-order approximation
with respect to  of the sub-hazard function of T is
h(T;tjx) ' hT(t;Tjx)
h
1 + i 1=2
 T(t;Tjx) (tjx)
i
(3.46)
where
(t;Tjx) =
R 1
t B(u;Tjx)fT(u;Tjx)du
ST(t;Tjx)
;
T(t;Tjx) =
@(t;Tjx)
@T
and  (tjx) =
HC(t;Cjx)
hT(t;Tjx)
:
93Similarly it can be shown that an approximation of the sub-hazard function for C is
h(C;tjx) ' hC(t;Cjx)
h
1 + i 1=2
 (t;Tjx)
i
: (3.47)
The approximations in (3.46) and (3.47) can be substituted into (3.45) so that the MPL
becomes
LM =
nT Y
i=1
8
<
:
e0
Txi
h
1 + i
 1=2
 T(ti;Tjxi) (tijxi)
i
P
l2Rti e0
Txl
h
1 + i
 1=2
 T(tl;Tjxl) (tljxl)
i
9
=
;

nC Y
k=1
8
<
:
e0
Cxk
h
1 + i
 1=2
 (tk;Tjxk)
i
P
q2Rtk e0
Cxq
h
1 + i
 1=2
 (tq;Tjxq)
i
9
=
;
: (3.48)
The MPL in (3.48) can be manipulated to obtain an approximation of the dierence
between the estimated regression coecients for T under the assumption of informative
censoring and under the assumption of non-informative censoring,
^ T   ^ T0 = fi(T)g 1f
nT X
i=1
[
@Gi
@T
] +
nC X
k=1
[
@Kk
@T
  xkHT(tk;Tjxk)]g; (3.49)
where
Gi =
P
l2Rti e0
TxlHC(ti;Cjxl)
P
l2Rti e0
Txl
Kk =
P
q2Rtk e0
CxqHT(tk;Tjxq)
P
q2Rtk e0
Cxq and
i(T) =  
@2 logLp
@T@0
T
:
Equation (3.49) can be used to conduct a sensitivity analysis for T as  makes small
departures from zero. This involves much more computation than the sensitivity analysis
presented by Siannis (2004) and Siannis et al. (2005). Estimation of the baseline hazard
function is required for use in the cumulative hazard functions in (3.49).
This sensitivity analysis can be extended to the situation where there are several types
of censoring, one of which is potentially informative and one which is ignorable. The
informative censoring process, CI, is allowed to contribute information to the likelihood
as before and the ignorable censoring process CE contributes only to the denition of the
risk sets. So if there are nCI potentially informative censored observations out of a total
of nC censored observations, then the MPL takes the form,
LI
M =
nT Y
i=1
h(T;tijxi)
P
l2Rti h(T;tijxi)
nCI Y
k=1
h(CI;tkjxk)
P
q2Rtk h(CI;tqjxq)
:
This is similar to (3.45) but with the second product only over the nCI potentially infor-
matively censored observations, rather than all the censored observations.
943.6.1 Application to the Liver Registration data set
The sensitivity analysis for the Cox proportional hazards model that was described in
Section 3.6 is applied to the Liver Registration data set in this section. As both potentially
informative and non-informative censoring is observed in this data set, then the sensitivity
analysis that allows several types of censoring is used. This means the sensitivity analysis
equation in (3.49) becomes
^ T   ^ T0 = fi(T)g 1f
nT X
i=1
[
@Gi
@T
] +
nCI X
k=1
[
@Kk
@T
  xkHT(tk;Tjxk)]g: (3.50)
The equation in (3.50) is almost identical to (3.49), but with the second summation only
over those patients who are potentially informatively censored. We see that to apply the
sensitivity analysis, we require estimates of T and C, as well as the baseline hazard
functions HT(tk;Tjxk) and HC(tk;Cjxk).
The parameter estimates substituted into (3.50) will be those from the Cox propor-
tional hazards model assuming non-informative censoring. The estimated values of T and
C when it is assumed that  = 0 are given in Tables 3.4 and 3.5. The same covariates
were used in both the model for time to failure and the model for time to censoring. These
covariates were primary liver disease category, ethnicity, UKELD score, age, serum sodium
at time of registration and INR at time of registration. These are the variables that were
found to be signicant for time to failure when tting a Cox proportional hazards model.
The baseline hazard functions in (3.50) are estimated by the Breslow estimate of the
baseline cumulative hazard function. This is a step function where
~ H0(t) =
k X
j=1
dj
P
l2R(t(j)) exp(^ 
0
xl)
for t(k)  t < t(k+1), k = 1;2;:::;r 1, where dj is the number of events at the jth ordered
event time t(j) and r is the total number of events observed.
Table 3.6 shows the estimated values of the components of ^ T   ^ T0 for  = 0:2 and
 = 0:3. Positive changes in the parameter estimates mean that the hazard ratios of the
covariates are being underestimated by the model assuming non-informative censoring.
Conversely, negative changes in the parameter estimates mean that the hazard ratios for
the covariates are overestimated by the model that assumes  = 0.
From Table 3.6, we can see that the sensitivity analysis for the Cox proportional
hazards model suggests most of the hazard ratios for the levels of primary liver disease
category are being overestimated by the model that assumes non-informative censoring,
with the exception of patients with cancer or hepatitis B infection. The sensitivity analysis
also suggests that the hazard ratios for all levels of patient ethnicity, the UKELD score,
95Parameter Estimate Standard p-value Hazard 95% Condence
Error Ratio Interval for
Parameter Estimate
PLD - PBC -0.1647 0.3442 0.632 0.848 (-0.839,0.510)
PLD - PSC -0.9295 0.3978 0.020 0.395 (-1.709,-0.150)
PLD - ALD -0.2665 0.3222 0.408 0.766 (-0.898,0.365)
PLD - AID 0.1275 0.3392 0.707 1.136 (-0.537,0.792)
PLD - HCV 0.4138 0.3371 0.220 1.513 (-0.247,1.075)
PLD - HBV -0.4116 0.5820 0.480 0.663 (-1.552,0.729)
PLD - Cancer -1.0664 0.7754 0.169 0.344 (-2.586,0.453)
PLD - Metabolic 0.9208 0.3662 0.012 2.511 (0.203,1.639)
PLD - Other 0.4064 0.3438 0.237 1.501 (-0.267,1.080)
PLD - Acute 0
Ethnicity - White 1.1246 1.0080 0.265 3.079 (-0.851,3.100)
Ethnicity - Asian 0.0538 1.0484 0.959 1.055 (-2.001,2.109)
Ethnicity - Black 1.0239 1.1218 0.361 2.784 (-1.175,3.223)
Ethnicity - Chinese -0.4562 1.4345 0.751 0.634 (-3.268,2.355)
Ethnicity - Other 0
UKELD 0.2628 0.0192 < 0:001 1.301 (0.225,0.300)
Age 0.0331 0.0062 < 0:001 1.034 (0.021,0.045)
Sodium 0.0701 0.0169 < 0:001 1.073 (0.037,0.103)
INR -0.2300 0.0986 0.020 0.795 (-0.423,-0.037)
Table 3.4: The parameter estimates, estimated hazard ratios, p-values and 95% condence
intervals from the Cox model for time to failure assuming non-informative censoring
96Parameter Estimate Standard p-value Hazard 95% Condence
Error Ratio Interval for
Parameter Estimate
PLD - PBC -0.2282 0.1448 0.115 0.796 (-0.512,0.056)
PLD - PSC -0.1403 0.1447 0.333 0.869 (-0.424,0.143)
PLD - ALD -0.2081 0.1353 0.124 0.812 (-0.473,0.057)
PLD - AID -0.1788 0.1448 0.217 0.836 (-0.463,0.105)
PLD - HCV 0.0545 0.1400 0.697 1.056 (-0.220,0.329)
PLD - HBV 0.1567 0.1815 0.388 1.170 (-0.199,0.512)
PLD - Cancer 0.6728 0.1585 < 0:001 1.960 (0.362,0.983)
PLD - Metabolic 0.0645 0.1705 0.705 1.067 (-0.270,0.399)
PLD - Other -0.4106 0.1492 0.006 0.663 (-0.703,-0.118)
PLD - Acute 0
Ethnicity - White 0.3841 0.2550 0.132 1.468 (-0.116,0.884)
Ethnicity - Asian 0.3081 0.2635 0.242 1.361 (-0.208,0.825)
Ethnicity - Black 0.4820 0.2959 0.103 1.619 (-0.098,1.062)
Ethnicity - Chinese 0.8348 0.3731 0.025 2.304 (0.104,1.566)
Ethnicity - Other 0
UKELD 0.0538 0.0078 < 0:001 1.055 (0.038,0.069)
Age 0.0012 0.0023 0.595 1.001 (-0.003,0.006)
Sodium 0.0316 0.0076 < 0:001 1.032 (0.017,0.046)
INR -0.0405 0.0416 0.330 0.960 (-0.122,0.041)
Table 3.5: The parameter estimates, estimated hazard ratios, p-values and 95% condence
intervals from the Cox model for time to censoring assuming non-informative censoring
97serum sodium and INR are being underestimated by the model that assumes  = 0.
Finally, the sensitivity analysis suggests that the hazard ratio for age is being slightly
overestimated.
The results of this sensitivity analysis for the Cox proportional hazards model in Table
3.6 can be compared to the results of the sensitivity analysis for a Weibull proportional
hazards model in Table 3.1 in Section 3.3.2. Both of the sensitivity analyses are approxi-
mating the change in parameter estimates if informative censoring is assumed instead of
non-informative censoring. Both models include primary liver disease category, age, eth-
nicity and UKELD score, so the estimated changes in the parameter estimates for these
variables can be compared.
The sensitivity analyses applied in this section and Section 3.3.2 give similar results for
the majority of the parameter estimates. However, the sensitivity analysis from Siannis
(2004) suggests that the hazard ratio for cancer patients is overestimated while the sensi-
tivity analysis from Siannis (2011) suggest this hazard ratio is being underestimated. Also,
the sensitivity analysis from Siannis (2011) suggests that the hazard ratios for all levels
of ethnicity are being underestimated, but the sensitivity analysis from Siannis (2004)
suggests that the hazard ratios for white and black patients are being overestimated. The
two approaches also disagree about the eect of informative censoring on the hazard ratio
for the UKELD score. Siannis (2004) suggests it is being overestimated by the model that
assumes  = 0, whereas Siannis (2011) suggests it is underestimated.
Tables 3.7 and 3.8 show the approximate parameter estimates for Cox proportional
hazards models assuming  = 0:2 and  = 0:3 respectively. These parameter estimates are
obtained by adding the parameter estimates from the model assuming non-informative
censoring in Table 3.4 to the values in Table 3.6. The p-values of the estimates are
also shown. These are all calculated using the standard errors of the estimates from the
model assuming non-informative censoring. The reason that we can do this was discussed
previously in Section 3.3.2. It was shown in Siannis et al. (2005) that
SE(^ ) ' SE(^ 0) + O(2):
As only linear values of  are considered in the sensitivity analysis then the standard
error of the parameter estimate from the model assuming informative censoring can be
approximated by the standard error of the parameter estimate from the model assuming
non-informative censoring. Again, this only applies if the value of  is fairly small.
3.7 Rotnitzky et al. (2007) Sensitivity Analysis
In sections 3.3 to 3.6, the sensitivity analyses assess the sensitivity of the results under the
assumption of non-informative censoring if informative censoring is assumed instead. The
98Parameter ^ T0:2   ^ T0 ^ T0:3   ^ T0
PLD - PBC -0.0625 -0.0937
PLD - PSC -0.0746 -0.1119
PLD - ALD -0.0483 -0.0724
PLD - AID -0.0604 -0.0906
PLD - HCV -0.0243 -0.0365
PLD - HBV 0.0931 0.1397
PLD - Cancer 0.0172 0.0258
PLD - Metabolic -0.0423 -0.0634
PLD - Other -0.0919 -0.1379
Ethnicity - White 0.0502 0.0754
Ethnicity - Asian 0.0605 0.0908
Ethnicity - Black 0.0505 0.0757
Ethnicity - Chinese 0.2376 0.3564
UKELD 0.0039 0.0058
Age -0.00003 -0.00005
Sodium 0.0028 0.0042
INR 0.0118 0.0177
Table 3.6: The estimated values of ^ T   ^ T0 for  = 0:2 and  = 0:3, calculated by
applying the Siannis (2011) sensitivity analysis to the Liver Registration data set
99Parameter Estimate Hazard Ratio p-value 95% Condence
Interval
PLD - PBC -0.2272 0.797 0.509 (-0.902,0.573)
PLD - PSC -1.0041 0.366 0.012 (-1.784,-0.075)
PLD - ALD -0.3148 0.730 0.329 (-0.946,0.413)
PLD - AID 0.0671 1.069 0.843 (-0.598,0.853)
PLD - HCV 0.3895 1.476 0.248 (-0.271,1.099)
PLD - HBV -0.3184 0.727 0.584 (-1.646,0.822)
PLD - Cancer -1.0493 0.350 0.176 (-2.603,0.470)
PLD - Metabolic 0.8786 2.408 0.016 (0.161,1.681)
PLD - Other 0.3145 1.370 0.360 (-0.359,1.172)
PLD - Acute 0
Ethnicity - White 1.1749 3.238 0.244 (-0.901,3.151)
Ethnicity - Asian 0.1143 1.121 0.913 (-2.062,2.169)
Ethnicity - Black 1.0744 2.928 0.338 (-1.225,3.273)
Ethnicity - Chinese -0.2186 0.804 0.879 (-3.506,2.593)
Ethnicity - Other 0
UKELD 0.2667 1.306 < 0:001 (0.221,0.304)
Age 0.0331 1.034 < 0:001 (0.021,0.045)
Sodium 0.0729 1.076 < 0:001 (0.034,0.106)
INR -0.2300 0.804 0.027 (-0.435,-0.025)
Table 3.7: The parameter estimates, estimated hazard ratios, p-values and 95% condence
intervals for the Cox model assuming informative censoring with  = 0:2. These values
were found using the estimates from the Cox model assuming non-informative censoring
and the estimated dierences from the Siannis (2011) sensitivity analysis.
100Parameter Estimate Hazard Ratio p-value 95% Condence
Interval
PLD - PBC -0.2584 0.772 0.453 (-0.933,0.604)
PLD - PSC -1.0414 0.353 0.009 (-1.821,-0.038)
PLD - ALD -0.3389 0.713 0.293 (-0.970,0.437)
PLD - AID 0.0369 1.038 0.914 (-0.628,0.883)
PLD - HCV 0.3774 1.458 0.263 (-0.283,1.111)
PLD - HBV -0.2719 0.762 0.640 (-1.692,0.869)
PLD - Cancer -1.0407 0.353 0.180 (-2.612,0.479)
PLD - Metabolic 0.8575 2.357 0.019 (0.140,1.702)
PLD - Other 0.2685 1.308 0.435 (-0.405,1.218)
PLD - Acute 0
Ethnicity - White 1.2000 3.320 0.234 (-0.927,3.176)
Ethnicity - Asian 0.1446 1.156 0.890 (-2.092,2.200)
Ethnicity - Black 1.0996 3.003 0.327 (-1.251,3.298)
Ethnicity - Chinese -0.0998 0.905 0.945 (-3.624,2.712)
Ethnicity - Other 0
UKELD 0.2686 1.308 < 0:001 (0.219,0.306)
Age 0.0331 1.034 < 0:001 (0.021,0.045)
Sodium 0.0743 1.077 < 0:001 (0.033,0.108)
INR -0.2123 0.809 0.031 (-0.441,-0.019)
Table 3.8: The parameter estimates, estimated hazard ratios, p-values and 95% condence
intervals for the Cox model assuming informative censoring with  = 0:3. These values
were found using the estimates from the Cox model assuming non-informative censoring
and the estimated dierences from the Siannis (2011) sensitivity analysis.
101sensitivity analysis presented in this section has a dierent aim from all the sensitivity
analyses considered so far. Rotnitzky et al. (2007) derive a sensitivity analysis that as-
sesses the sensitivity of an estimator that accounts for informative censoring by adjusting
for measured prognostic factors to dierent levels of residual dependence. The estima-
tor accounts for potentially informative censoring by assuming sequential ignorability of
censoring which means that after adjusting for all the measured prognostic factors, the
time to event variables and time to censoring variables are independent of each other.
However, it is possible that some of the dependence between the two variables could be
due to unmeasured factors, which is called residual dependence.
A semi-parametric model was used in Scharfstein and Robins (2002) to allow for resid-
ual dependence between the two variables after incorporating a vector of covariates. How-
ever, this model only allowed one censoring mechanism. This meant that either all the
censoring in a data set would have to be treated as informative, even if is administrative
censoring, or any data after the rst occurrence of administrative censoring is disregarded.
Scharfstein and Robins (2002) adopt the latter strategy. An extension of this model was
presented in Rotnitzky et al. (2007) that allowed for multiple causes of censoring. This is
the model that will be used here as there is administrative censoring as well as possibly
informative censoring in the Liver Registration data set.
In Section 3.7.1 all the necessary notation for the model is presented and the form of
the model that will be used is given. This model will then be used to conduct a sensitivity
analysis for the assumption of sequential ignorability of censoring for the Liver Registration
data set.
3.7.1 Notation
All of the variables dened in this section come from Rotnitzky et al. (2007), although in
some cases the notation used has been changed slightly so that it is consistent with the
notation used in the rest of this chapter.
Let T and C be the times from entry into the study to the time of death and time
of censoring, respectively. The maximum follow-up time that will be used when applying
this method is . As it is possible that either of these events could occur after time , we
dene T = min(T;) and C = min(C;). However, Y = min(T;C) is actually observed.
The maximum possible follow-up time for any patient is . However, for a technical
reason, any data that was recorded after time  =    , where  is a small positive
number, needs to be disregarded. The technical reason is that the condition
hC;j(ujV H(u);T;T > u) < K with probability 1; (3.51)
102where
hC;j(uj;T > u) = lim
du!0
fPr(u  C < u + du;J = jjC  u;T > u;)=dug;
has to hold for all u 2 (0;) and some constant K. Condition (3.51) will be false when
 =  since all patients who are uncensored just before  will be censored when the
study ends at this time. Therefore  =     for some  > 0 is used instead.
A vector of covariates V(t) is recorded at either predetermined or random times. The
history of this covariate vector is dened as  V(t) = fV(u);0  u  tg. The vector of
baseline covariates is V(0), and for u > 0, V(u) is the vector of covariate values at time
u, if it happened to be a measurement time, or the last values recorded before u if it was
not a measurement time.
As we are allowing several types of censoring within the model, a variable that dis-
tinguishes between the dierent types is needed. Let J 2 f1;2;:::;jg denote the cause
of censoring, where j is the number of dierent censoring types. There is also the event
indicator  = I(T  C), and we let J = 0 if  = 1.
So, the observed data are the independent and identically distributed O1;:::;On,
where Oi = (i;Yi;Ji;  V(Yi)). These will be used to estimate ST(t) = Pr(T > t) for
any t 2 (0;).
We will consider estimators of ST(t) under the following assumption about the cen-
soring variables, for j = 1;:::;j and u 2 [0;),
hC;jfuj V(u);T;T > ug = h0;jfu;  V(u)gexp[qjfu;  V(u);Tg] (3.52)
where h0;jfu;  V(u)g is an unknown non-negative function of both u and  V(u). The func-
tions qjfu;  V(u);Tg, are known functions of u,  V(u) and T, that are called cause-specic
censoring bias functions. They measure the dependence on the hazard ratio scale between
T and censoring due to cause j at time u, after adjusting for the measured prognostic
factors in  V(u). If qj is set to zero, then for censoring cause j, sequential ignorability of
censoring is being assumed. This is the assumption used in Robins and Finkelstein (2000)
when constructing IPCW estimators. This assumes that time to death and time to censor-
ing are independent after adjusting for covariates that are prognostic factors for both the
time to death and time to censoring variables. If no prognostic factors are included in the
model and qj is set to zero, then this is equivalent to the assumption of non-informative
censoring.
The model presented in (3.52) is referred to as model Aq. Is is only possible estimate
ST(t) under this model when  V(u) is low dimensional, such as equal to a single base-
line discrete covariate V for all u. This is because estimation of ST(t) under this model
103requires estimation of
H0;jfu;  V(u)g =
Z u
0
h0;jfs;  V(s)gds; forj = 1;:::;j:
This is not feasible when  V(u) is high dimensional, so when this is the case the dimen-
sionality of the unknown functions h0;jfu;  V(u)g needs to be reduced. This can be done
by assuming a semi-parametric model of the form
h0;jfu;  V(u)g = h0;j(u)exp[0
jwjfu;  V(u)g] j = 1;:::;j (3.53)
where h0;j() is an unknown function, wjfu;  V(u)g is a specied vector function of  V(u)
and j is a vector of unknown parameters.
When the additional restriction in (3.53) is imposed on model Aq, then the resulting
model is called model Bq.
3.7.2 Estimation identities
This section outlines the identities that are required to construct the estimator of ST(t),
all of which are given in Rotnitzky et al. (2007). The fundamental identity used is
E


fuj V(u);T;H0g
fTj V(u);T;H0g
 V(u);T;T > u;Y  u

= 1 for all u 2 (0;]: (3.54)
where
fuj V(u);T;H0g = exp

 
Z t
0
hCfuj V(u);T;T > ugdu

=
j
Y
j=1
Y
0ut
 
1   exp[qjfu;  V(u);Tg]dH0;jfu;  V(u)g

:
This identity implies that ST(t) is the solution of the population moment equation
E


fTj V(T);T;h0g
fI(T > t)   ST(t)g

= 0: (3.55)
We shall impose the condition that for all u 2 (0;) and some constant K,
hC;jfuj V(u);T;T > ug < K with probability 1
so that under this condition and model Bq, (3.54) implies that H0;jfu;  V(u)g satises
H0;j(u) =
Z u
0
hC;j(sjT > s)ds
E


fsj  V(s);T;H0g
fTj  V(T);T;H0g exp
h
0
jwjfs;  V(s)g + qjfs;  V(s);Tg
i
C  s;T > s
: (3.56)
104It also follows from identity (3.54) that, under model Bq, when  and H0 are set at
their true values,
EfdMC;j(u;H0;)j V(u);T;T > u;Y  ug = 0
where
dMC;j(u;H0;) = dNC;j(u)   
fuj V(u);T;;H0g
fTj V(T);T;;H0g
dH0;j(u)rjfu;  V(u);T;jg; (3.57)
rjfu;  V(u);T;jg = exp

0
jwjfu;  V(u)g + qjfu;  V(u);Tg

and
NC;j(u) = I(C  u;J = j):
The functions fj V();T;;H0g in (3.57) are dened like fj V();T;H0g but with
exp[qjfu;  V(u);Tg] and H0fu;  V(u)g replaced by rjfu;  V(u);T;jg and H0(u) respec-
tively.
However, we shall construct estimating equations from Efm(O;;H0;a)g = 0, where
for any collections of functions a = fajf;  V()g : j = 1;:::;jg, we have
m(O;;H;a) =
j
X
j=1
Z
dMC;j(u;H0;)ajfu;  V(u)gI(T > u;Y  u): (3.58)
This equation is used to construct estimating equations as it depends only on observables
and is satised at the true values of  and H0.
3.7.3 Parameter estimation under model Bq
In this section, the estimating equations used to nd estimates of H0,  and nally ST(t)
are given. Again all these equations come from Rotnitzky et al. (2007).
Under model Bq,  has to be estimated before an estimator of ST(t) can be found. If
H0 were known, then  could be estimated using
X
i
m(Oi;;H0;d) = 0;
where djfu;  V(u)g are user-specied functions. Rotnitzky et al. (2007) say that a natural
choice is
djfu;  V(u)g = (00;wj(u;  V(u))0;00)0;
where the rst and last 0 are zero vectors with
Pj 1
l=1 dim(l) and
Pj
l=j+1 dim(l) rows
respectively. This form for djfu;  V(u)g is also used here.
As H0 is unknown, then it has to be estimated. Equation 3.56 cannot be used to
construct an estimator for H0 as the RHS of the equation still depends on . However,
105a prole estimator ~ H
0;j(u) can be computed by solving the empirical version of (3.56) for
each xed , using that (3.56) is equivalent to
H
0;j(u) =
Z u
0
 dFXj=0;J=j(s)Pr( = 0;J = j)
E
h
I(T  s)
fsj  V(s);T;;H
0 g
fTj  V(T);T;;H
0 grjfs;  V(s);T;jg
i:
So, ~ h
0;j(u) = 0 if u is not a censoring time, and at each Cm, ^ h0;j is the solution to
~ h
0;j(Cm) =
n(j)
m
"
n X
i=1
iI(Ti > Cm)
fC 
mj Vi(C 
m);Ti;; ~ H
0 g
fTij Vi(Ti);Ti;; ~ H
0 g
rjfCm;  Vi(Cm);Ti;jg
# 1
where, for each ,
fuj V(u);T;; ~ H
0 g =
j
Y
j=1
Y
C`j0<C`u
h
1   ~ h
0;j(C`)rjfC`;  V(C`);T;jg
i
;
and fu j V(u );T;; ~ H
0 g is dened as fuj V(u);T;; ~ H
0 g but with the second product
ranging over all C` strictly less than u. The estimator ~ h
0;j(Cm) needs to be computed
recursively.
Now that we have an estimator ~ H
0 , we can obtain an estimator ^  of  using
n X
i=1
m(Oi;; ~ H
0 ;d) = 0:
Finally we can compute ^ ST(t) using
n X
i=1
i
fTij Vi(Ti);Ti; ^ ; ~ H^ 
0 g
fI(Ti > t)   ST(t)g = 0;
which is based on (3.55).
It is also possible to derive equations to give the variance but they are not presented
here. The full derivation of equations for the variance is given in Rotnitzky et al. (2007).
3.7.4 Application of sensitivity analysis to the Liver Registration data
set
In the Liver Registration dataset, we want to estimate ST(t) = Pr(T > t) for any
t 2 (0;), where T = min(T;),  = 1260 and T is the time from registration on the
waiting list until death. So,  = 1260 is used as the maximum follow up time observed
was 1265 days as we do not want to discard too much data just to satisfy a technical
issue. The choice of  = 1260 is fairly arbitrary and we could have easily used  =
1261;1262;1263; or1264 instead.
106In our dataset, there are two competing censoring mechanisms, so j = 2. The rst
censoring time, j = 1, is the time to administrative censoring, which is assumed to be
non-informative so q1 is set to zero. The second censoring time j = 2, is the time to
transplant and
q2ft;  V(t);T;!;g = !fI(T < )(T   t) + I(T  )(   t)g
is the censoring bias function for this cause of censoring. It is assumed that ! is known and
takes values in the set f 1; 0:7; 0:5; 0:3;0;0:3;0:5;0:7;1g. These values are chosen as
! is the assumed amount of residual dependence and we need a reasonable number of
values ranging from 1 to -1 to assess the sensitivity of the estimator to dierent amounts
of residual dependence. We set  = 1335 days and this represents roughly the expected
time until the event for subjects who have not experienced the event by 1260 days.
Negative values of ! are equivalent to assuming that, among patients who are at risk
at time t and with the same covariate history up to t, those who would experience the the
event earlier are more likely to be censored at time t than those who would experience the
event later. Also when ! < 0, the term I(T  t)(   t) is equivalent to assuming that,
among subjects who at risk at time t and with the same covariate history up to time t,
the hazard of censoring at time t for whose who would experience the event after time  is
expf!(  )g times smaller than the hazard of censoring for those who would experience
the event just before time .
The covariates that are included in  V(u) are time-dependent UKELD and age. There
are only two UKELD observations for patients who receive a transplant, these are taken
at time of registration and time of transplant. Therefore linear interpolation is used to
obtain values of UKELD at time values between these two points. For all other patients,
there is only the UKELD score at time of registration, so this value is used at all times.
These two covariates are the only ones included in the model as the other possible
covariates that could have been included were ethnicity and primary liver category, both of
which are categorical variables with several levels. The dimensionality that these covariates
add to the model would have made estimation of  under the semi-parametric model much
more computationally intensive.
The programs used to carry out the sensitivity analysis given in Rotnitzky et al. (2007)
are available online from
http://www.blackwellpublishing.com/rss.
The programs available from this website are used here and amended slightly so that the
sensitivity analysis could be carried out on the Liver Registration dataset.
The plot in Figure 3.12 shows the results of the sensitivity analysis. The thicker solid
line is ^ ST(t) when it is assumed that q2 = 0. This is the model that assumes sequential
107ignorability of censoring after adjusting for time-dependent UKELD and recipient age.
The Kaplan-Meier estimate of the survival function is included for comparison, this is
given by the thinner solid line. The dotted lines on the plot are the estimates of the
survival function when there is some negative residual dependence between time to event
and time to censoring after adjusting for the covariates in  V(u). Similarly, the dashed
lines are the estimates of the survival function when we assume the residual dependence
is positive.
Figure 3.12: Plot showing estimated survival functions when tting model Bq to the Liver
Registration dataset for various values of . The bolder solid line is the estimated survival
function when tting model Bq to the Liver Registration data set for  = 0. The other
solid line is the Kaplan-Meier estimate of the survival function.
The dashed and dotted lines on the plot show that the estimate of the survival function
could change considerably if some of the values of the residual dependence that have been
assumed are feasible. However, the covariates that have been included, particularly time-
dependent UKELD, are signicant predictors of time to death and time to censoring. So it
is reasonable to assume that after adjusting for these covariates there can only be a small
to moderate amount of residual dependence. Therefore it can reasonably be assumed
that the residual dependence is likely to be in the interval [ 0:3;0:3], which gives tighter
108bounds on the estimate of the survival function. However, even these tighter bounds are
too wide to be of much use in a practical application.
The estimator that assumes q2 = 0, which is the assumption of sequential ignorability is
not similar to the IPCW estimators tted in Section 3.1.4, despite using a similar weighted
approach. This is not just due to dierent covariates being used in the models for time to
censoring for each of the estimators. It is because the estimator used here is not the KM
estimator, instead it is
^ ST(t) =
Pn
i=1 I(Ti  Ci)I(Ti > t)=fTij Vi(Ti);Ti; ^ ; ~ H^ 
0 g
Pn
i=1 I(Ti  Ci)=fTij Vi(Ti);Ti; ^ ; ~ H^ 
0 g
;
which is the number of failures yet to occur weighted by fTij Vi(Ti);Ti; ^ ; ~ H^ 
0 g, over the
total number of failures weighted by fTij Vi(Ti);Ti; ^ ; ~ H^ 
0 g. In comparison, the IPCW
KM estimator derived in Section 3.1.1 is
^ ST(t) =
Y
fi;ti<tg
0
@1  
i ^ Wi(ti)
nPn
k=1 Rk(ti) ^ Wk(ti)
o
1
A:
If the weight used is ^ Wi(t) = 1= ^ KV
i (t) where
^ KV
i (t) =
Y
fj;tj<t;j=0g
[1   ^ h0(tj)expf^ 
0
CVi(tj)g];
then it appears that similar weights are used for the IPCW KM estimator and the estimator
presented in this section when ! = 0. However, the IPCW KM estimator uses Breslow's
estimator of the hazard function, which is not used by Rotnitzky et al. (2007) when
estimating the hazard function.
3.8 Summary
In Chapter 2, estimators that could be used to give bounds on the estimated survival
function were reviewed. In this chapter, alternative approaches that can be used when
there is potentially informative censoring in a data set are reviewed. These include ap-
proaches that use regression models for the censoring processes and sensitivity analyses for
the parameters of non-informative censoring models. Generally, the methods presented in
this chapter allow covariates to be incorporated much more easily than the estimators con-
sidered in Chapter 2. A summary of the advantages and disadvantages of the estimators
that use models for the censoring process is given in Table 3.9. Also, the advantages and
disadvantages of the sensitivity analyses reviewed in this chapter are summarised in Table
3.10. All the approaches given in this chapter share a disadvantage that is not included in
Tables 3.9 and 3.10. This is that they all rely on some untestable assumption about the
109nature of the dependence between T and C, due to the identiability issues described in
Section 1.1.2.
The most widely used approach that uses a regression model for the censoring process
weights the contribution of individuals in the data set by the inverse of the probability of
the individual remaining uncensored under this model. If these weighted contributions are
used in the standard methods, such as the KM estimate of the survival function or Cox's
proportional hazards model, then estimates of the survival function or parameters in the
absence of any censoring can be obtained. The various models that are considered for
the censoring process are Cox's proportional hazards model, Weibull proportional hazards
model and Aalen's additive hazard model. We recommend use of a Cox proportional
hazards model as it can be easily tted using standard software and can also incorporate
time-dependent covariates fairly easily. These inverse probability of censoring weighting
methods use the assumption of sequential ignorability of censoring. This means that if all
the prognostic factors for both T and C are adjusted for in the model for censoring, it can
be assumed that C would then be independent of T. However, it is possible that some of
the dependence between T and C is due to unmeasured factors, which is called residual
dependence.
In Sections 3.3 to 3.6, methods are described that assess the sensitivity of parameter
estimates from standard models to the assumption of informative censoring.
Firstly, two sensitivity analyses that use parametric survival models are considered.
Both of these methods are computationally simple but cannot be used for a wide range of
data sets as they use only standard parametric survival models. The change in parameter
estimates for both of these sensitivity analyses can be expressed in the same form, which
is the correlation coecient of T and C multiplied by a sensitivity index, which allows
direct comparison of the two methods. We recommend using the sensitivity analysis
given in Siannis et al. (2005) and Siannis (2004) for parametric survival models as it
allows estimation of the change in individual parameter estimates for covariates unlike
the sensitivity analysis from Zhang and Heitjan (2006) which only allows use of a linear
predictor. Also the sensitivity analysis in Zhang and Heitjan (2006) gives values of the
sensitivity index that seem unfeasibly large.
Then, two sensitivity analyses for the Cox proportional hazards model are given. These
approaches are much more computationally intensive than those for parametric models but
can be applied to a greater number of data sets as the Cox proportional hazards model
is more exible than standard parametric survival models. The sensitivity analysis in
Siannis (2011) is more computationally intensive than the sensitivity analysis in Siannis
et al. (2005) and Siannis (2004) as it requires estimation of the baseline hazard function.
However, the sensitivity analysis in Huang and Zhang (2008) is much more computationally
110intensive than that in Siannis (2011). It also requires more untestable assumptions as a
copula function needs to be specied as well as the level of dependence between T and C.
It is for these reasons that we recommend use of the sensitivity analysis in Siannis (2011)
for the Cox proportional hazards model.
Finally, a sensitivity analysis for an estimator that already accounts for informative
censoring is considered. This is derived in Rotnitzky et al. (2007) and considers the
sensitivity to residual dependence of an estimator that assumes sequential ignorability
of censoring. Unfortunately, this estimator is not the same as the inverse probability of
censoring weighted estimators considered previously. A semi-parametric model containing
prognostic factors for T and C is used for C. Weights using the survival function from
this semi-parametric model are used when deriving estimators of the marginal survival
function for T. This approach can then be used to give bounds on the estimator that
assumes sequential ignorability of censoring for dierent amounts of residual dependence.
The drawbacks of this method are that the bounds derived are often too wide to be of use
in a practical setting and it is so computationally intensive that it is not easy to include
lots of covariates or factors with many levels.
The literature review carried out in this chapter has several important conclusions. The
rst is that the inverse probability of censoring weighted estimators presented in Section 3.1
are the most appropriate estimators for use in practical applications that we have found in
the literature. Therefore, similar weights will be used when developing the survival benet
methodology in Chapter 6. Secondly, the sensitivity analyses described in Sections 3.3 to
3.6 are the most useful methodologies in the literature for assessing the sensitivity of results
from standard models to the assumption of informative censoring. However, each of these
methodologies have disadvantages that aect its usefulness is a practical setting. This is
our motivation for the sensitivity analysis for piecewise parametric survival models derived
in Chapter 4, which has the exibility of the sensitivity analyses for Cox's proportional
hazards model while retaining the computational simplicity of the sensitivity analyses for
standard parametric survival models.
111Advantages Disadvantages
IPCW
estimators
 Uses sequential ignorabil-
ity of censoring assumption
which is fairly easy to un-
derstand and it seems intu-
itive that dependence would
be caused by shared prognos-
tic factors.
 The Cox model for time to
censoring can be tted us-
ing standard software and it
does not require much com-
putation to obtain weights.
 Most standard software can
easily incorporate weights
into Cox models.
 It is not possible to es-
tablish whether the correct
model for censoring has been
used.
 There may be residual de-
pendence that is not ex-
plained by shared prognostic
factors, which would result
in IPCW estimates being bi-
ased.
Weighted
estimators
using
Aalen's
additive
hazard model
 Uses sequential ignorabil-
ity of censoring assumption
which is fairly easy to un-
derstand and it seems intu-
itive that dependence would
be caused by shared prognos-
tic factors.
 Uses Aalen's additive haz-
ard model which is more ex-
ible than Cox's proportional
hazards model.
 It is not possible to es-
tablish whether the correct
model for censoring has been
used.
 There may be residual de-
pendence that is not ex-
plained by shared prognostic
factors, which would result
in IPCW estimates being bi-
ased.
 It is more dicult to
t Aalen's additive hazard
model than Cox's propor-
tional hazards model using
standard software.
Table 3.9: Summary of the advantages and disadvantages of the estimators that use models
of the censoring process that are reviewed in Chapter 3.
112Advantages Disadvantages
Sensitivity
analysis in
Siannis et al.
(2005) and
Siannis
(2004)
 Computation of sensitivity anal-
ysis equations is fairly simple.
 Allows estimation of change in
individual parameter estimates as
well as a linear predictor.
 Only allows use of standard
parametric survival models, which
means it can only be applied to a
restricted number of data sets.
Sensitivity
analysis in
Zhang and
Heitjan
(2006)
 Computation of sensitivity anal-
ysis equations is fairly simple.
 Only allows use of standard para-
metric survival models.
 Can only be carried out on scalar
parameters or linear predictors.
 Gives values of the sensitivity in-
dex that seem unfeasibly large.
Sensitivity
analysis in
Huang and
Zhang (2008)
 Uses Cox's proportional hazards
model, which is more exible
than standard parametric survival
models.
 Allows estimation of the change
in individual parameter estimates.
 Very computationally intensive,
much more than the sensitivity
analysis in Siannis (2011).
 Requires more untestable as-
sumptions than other methods re-
viewed in Chapter 3, as a copula
needs to be chosen as well as the
level of dependence.
Sensitivity
analysis in
Siannis
(2011)
 Uses Cox's proportional hazards
model, which is more exible
than standard parametric survival
models.
 Allows estimation of the change
in individual parameter estimates.
 More computationally intensive
than the sensitivity analyses in
Siannis et al. (2005), Siannis
(2004) and Zhang and Heitjan as
it requires estimation of the base-
line hazard function.
Sensitivity
analysis in
Rotnitzky
et al. (2007)
 Allows assessment of the sensitiv-
ity to residual dependence of an
estimator that assumes sequential
ignorability of censoring.
 The estimator used is not the
same as the IPCW estimator,
which is more widely used.
 Very computationally intensive,
it is not possible to include lots
of covariates or factors with many
levels.
 The bounds on the estimate of
the survival function found are of-
ten too wide to be of use practi-
cally.
Table 3.10: Summary of the advantages and disadvantages of the sensitivity analyses
reviewed in Chapter 3.
113114Chapter 4
Sensitivity Analysis for
Informative Censoring in
Piecewise Exponential Models
Sensitivity analyses that estimate how the results from tting standard models would
change in the presence of informative censoring are useful, due to the identiability issues
that we face. It is for this reason that here we present a sensitivity analysis method
that is not only suited to our particular setting, but could also be applied to many other
situations.
The method allows us to estimate the change in the parameter estimates for a piecewise
exponential model when we assume a small amount of informative censoring instead of
non-informative censoring. This extends the sensitivity analysis in Siannis et al. (2005)
and Siannis (2004), which only considered standard parametric models. The method they
present is appealing as it is easy to apply, but it could be improved by extending the
range of models to which it applies. We chose to work with piecewise exponential models
as by using sensible cutpoints to split the study time into intervals and assuming constant
hazards in each interval, we can approximate a wide range of baseline hazard functions.
A sensitivity analysis that uses the same assumption for the association between T and
C is given in Siannis (2011). However, this sensitivity analysis is for the Cox proportional
hazards model instead of a parametric model. The sensitivity analysis presented here
retains the computational simplicity of the parametric analyses of Siannis (2004) and
Siannis et al. (2005) whilst enjoying the exibility of the approach of Siannis (2011).
We will rst outline the sensitivity analysis for a piecewise exponential model with a
scalar parameter in each interval. The sensitivity analysis will then be extended so that
covariates can be included.
1154.1 Notation and Model Specication
We are interested in the joint distribution of T, the time to failure variable and C, the
time to censoring variable, so we can assess the dependence between the two. However,
we only observe Y = min(T;C) along with an indicator function I = 1 if T  C and I = 0
otherwise. This means that we must make additional assumptions before we can identify
the joint distribution.
A piecewise exponential model will be used for the marginal distributions of both T
and C. We split the study time into intervals and assume a constant hazard in each
interval. This approach was introduced in Breslow (1974); it is what is now called the
piecewise exponential model. This should give us greater exibility than the standard
exponential and Weibull models, as we can approximate most hazard functions.
As we have introduced intervals into the model, we use a piecewise approach to ob-
tain the log-likelihood. We only have the observation time, yi, for each individual and
the piecewise approach requires a time variable corresponding to each interval for each
individual. Therefore we dene the exposure time for individual i in interval j, which is
yij = aj   aj 1 j = 1;:::;Ni   1
yij = yi   aNi 1 j = Ni;
where aj is the upper endpoint of the jth interval. The lower endpoint of the rst interval
is a0 = 0. Here Ni denotes the number of the interval in which individual i experiences
either failure or the censoring of interest at time yi. Once having experienced one of these
events, individual i has no further exposure in later intervals.
Therefore, there are now three possible times that may be observed for each individual
at risk in any of the intervals. These are T, the failure time, CI, the censoring that occurs
within an interval, and CE, the censoring at the end of an interval. We will treat the
censoring at the end of each interval, which has been introduced by the use of a piecewise
model, as independent of any censoring that takes place in the intervals. This censoring
is similar to end of study censoring, which is also usually treated as non-informative
censoring.
Two indicator variables are needed, rst to distinguish between a failure time and a
censored time and then to distinguish between the two dierent types of censoring. These
indicator variables are
Iij =
8
<
:
1; if ith individual fails in jth interval
0; if ith individual does not fail in jth interval
116and, when Iij = 0,
Zij =
8
<
:
1; when individual i censored before the end of interval j
0; when individual i censored at the end of interval j:
As we are using a piecewise exponential model, we can take advantage of the lack of
memory between the intervals. If we condition on T > aj 1, then the survivor function
ST(tjT > aj 1) = ST(t aj 1) for the jth interval depends only on the parameter associ-
ated with that interval, j, and the mean of the distribution in the jth interval is given by
 1
j . Let tj = t aj 1 be the amount of time passed in the jth interval, then the survivor
function can be denoted by ST(tj;j). For the ith individual, the survivor function for the
jth interval would be ST(yij;j). The density, hazard and integrated hazard functions for
T in the jth interval,
fT(tj;j) =  
d
dt
ST(tj;j); hT(tj;j) =  
d
dt
logST(tj;j);
and HT(tj;j) =  logST(tj;j);
also only depend on j. The score and information functions for the density function
fT(tj;j) are dened by
sT(t;j) =
@
@j
logfT(tj;j) and ij = VarTfsT(T;j)g:
Similarly, if we condition on C > aj 1 then the survivor function SC(cjC > aj 1) for CI in
the jth interval only depends on the nuisance parameter, j. For ease of notation, without
ambiguity subscript C will be used for functions relating to CI. Let cj = c   aj 1 and
the survivor function for CI in the jth interval can be denoted SC(cj;j). There are the
corresponding functions fC(cj;j), hC(cj;j), HC(cj;j), sC(c;j) and ij for CI.
It is now necessary to make an assumption concerning the conditional distribution of
CI given T, so that we can identify the joint distribution of T and CI. As in Siannis et
al. (2005), Siannis (2004) and Siannis (2011), we assume that the conditional distribution
of CI given T has the same parametric distribution as the marginal distribution of CI.
However, the parameter of the conditional density is allowed to depend on T. Therefore,
the conditional density in the jth interval can be written explicitly as
fCjT(cjjt;j;;j) = fC(cj;j + i 1=2
j B(tj;j));
where ij is the information function for CI. The dependence between T and CI is dened
by  and B(tj;j). These can be thought of as a correlation coecient, that quanties
the amount of dependence between the two processes, and a bias function which gives a
form to this dependence. More specically, B(tj;j) quanties the dependence between T
117and censoring just after time t, for those who remain at risk at time t, as discussed in 3.3.
The choice of the form of the bias function that we will use in this method is discussed in
Section 4.2.1.
As we will let the parameters vary between the intervals, we will have the vectors 
and  with j and j being the scalar parameters in the jth of the m intervals in our
model.
4.2 Development of Sensitivity Analysis
Here we describe the development of a sensitivity analysis that can be applied to piecewise
data. This is an extension of the approaches set out in Siannis et al. (2005) and Siannis
(2004). At rst it will not incorporate covariates but it will be shown that it can be
extended to do so in Section 4.2.3.
Let `(;), be the log-likelihood function when T and CI are dependent as outlined
above in Section 4.1. Then
`(;) =
n X
i=1
m X
j=1
n
Iij logK1(yij) + Zij(1   Iij)logK2(yij)
+ (1   Iij)(1   Zij)logK3(yij)
o
; (4.1)
where
K1(yij) =
Z 1
yij
fT;C(yij;u)du
K2(yij) =
Z 1
yij
fT;C(u;yij)du
and K3(yij) =
Z 1
yij
Z 1
yij
fT;C(t;c)dtdc: (4.2)
These can be thought of as the likelihood contributions for each of the three types of
observations that may occur in each interval. To avoid having integrals in the above
contributions that cannot be evaluated analytically, the joint density for T and CI in the
jth interval is written
fT;C(tj;cj) = fT(tj;j)fC(cj;j + i 1=2
j B(tj;j))
' fT(tj;j)fC(cj;j)[1 + i 1=2
j sC(cj;j)B(tj;j)]: (4.3)
Now that the model has been fully specied, it is possible to nd approximations of
the contributions in (4.2). Once these have been substituted into (4.1), the log likelihood
118becomes:
`(;) ' `0(;)   
n X
i=1
m X
j=1
i 1=2
j
n
IijB(yij;j)
@
@j
HC(yij;j)
+ (1   Iij)(1   Zij)
@
@j
HC(yij;j)(yij;j)
  Zij(1   Iij)sC(yij;j)(yij;j)
o
; (4.4)
where
(yij;j) =
Z 1
yij
B(u;j)fT(u;j)du
ST(yij;j)
and
`0(;) =
n X
i=1
m X
j=1
n
Iij loghT(yij;j) + Zij(1   Iij)loghC(yij;j)
  HT(yij;j)   HC(yij;j)
o
: (4.5)
For a xed value of , ^  is the vector of values that maximises (4.4). Note that the rst
term in (4.4), `0(;), is the log-likelihood in the non-informative censoring model.
To be able to assess how much the parameter estimates change under the assumption of
dependent censoring, an estimate of the dierence between them is needed. The estimate
of j under the assumption of dependent censoring in the jth interval is denoted by ^ j.
Similarly the estimated value of the parameter under independent censoring in the jth
interval is denoted as ^ 0j. To be able to obtain an approximation of the dierence between
these two values, it is necessary to use Taylor expansions about j of the score functions
r0(^ 0j) =
@
@j
`0(;)
 
 
^ 0j
and r(^ j) =
@
@j
`(;)
 
 
^ j
: (4.6)
These are the score functions for the jth interval under the assumption of independent and
dependent censoring respectively. Therefore they are the score functions for the likelihoods
given in (4.4) and (4.5) respectively.
The score functions given in (4.6) are expanded about j and set equal to zero to give
r0(^ 0j) ' r0(j)   (^ 0j   j)ij() = 0
r(^ j) ' r(j)   (^ j   j)ij() = 0 (4.7)
where
ij() =  
@2
@2
j
`0(;):
Rearranging the two equations in (4.7) gives
(^ j   ^ 0j)ij() ' r(j)   r0(j):
119So, an approximation of the dierence between the parameter estimates is given by
^ j   ^ 0j ' (ij()) 1 X
i2Rj
i 1=2
j
n
Zij(1   Iij)sC(yij;j)
@(yij;j)
@j
  (1   Zij)(1   Iij)
@HC(yij;j)
@j
@(yij;j)
@j
  Iij
@HC(yij;j)
@j
@B(yij;j)
@j
o
(4.8)
for the jth interval, where Rj is the set of individuals who are at risk in the jth interval.
We see that in (4.8) there are parameter estimates on the LHS and parameters on the
RHS of the expression. This is a result of rearranging the two equations in (4.7). It means
that when the sensitivity analysis is applied, sensible estimates of the parameters must be
substituted into the RHS of (4.8).
4.2.1 Choice of B(t;)
The argument presented in this section gives a general method for choosing the bias func-
tion B(tj;j) in the jth interval. This is adapted from the argument that was presented
in Siannis et al. (2005) as justication for the choice of bias function. For simplicity, we
will look at the case where there are just scalar parameters, j and j in each interval. We
shall assume that non-ignorability comes from the correlation between individual-specic
random eects in the distributions of T and C. Then for a given patient, T and C would
be independent given the random eects with density functions given by
gT(tj;j + Ti
 1=2
j ) and gC(c;j + Ci 1=2
j );
where T and C are random eects with mean zero, variances 2
T and 2
C and covariance
TC. We shall assume that all three of these second moments are fairly small, with the
same order of magnitude. This will allow the use of Taylor expansions around T = 0 and
C = 0, where we ignore terms that are above second order. These can be used to gain
approximations to the marginal distributions of T and C where
fT(tj;j) = E
h
gT(j + Ti
 1=2
j )
i
' gT(tj;j) +
2
T
2ij
@2gT(tj;j)
@2
j
and similarly
fC(cj;j) ' gC(cj;j) +
2
C
2ij
@2gC(cj;j)
@2
j
:
Also, an approximation of the joint distribution can be found from
fT;C(tj;cj) = E
h
gT(tj;j + Ti
 1=2
j )gC(c;j + Ci 1=2
j )
i
:
120Once the Taylor expansions have been multiplied out and we have used the fact that we
can write
fT(tj;j)fC(cj;j) ' gT(tj;j)gC(cj;j) +
2
C
2ij
gT(tj;j)
@2
@2
j
gC(cj;j)
+
2
T
2ij
gC(cj;j)
@2
@2
j
gT(tj;j)
then the joint density can be written as
fT;C(tj;cj) ' fT(tj;j)fC(cj;j)[1 + TC(ijij) 1=2sT(tj;j)sC(cj;j)]: (4.9)
If we compare (4.9) to (4.3), then we can see that with  appropriately dened, the two
equations will be equal if
B(tj;j) = i
 1=2
j sT(tj;j):
Other justications for choosing this form of B(tj;j) may be given. The two justi-
cations given here are from Siannis (2011). Firstly, the form of the dependence here is
completely unknown so any assumptions made about it should be as weak as possible as
far as information about j is concerned. There is also a nice symmetry in the competing
risks set-up if this B(tj;j) is used. It means the conditional distribution of C given T
has the same form as the conditional distribution of T given C.
4.2.2 Proportional hazards structure
As in Siannis et al. (2005) and Siannis (2004), we use a proportional hazards structure to
simplify our model so that the hazard functions of T and CI have the form
hT(tj;j) = ejh
T(tj) and hC(cj;j) = ejh
C(cj);
where h
T(tj) and h
C(cj) are baseline hazard functions. Consequently,
sT(tj;j) = 1   HT(tj;j); sC(cj;j) = 1   HC(cj;j) and ij = ij = 1: (4.10)
If we take B(tj;j) to be the standardized score function, the reasoning for which was
outlined in Section 4.2.1,
B(tj;j) = i
 1=2
j sT(tj;j) (4.11)
then we can combine (4.10) and (4.11) to give
B(tj;j) = 1   HT(tj;j) and (tj;j) = HT(tj;j): (4.12)
This proportional hazards structure also allows us to give simple expressions for the partial
derivatives in (4.8) as
@
@j
HT(tj;j) = HT(tj;j) and
@
@j
HC(cj;j) = HC(cj;j): (4.13)
121If we now apply the proportional hazards structure to (4.8), it will simplify greatly to
give
^ j   ^ 0j ' ij()
 1 X
i2Rj

HT(yij;j)HC(yij;j)   Zij(1   Iij)HT(yij;j)
	
; (4.14)
which applies to the jth interval, where
ij() =  
@2
@2
j
`0(;) =
X
i2Rj
HT(yij;j): (4.15)
Notice that it is necessary to perform the sensitivity analysis separately on the parameters
for each interval. We are justied to use the proportional hazards structure as long as the
proportional hazards assumption holds within each interval. The piecewise exponential
model satises this as the hazard functions for T and CI are piecewise constant. These
piecewise constant hazards can provide a fair approximation to most hazard functions
provided sensible cut-points for the intervals are identied. Large intervals may be used
when the hazard function is changing slowly. When it is changing rapidly small intervals
would capture this better. This gives more exibility than the Weibull model assumed
in Siannis (2004) because the hazard for a Weibull distribution has to be monotonic, and
there is no such restriction when using a piecewise constant hazard.
4.2.3 Inclusion of covariates
Siannis et al. (2005) also show how covariates can be included in the sensitivity analysis
approach. This has been briey discussed previously in Section 3.3. A similar approach
is used in this section to incorporate covariates into the sensitivity analysis for piecewise
parametric models. Siannis et al. (2005) derive an equation that approximates the value
of ^    ^ 0, where  is the vector of parameters for the covariate vector x that replaces
the scalar parameter . However, when applying their method to data they only consider
the change in the linear predictor w(x) = 0
jx as it is computationally simpler. In this
section, we will consider both approaches and derive equations for a sensitivity analysis
for  and a sensitivity analysis for w(x).
In order to incorporate covariates in the sensitivity analysis for piecewise parametric
models, we replace the scalar parameters j and j in the jth interval by 0
jx and 0
jx.
However,  is a nuisance parameter so we will introduce the scalar j = 0
jx. It is due
to its dependence on j, that  is also dependent on j. The use of piecewise exponential
models with covariates is described in Friedman (1982). The hazard function of the ith
individual in the jth interval is dened to be
hij = exp(j +
p X
k=1
kxik): (4.16)
122This is the same as splitting 0
jx into an intercept for each interval, j, and a component
for the p covariates included in the model, given by
Pp
k=1 kxik, which remains constant
over the intervals.
Firstly, we derive the sensitivity analysis for the function wj(x) = 0
jx rather than j.
This is done using a method similar to that used in Section 4.2 but with expansions of the
score functions
r0(w0j(x)) =
@
@w0j(x)
`0(wj(x);zj(x)); and
r(wj(x)) =
@
@wj(x)
`(wj(x);zj(x)):
Note that the function z(x) =  does not contain the parameter of interest. Then the
dierence in the linear predictors would be given by:
^ w(x)   ^ w0(x) ' 
X
i2Rj
HT(yij;;x)[HC(yij;ij)   (1   Iij)Zij]
X
i2Rj
HT(yij;;x)
; (4.17)
using i(;~ x) =
Pn
i=1
Pm
j=1 HT(yij;;x) and where Rj is the risk set in the jth interval.
Deriving a sensitivity analysis for  is much simpler if the model is expressed as a vector
of parameters that stays constant over all the intervals. This is possible for the piecewise
exponential model and we will now show how to reformulate the parameter vector.
When including covariates there is a vector of parameters j for each interval. Only
the intercept component changes across intervals. If we consider the case without other
covariates, then this means we can express the log-hazard of failure for the ith individual
in the jth interval as
loghT(t) = j
It is possible to t the same model with a vector of parameters , that remains constant
over all the intervals. This is achieved by specifying a constant intercept over all intervals,
0, along with a factor, vj, that indicates the interval under consideration. The log-hazard
dened above can then be expressed as
loghT(t) = 0 + 0vj
The parameter estimates of this factor correspond to the contrasts between the intercept
in a given interval and the baseline intercept. As this approach means that we will always
have a vector of parameters, it is trivial to consider standard covariates as well. However,
we now need to make clear the dependence of the vector of covariates on both i and j. So
to remain consistent with previous notation we dene xij to be the vector of covariates
for individual i in interval j.
123We dene the model for the censoring time variable, CI, in the same way. We will
continue to consider the scalar ij = 0xij for the ith individual in the jth interval, as 
is a nuisance parameter.
The lack of memory between intervals is still being used so the functions for T and CI
are still conditioned on the individual surviving beyond time aj 1.
In a sample of n observations with m intervals, ~ x is the array containing the xij vectors
and  is the matrix with the ij as its elements. So the log-likelihood when we include
covariates becomes:
`(;;~ x) ' `0(;;~ x)   
n X
i=1
m X
j=1
i 1=2
ij
n
IijB(yij;;xij)
@
@i
HC(yij;ij)
+ (1   Iij)(1   Zij)
@
@ij
HC(yij;ij)(yij;;xij)
  Zij(1   Iij)sC(yij;ij)(yij;;xij)
o
; (4.18)
where
(yij;;xij) =
Z 1
yij
fT(u;;xij)B(u;;xij)du
ST(yij;;xij)
:
The log-likelihood for the model where T and C are independent is given by
`0(;;~ x) =
n X
i=1
m X
j=1
n
Iij loghT(yij;;xij) + Zij(1   Iij)loghC(yij;ij)
  HT(yij;;xij)   HC(yij;ij)
o
: (4.19)
The derivation of a sensitivity analysis for  requires use of the Taylor expansions
about  of the vector score functions
r0(^ 0) =
@
@0
`0(;;~ x) and r(^ ) =
@
@
`(;;~ x)
to obtain an approximation to the change in the estimated parameters. The expansions
ignoring any quadratic terms or higher are
r0(^ 0) ' r0()   (^ 0   )i(;~ x) = 0;and
r(^ ) ' r()   (^    )i(;~ x) = 0: (4.20)
An expression for the dierence in the vector of parameter estimates can be obtained by
rearranging the linear expansions in (4.20). This is given by
^    ^ 0 ' i(;~ x) 1(r()   r0()); (4.21)
124where the kth component of r()   r0() is

n X
i=1
m X
j=1
i 1=2
ij

Zij(1   Iij)sC(yij;ij)
@
@k
(yij;;xij)
  (1   Iij)(1   Zij)
@
@ij
HC(yij;ij)
@
@k
(yij;;xij)
  Iij
@
@k
B(yij;;xij)
@
@ij
HC(yij;ij)

; (4.22)
and the (k;l)th element of the information matrix i(;~ x) is
 
@2
@k@l
`0(;;~ x):
Again (4.22) can be greatly simplied by assuming a proportional hazards structure. This
is done using equations similar to those in Section 4.2.2, except that the derivative of the
integrated hazard function for T is now
@
@k
HT(yij;;xij) = xijkHT(yij;;xij):
So, the expression for the kth component of r()   r0() becomes:

n X
i=1
m X
j=1
xijkHT(yij;;xij)
h
HC(yij;ij)   (1   Iij)Zij
i
; (4.23)
and the (k;l)th element of i(;~ x) is
n X
i=1
m X
j=1
xijkxijlHT(yij;;xij): (4.24)
We can then use the parameter estimates found using the sensitivity analysis in (4.21)
to obtain an approximation to the change in the linear predictors, ^ w(xij) and ^ w0(xij)
for the ith individual in the jth interval in the data set with covariate vector xij. The
equation used to do this is
^ w(xij)   ^ w0(xij) = ^ 
0
xij   ^ 
0
0xij:
This approach that gives a sensitivity analysis for  is much more computationally time
consuming carrying out the sensitivity analysis on w(x). However, it is useful as it allows
the eect of informative censoring on individual parameters to be estimated. Therefore,
a sensitivity analysis for  will be applied to the Liver Registration data set using the
expression in (4.21).
1254.3 Application to the Liver Registration Data set
We will now apply the sensitivity analyses derived in Section 4.2 to the Liver Registration
dataset. We assume that the lifetime and censoring variables each have piecewise expo-
nential marginal distributions. Starting values for the cut points were chosen by splitting
the time period into intervals with roughly equal numbers of observations in each interval.
Then, the models with the intervals that give the largest value of the likelihood were found
for 3 and 4 intervals. The log-cumulative hazard plots were then examined to check if the
assumed model is appropriate. The 3-interval model was found to be appropriate and
the 4-interval model did not seem to give any improvement. Therefore in the interest of
parsimony, we used the 3-interval model with cut points at 40 and 165 days.
To determine whether this chosen model gives a signicantly better t than the corre-
sponding standard Weibull models, the dierences in  2 log ^ L for the models were found.
If the true hazard is Weibull, then the dierence in  2 log ^ L for the Weibull model and the
piecewise exponential model should be approximately 2
m 2. The piecewise exponential
model was signicantly better than the Weibull for time to censoring (p < 0:0001) but
not for time to death (p=0.85). As the same form of model must be used for both time
to death and time to censoring when applying the sensitivity analysis, then the use of
piecewise exponential models for the marginal distributions of the failure and censoring
variables is justied for the Liver Registration data.
These models can be tted using standard statistical software packages (such as PROC
LIFEREG in SAS) as long as the data have been correctly formatted in a counting process
format that gives both a start and stop time for the observation. There are multiple lines
of data for an individual if they are at risk in multiple intervals. The exposure times that
were dened earlier are used along with the indicator variables, Iij and Zij.
4.3.1 Sensitivity analysis for scalar parameters
Firstly, the sensitivity analysis is applied to the Liver Registration data set assuming that
T and C have piecewise exponential marginals distributions with scalar parameters in
each interval. The derivation of this method was given in Section 4.2, with the simplied
sensitivity analysis equation given in Section 4.2.2. The parameters of interest here are
the scalar parameters for T in each interval. The scalar parameters for C in each interval
are treated as nuisance parameters
When we assume that T and C have piecewise exponential marginals distributions
126with scalar parameters in each interval, then the hazards and associated functions are
hT(tj;j) = ej; hC(cj;j) = ej;
HT(tj;j) = ejtj; HC(cj;j) = ejcj;
ST(tj;j) = exp( ejtj); and SC(cj;j) = exp( ejcj): (4.25)
The form of the functions in (4.25) can be substituted into (4.14) to give the sensitivity
analysis equation
j   0j ' 
X
i2Rj
fe^ jy2
ij   yij(1   Iij)Zijg
X
i2Rj
yij
; (4.26)
for the jth interval. We can see that (4.26) has no dependence on the parameter of interest
in the jth interval, j, but does require a value of the nuisance parameter j to be used.
The value of j that will be used is the estimate found using the likelihood in (4.5), which
assumes non-informative censoring. The maximum likelihood estimate of j is
^ j =
X
i2Rj
Zij(1   Iij)
X
i2Rj
yij
:
The values of ^ j found for the Liver Registration data set are -4.9189, -5.2320 and -5.5695
for intervals 1, 2 and 3 respectively.
Table 4.1 shows the approximate values of ^ j   ^ 0j found by applying the sensitivity
analysis equation in (4.26). We can see that the sensitivity analysis suggests that the
largest changes in parameter estimates occurs in the nal interval for the Liver Registration
data set.
Interval (j) ^ 0:2j   ^ 0j ^ 0:3j   ^ 0j
1 0.0274 0.0411
2 0.0607 0.0911
3 0.1343 0.2015
Table 4.1: Table showing the estimated change in the parameter estimates for each interval
from the sensitivity analysis using  = 0:2 and  = 0:3.
Table 4.2 shows the parameter estimates for time to death assuming non-informative
censoring, along with the approximate parameter estimates for  = 0:2 and  = 0:3. The
127values ^ 0j are the maximum likelihood estimates given by
X
i2Rj
Iij
X
i2Rj
yij
:
The values ^ 0:2j and ^ 0:3j are the approximate parameter estimates found by adding the
values from the sensitivity analysis in Table 4.1 to ^ 0j.
k ^ 0k p-value ^ 0:2k p-value ^ 0:3k p-value
1 -6.7799 < 0:0001 -6.7525 < 0:0001 -6.7387 < 0:0001
2 -6.9056 < 0:0001 -6.8448 < 0:0001 -6.8145 < 0:0001
3 -7.6375 < 0:0001 -7.5031 < 0:0001 -7.4360 < 0:0001
Table 4.2: Table showing the parameter estimates for time to death assuming non-
informative censoring, along with the approximate parameter estimates for  = 0:2 and
 = 0:3 found using the results in Table 4.1.
4.3.2 Sensitivity analysis including covariates
We will now apply sensitivity analyses that include covariates to the Liver Registration
data set. There are two methods of doing this, either a sensitivity analysis for w(x) or a
sensitivity analysis for , both of which are detailed in Section 4.2.3. We shall apply both
methods to the data set so that the results from each can be compared. The sensitivity
analysis for w(x) is applied rst, followed by the sensitivity analysis for .
In the initial data analysis for the Liver Registration data set, it was found that primary
liver disease category, recipient ethnicity, age and UKELD score are signicant for time
to death and primary liver disease category, UKELD score, recipient height and recipient
blood group are signicant for time to censoring. Therefore, these covariates should be
included in the models used in the sensitivity analysis.
If we let wj(xi) = 0
jxi and zj(xi) = 0
jxi, then the hazards and associated functions
for T and C with piecewise exponential marginal distributions can be expressed as:
hT(tj;j;xi) = ewj(xi) hC(cj;j;xi) = ezj(xi)
HT(tj;j;xi) = ewj(xi)tj HC(cj;j;xi) = ezj(xi)cj
ST(tj;j;xi) = exp( ewj(xi)tj) SC(cj;j;xi) = exp( ezj(xi)cj) (4.27)
These can now be substituted into (4.17) to approximate ^ wj(x)  ^ w0j(x). To calculate
this we need ^ z0j(x), which is the estimated linear predictor for time to censoring assuming
128Figure 4.1: Boxplots showing the distribution of ^ z0j(x) in each of the three intervals for
the Liver Registration data.
non-informative censoring. The distributions of ^ z0j(x) for the Liver Registration data are
shown by the boxplots in Figure 4.1. We see that the median value of ^ z0j(x) decreases
across the intervals, which shows that the hazard of censoring is generally smaller in the
later intervals. We also see that the majority of patients have values of ^ z0j(x) that fall in
the middle of the observed range for each interval, with only a small number at either of
the extremes.
The approximation for ^ wj(x)  ^ w0j(x) when conducting a sensitivity analysis on w(x)
is obtained by substituting the functions from (4.27) into (4.17). This then gives:
^ wj(x)   ^ w0j(x) ' 
X
i2Rj
fe^ z0(x)y2
ij   yij(1   Iij)Zijg
X
i2Rj
yij
: (4.28)
The equation in (4.28) requires the same covariate vector to be used in both the models
for time to death and time to censoring. Therefore, we include age, recipient ethnicity,
129primary liver disease category, UKELD score, recipient height and recipient blood group
as covariates in the models for time to death and time to censoring.
The sensitivity analysis in (4.28) only considers an arbitrary vector of covariates x,
when we want to assess the change in parameter estimates for all individuals in the dataset.
Therefore we need to plot the estimated value of ^ w(x)   ^ w0(x) against the entire range
of values that ^ z0j(x) takes across all the individuals in jth interval, which is shown for
all 3 intervals in Figure 4.2. This gure shows the plot for  = 0:2 and 0.3. It can be
seen from Figure 4.2 that the second and third intervals have larger estimated values of
^ wj(x)  ^ w0j(x) than the rst interval. The largest values of ^ wj(x)  ^ w0j(x) are observed
for the patients with the largest values of ^ z0j(x) or the highest hazards of censoring.
However if we consider the distributions of ^ z0j(x) shown in Figure 4.1, then we can see
that only a small number of individuals will have these large changes in ^ wj(x)   ^ w0j(x).
This means the eect of informative censoring is small for the majority of patients in the
Liver Registration data. However, as some individuals have a large estimated change in
the linear predictors, then any inferences may be misleading if non-informative censoring
was assumed, and there is even a moderate amount of dependence between the time to
death and time to censoring variables.
Figure 4.2: Plot of sensitivity analysis expression in (4.28) for observed values of ^ z0j(x) for
the Liver Registration data in each of the three intervals with  = 0:2; 0:3, when applying
the sensitivity analysis for w(x)
Now the sensitivity analysis for  is applied to the Liver Registration data set. This
130allows the change in individual components of the vector of parameter estimates to be
estimated, instead of just looking at the change in the linear predictor w(x). The equations
for this sensitivity analysis were also derived in Section 4.2.3.
The hazards and associated functions for T and C are now given by
hT(tj;;xij) = e0xij; hC(cj;;xij) = ez(xij);
HT(tj;;xij) = e0xijtj HC(cj;;xij) = ez(xij)cj;
ST(tj;;xij) = exp( e0xijtj); and SC(cj;;xij) = exp( ez(xij)cj); (4.29)
where the value of interest is the parameter vector , with z(x) again being treated as a
nuisance parameter. The expressions in (4.29) can be substituted in (4.23) from Section
4.2.3 to give

n X
i=1
m X
j=1
fxijke0xijyij[ez(xij)yij   (1   Iij)Zij]g; (4.30)
for the kth component of r()   r0(). The (k;l)th element of the information matrix
i(; ~ x) also becomes
n X
i=1
m X
j=1
xijkxijle0xijyij (4.31)
when the form of the integrated hazard function for T in (4.29) is substituted into (4.24)
in Section 4.2.3. The expressions in (4.30) and (4.31) can then be used in
^    ^ 0 ' i(; ~ x) 1(r()   r0());
to conduct a sensitivity analysis for .
We can see that, unlike the previous expressions for the sensitivity analyses for scalar
parameters and w(x), (4.30) and (4.31) contain the parameter vector of interest, , as
well as the nuisance parameter, z(x). This means that values of  will need to substituted
into (4.30) and (4.31) along with values of z(x) to carry out the sensitivity analysis. The
values used are the MLEs from the piecewise exponential model assuming non-informative
censoring.
Also, although it is assumed, for notational simplicity, that the models for T and
C use the same covariate vector xij, it is possible to use separate models for the two
variables. Therefore, primary liver disease category, recipient ethnicity, recipient age and
UKELD score will be included in the model for time to death and primary liver disease
category, UKELD score, recipient height and recipient blood group in the model for time
to censoring.
Table 4.3 shows the estimated values of the components of ^    ^ 0 for  = 0:2 and  =
0:3. We see that for some covariates there are positive changes in the parameter estimates,
while others have negative changes in the parameter estimates. Positive values in Table
1314.3 mean that the element of ^  for that covariate is larger than the corresponding element
of ^ 0. So, this suggests that the hazard ratio of the covariate is being underestimated by
the model assuming non-informative censoring. Conversely, negative values in Table 4.3
mean that the parameter estimate for the covariate from the model assuming informative
censoring is smaller than the corresponding parameter estimate from the model assuming
non-informative censoring. Therefore, the sensitivity analysis is suggesting that the hazard
ratio for these covariates are overestimated by the model that assumes  = 0.
The sensitivity analysis for  suggests that the majority of the hazard ratios for the
levels of primary liver disease category are overestimated by the model that assumes non-
informative censoring, apart from patients with hepatitis B infection, cancer or metabolic
liver disease, whose hazard ratios are being underestimated. Similarly, most of the hazard
ratios for the levels of recipient ethnicity are being overestimated with the exception of pa-
tients of oriental ethnic origin, whose hazard ratio is being underestimated. The sensitivity
analysis also suggests that there should be small alterations made to the parameter esti-
mates for the UKELD score and recipient age from the model assuming non-informative
censoring. However, the parameter estimate for recipient age should be reduced while the
parameter estimate for the UKELD score needs to be increased.
Table 4.4 shows the approximate parameter estimates for piecewise exponential models
assuming  = 0:2 and  = 0:3 respectively. The parameter estimates for the model
assuming non-informative censoring are also shown. These parameter estimates assuming
 = 0:2 and  = 0:3 are obtained by adding the values of ^  in Table 4.4 to the values in
Table 4.3. The p-values of all the estimates are also shown. These are calculated using
the standard errors of the estimates from the model assuming non-informative censoring.
This can be done as Siannis et al. (2005) show that
fVar(^ )g1=2 ' fVar(^ 0)g1=2 + O(2):
Only linear values of  are considered in the sensitivity analysis so the standard error of the
parameter estimate from the model assuming informative censoring can be approximated
by the standard error of the parameter estimate from the model assuming non-informative
censoring. This approximation should only be used if the value of  is fairly small.
The approximate values of ^ 0:2 and ^ 0:3 given in Table 4.4 can be used to nd the
change in the estimated linear predictor for T under this sensitivity analysis. This is done
for each individual in the data set using the expression
^ w(xij)   ^ w0(xij) = ^ 
0
xij   ^ 
0
0xij:
The largest value of this change that is estimated by the sensitivity analysis is 0.2289 for
 = 0:2 and 0.3434 for  = 0:3. These values are much smaller than the corresponding
132Parameter ^ 0:2   ^ 0 ^ 0:3   ^ 0
Intercept 0.18243 0.27364
PLD - PBC -0.03830 -0.05746
PLD - PSC -0.01971 -0.02956
PLD - ALD -0.02469 -0.03703
PLD - AID -0.02944 -0.04416
PLD - HCV -0.01639 -0.02458
PLD - HBV 0.02421 0.03631
PLD - Cancer 0.04255 0.06383
PLD - Metabolic 0.01421 0.02132
PLD - Other -0.04777 -0.07165
Ethnicity - White -0.02683 -0.04025
Ethnicity - Asian -0.00012 -0.00018
Ethnicity - Black -0.03322 -0.04983
Ethnicity - Chinese 0.00443 0.00665
UKELD 0.00020 0.00029
Age -0.00013 -0.00020
j - Interval 1 -0.10709 -0.16063
j - Interval 2 -0.08191 -0.12286
Table 4.3: Table showing the components of ^    ^ 0 approximated by the sensitivity
analysis for  = 0:2 and  = 0:3.
133Parameter ^ 0 p-value ^ 0:2 p-value ^ 0:3 p-value
Intercept -20.54993 < 0:0001 -20.36750 < 0:0001 -20.27629 < 0:0001
PLD - PBC -0.23181 0.49682 -0.27011 0.42849 -0.28926 0.39649
PLD - PSC -0.93303 0.01862 -0.95274 0.01627 -0.96259 0.01520
PLD - ALD -0.46799 0.13534 -0.49268 0.11592 -0.50502 0.10707
PLD - AID -0.02429 0.94191 -0.05373 0.87194 -0.06845 0.83729
PLD - HCV 0.23191 0.48051 0.21553 0.51206 0.20733 0.52823
PLD - HBV -0.44046 0.44924 -0.41626 0.47455 -0.40415 0.48749
PLD - Cancer -1.46458 0.05627 -1.42203 0.06381 -1.40075 0.06789
PLD - Metabolic 0.64451 0.07151 0.65872 0.06548 0.66583 0.06262
PLD - Other 0.36075 0.28898 0.31298 0.35759 0.28910 0.39545
Ethnicity - White 0.97872 0.33155 0.95189 0.34498 0.93848 0.35182
Ethnicity - Asian -0.02734 0.97917 -0.02746 0.97908 -0.02752 0.97904
Ethnicity - Black 0.92243 0.41008 0.88921 0.42715 0.87260 0.43583
Ethnicity - Chinese -0.72652 0.61251 -0.72209 0.61468 -0.71987 0.61577
UKELD 0.19145 < 0:0001 0.19164 < 0:0001 0.19174 < 0:0001
Age 0.03019 < 0:0001 0.03005 < 0:0001 0.02999 < 0:0001
j - Interval 1 0.21283 0.22803 0.10574 0.54923 0.05220 0.76750
j - Interval 2 0.47753 0.00265 0.39562 0.01279 0.35467 0.02562
Table 4.4: Table showing the parameter estimates for the model assuming non-informative
censoring, along with the parameter estimates approximated by the sensitivity analysis for
 = 0:2 and  = 0:3. The p-values are also shown, these are all found using the standard
errors from the model assuming non-informative censoring.
134values estimated by the sensitivity analysis for w(x). Therefore an investigation into which
of these two sensitivity methods is more accurate would be useful.
4.4 Summary
In this chapter, we present a general method that allows us to estimate the change in
parameter estimates for piecewise parametric models if we assume a small amount of
informative censoring instead of non-informative censoring. The method is rst derived
assuming only scalar parameters in each interval in the models for time to death and time
to censoring. It is then extended to include a vector of covariates. To include covariates
we need to use piecewise parametric models that can be expressed in terms of parameter
vectors that remain constant over all intervals, as the parameter estimates in all the
intervals need to be estimated at the same time.
The method presented in this chapter is a compromise between the sensitivity analysis
given in Siannis et al. (2005) and Siannis (2004) and the sensitivity analysis in Siannis
(2011). Our method has the exibility of the Cox model that is used in Siannis (2011), but
it computationally simpler like the methods in Siannis et al. (2005) and Siannis (2004).
When including covariates in the method, it is possible to apply a sensitivity analysis
for either a linear predictor or a vector of parameters. The sensitivity analysis for a linear
predictor is computationally simpler but the sensitivity analysis for a parameter vector
allows us to examine the eect on individual parameter estimates not just the overall eect.
These two methods give very dierent values of the estimated changes in the parameter
estimates, therefore an investigation into which method is more accurate would be useful.
This is why the model that assumes informative censoring that can be approximated using
the sensitivity analysis will be tted to the Liver Registration data set in Chapter 5.
135136Chapter 5
Evaluating and Extending
Sensitivity Analysis
Having developed and applied the sensitivity analysis, we now investigate its properties.
Firstly, we will assess how close the approximation is for the dataset of interest. However,
we also want to be able draw some more general conclusions about the behaviour of
the sensitivity analysis. Therefore, simulations will be used to test the accuracy of the
sensitivity analysis for many dierent combinations of the parameters. Based on the
results of these simulations, we will make recommendations on possible ways to improve
the sensitivity analysis.
To nd the true dierence between the parameter estimates, it will be necessary to
t the dependence model that does not approximate the form of the joint distribution.
Thus we consider a slightly dierent change in the parameters than is approximated by
our sensitivity analysis equation. We do this because it is more useful to know how
accurate the sensitivity analysis is at estimating the change in parameter estimates from
the independence model to the dependence model that does not make any simplifying
assumptions. These assumptions were necessary in the last chapter to get a closed form of
the likelihood to work with. The tting of the dependence model will be detailed below,
including a brief description of some of the numerical methods that need to be used to t
the model.
The dependence model is tted to our example dataset and compared to the results
obtained for the sensitivity analysis in the previous chapter. Then a simulation study
will be used to assess the accuracy of the sensitivity analysis in a variety of situations.
All these investigations will consider the alternative sensitivity analysis as it is easier to
apply when using piecewise exponential models. Finally, a possible way of improving the
sensitivity analysis to overcome some of the issues that are raised by the simulation study
will be outlined.
1375.1 Fitting dependence model
We write the joint density of T and CI, as
fT;C(tj;cj) = fT(tj;j)fCjT(cjjtj;j;;j) (5.1)
As in Section 4.1 we assume that
fCjT(cjjtj;j;;j) = fC(cj;j + i 1=2
j B(tj;j)); (5.2)
with ij = 1 and B(tj;j) = ijsT(tj;j) = 1   ejt under our proportional hazards
structure, given in Section 4.2.2.
In addition, we assume piecewise exponential marginal models for both T and CI, so
fT(tj;;xj) = e0xje exp(0xj)t and fC(c;) = eje exp(j)c;
where the linear combination 0xj is replaced by a scalar parameter j, as it is just
a nuisance parameter. The vector  here is set up in the same way as the vector of
parameters in Section 4.2.3. It has a common intercept for all the intervals which is
adjusted for each interval by a factor giving the contrast between the baseline intercept
and the interval under consideration.
If we combine (5.1) and (5.2), and then substitute the exponential forms into the
resulting equation, then we obtain:
fT;C(tj;cj) = e0xje expf0xjgtjej+(1 expf0xjgtj)e exp(j+(1 expf0xgtj))cj: (5.3)
The parameter estimates for the full model will be obtained by nding the maximum
likelihood estimates of the likelihood detailed below
`(;;~ x) =
n X
i=1
m X
j=1
n
Iij logK1(yij) + Zij(1   Iij)logK2(yij)
+ (1   Iij)(1   Zij)logK3(yij)
o
; (5.4)
where
K1(yij) = e0xije expf0xijgyije exp(j+(1 expf0xijgyij))yij
K2(yij) =
Z 1
yij
e0xije expf0xijguej+(1 expf0xijgu)e exp(j+(1 expf0xijgu))yijdu
and
K3(yij) =
Z 1
yij
e0xije expf0xgue exp(j+(1 expf0xijgu))yijdu: (5.5)
These were obtained by substituting the form of the joint distribution given in (5.3) into
(4.2). From now on we will dene ^  as the vector of values that maximises the likelihood
138in (5.4). This should be close to the value of ^  dened in the previous chapter if the
approximation used in (4.3) is a good approximation of the joint distribution in (5.3).
The two integrals in (5.5) cannot be evaluated analytically. We use Gauss-Laguerre
quadrature as it will be easy to transform the integrals in (5.5) into the form
Z 1
0
e yg(y)dy
so we can approximate the integral by
N X
j=1
wjg(vj);
where wj and vj are respectively the set of weights and abscissas for the integer N. Here
N = 32 is used. We can then nd the maximum likelihood estimates using the downhill
simplex method of Nelder and Mead. This is inecient but robust for functions where we
can compute function evaluations but not derivatives. Both of these methods are outlined
in greater detail in Press et al.(1992).
5.1.1 Fitting the dependence model to the Liver Registration data set
To be able to assess the accuracy of the sensitivity analysis developed in Chapter 4, it is
necessary to t the dependence model described in Section 5.1 to the Liver Registration
data set. Firstly, this will be done assuming only scalar parameters in each interval
for the model for time to death and time to censoring. This will allow the accuracy of
the sensitivity analysis applied in Section 4.3.1 to be assessed. Covariates will then be
included to allow the accuracy of the sensitivity analyses applied in Section 4.3.2 to be
assessed. This should indicate whether a sensitivity analysis for the linear predictor w(x)
or a sensitivity analysis for the parameter vector  is more accurate.
The parameter estimates obtained by tting the dependence model to the Liver Reg-
istration data set with scalar parameters in each interval for the model for time to death
and time to censoring are given in Table 5.1. The parameter estimates obtained by tting
the corresponding independence model are included for comparison.
The sensitivity analysis from Section 4.3.1 which uses scalar parameters will now be
reapplied using  = 0:2698, which is the tted value from the dependence model. The
results of this sensitivity analysis are given in Table 5.2. The estimated values of ^ 0:2698k 
^ 0k found using the sensitivity analysis are compared to the observed values of ^ 0:2698k ^ 0k
found by taking the dierence of the values in Table 5.1. We can see that the sensitivity
analysis overestimates the change in the parameter estimates for the rst interval, but
underestimates the change in the parameter estimates in the second and third intervals.
The dependence model including covariates will now be tted to the Liver Registration
data set. The explanatory variables for time to death used are age at registration, recipient
139Parameter Estimate from the Estimate from the
independence model dependence model
 - 0.2698
1 -6.7799 -6.7571
2 -6.9056 -6.8206
3 -7.6375 -7.4458
1 -4.9189 -4.9137
2 -5.2320 -5.1008
3 -5.5695 -5.2806
Table 5.1: The parameter estimates obtained by tting the dependence model to the Liver
registration data set assuming scalar parameters in each interval for the models for time
to death and time to censoring. The parameter estimates from the independence model
are also given for comparison.
k Estimated value of Observed value of
^ 0:2698k   ^ 0k ^ 0:2698k   ^ 0k
1 0.0370 0.0228
2 0.0819 0.0850
3 0.1812 0.1917
Table 5.2: The estimated values of ^ 0:2698k   ^ 0k found using the sensitivity analysis from
4.3.1 and the observed values of ^ 0:2698k   ^ 0k found using the values in Table 5.1.
140ethnicity, primary liver disease category and UKELD score at registration. These are the
same covariates included in the model for time to death in Section 4.3.2 when applying the
sensitivity analysis for . However, only a scalar parameter is used for the model for time
to censoring. This is because the model is already has a fairly large number of dimensions
and including covariates for time to censoring would add enough extra dimensions to make
the convergence of the algorithms in Section 5.1 too slow. This means that the results
from this dependence model cannot be compared directly to the sensitivity analyses in
Section 4.3.2, as they use covariates in their models for time to censoring.
The estimates for the dependence model obtained are given in Table 5.3. To see how
much these vary from the estimates given by tting the independence model, ^ 0 is also
included in Table 5.3. The sensitivity analyses for w(x) and  are carried out using
 = 0:2769, which is the tted value from the dependence model. This allows the direct
comparison of the results of the sensitivity analyses with the results of the dependence
model in Table 5.3.
The sensitivity analysis for w(x) requires the same vector of covariates to be used
in the model for time to death and the model for time to censoring. This means that
the sensitivity analysis that is used for comparison with the results of the tted depen-
dence model includes primary liver disease category, recipient age, recipient ethnicity and
UKELD score as covariates in the models for time to death and time to censoring. The
plot in Figure 5.1 shows the estimated change in the linear predictor over the range of
^ z0j(x) observed in each of the intervals for the data for several values of . The solid line
is the sensitivity analysis for  = 0:2769, which is the tted value from the dependence
model. The dashed lines are the sensitivity analyses for  = 0:1377 and  = 0:4162 which
are the limits of 95% condence interval for  given in Table 5.3. These are included to
show how the change in estimated linear predictor is greatly aected by the value of 
used.
The maximum change in the linear predictor estimated by the sensitivity analysis using
 = 0:2769 is 0.6248, but the dashed lines suggest that this change could be anywhere
between 0.3107 and 0.9391. However, when calculating the dierence between ^ w(x) and
^ w0(x) using the parameter estimates in Table 5.3, the largest dierence observed was
0.3868.
This result shows that for the Liver Registration data, the sensitivity analysis tends to
overestimate the change in the estimated linear predictors. However, only a small number
of the patients in the data will have a discrepancy that is large. We already know that the
sensitivity analysis gives the largest changes in ^ w(x) and ^ w0(x) for the patients with the
largest values of ^ z0j(x). From Figure 4.1, we know that only a small number of patients
have values of ^ z0j(x) that are that large. So, for the majority of individuals in the Liver
141Parameter Estimate Estimate Standard 95% Condence
from from Error Interval
independence dependence
model model
 - 0.2769 0.0711 (0.1377,0.4162)
 - -5.0981 0.0221 (-5.1415,-5.0548)
 Intercept -20.5499 -20.0591 1.2500 (-22.5092,-17.6090)
Age 0.0302 0.0298 0.0061 (0.0180,0.0417)
Ethnicity - White 0.9787 1.0762 1.0105 (-0.9044,3.0568)
Ethnicity - Asian -0.0273 0.0598 1.0495 (-1.9972,2.1169)
Ethnicity - Black 0.9224 0.9775 1.1223 (-1.2221,3.1771)
Ethnicity - Chinese -0.7265 -0.5046 1.4260 (-3.2994,2.2903)
Ethnicity - Other 0 0
PLD - PBC -0.2318 -0.2548 0.3363 (-0.9140,0.4045)
PLD - PSC -0.9330 -0.9391 0.3927 (-1.7089,-0.1694)
PLD - ALD -0.4680 -0.4741 0.3083 (-1.0785,0.1302)
PLD - AID -0.0243 -0.0693 0.3288 (-0.7137,0.5751)
PLD - HCV 0.2319 0.1965 0.3248 (-0.4401,0.8331)
PLD - HBV -0.4405 -0.4647 0.5793 (-1.6001,0.6707)
PLD - Cancer -1.4646 -1.5034 0.7639 (-3.0007,-0.0062)
PLD - Metabolic 0.6445 0.6279 0.3518 (-0.0616,1.3174)
PLD - Other 0.3608 0.2560 0.3357 (-0.4019,0.9139)
PLD - Acute 0 0
UKELD 0.1914 0.1858 0.0099 (0.1664,0.2053)
j - Interval 1 0.2128 0.0241 0.1755 (-0.3198,0.3679)
j - Interval 2 0.4775 0.3317 0.1575 (0.0231,0.6403)
j - Interval 3 0 0
Table 5.3: Parameter estimates, standard errors and 95% condence intervals for the
dependence model when tted to the Liver Registration data set. The parameter estimates
obtained when tting the independence model to the Liver Registration data set are
included for comparison.
142Figure 5.1: The results of the sensitivity analysis for the linear predictor for time to failure
using the value of  estimated by the dependence model
Registration data the discrepancy between the results of the sensitivity analysis and the
change in ^ w(x) and ^ w0(x) using the results of the dependent model is small.
The results of the sensitivity analysis for  are given in Table 5.4. The estimated
values of ^ 0:2769   ^ 0 found using the sensitivity analysis are compared to the observed
values of ^ 0:2769   ^ 0 found by taking the dierence of the parameter estimates in Table
5.3. We can see from Table 5.4 that we have mixed results concerning the accuracy of the
sensitivity analysis. For most parameters the sensitivity analysis does correctly identify the
direction of the change in the parameter estimates. However for patients with metabolic
liver disease and white, Asian or black patients this is not the case. Even if the sensitivity
analysis correctly identies the direction of the change, then it may either overestimate or
underestimate the magnitude of the change.
Approximate values of ^ 0:2769 can be found by adding the estimated values of ^ 0:2769 
^ 0 given in Table 5.4 to the values of ^ 0 from Table 5.3. These values of ^ 0:2769 can then
be used to nd the change in the estimated linear predictor for T under this sensitivity
analysis. This is done for each individual in the data set using the expression
^ w0:2769(xij)   ^ w0(xij) = ^ 
0
0:2769xij   ^ 
0
0xij:
The largest value of this change that is estimated by the sensitivity analysis for  is
0.3869. This is very close to the observed change in the estimated linear predictor which
was 0.3868. These results suggest that the sensitivity analysis for  is more accurate
than the sensitivity analysis for w(x). Therefore, the sensitivity analysis for  should be
used when we wish to apply a sensitivity analysis to a piecewise exponential model with
covariates.
143Parameter Estimated values of Observed value of
^ 0:2769   ^ 0 ^ 0:2769   ^ 0
Intercept 0.6085 0.4908
PLD - PBC -0.0317 -0.0230
PLD - PSC -0.0161 -0.0061
PLD - ALD -0.0110 -0.0061
PLD - AID -0.0280 -0.0450
PLD - HCV -0.0300 -0.0354
PLD - HBV -0.0279 -0.0242
PLD - Cancer -0.0303 -0.0388
PLD - Metabolic 0.0096 -0.0166
PLD - Other -0.0192 -0.1048
Ethnicity - White -0.0647 0.0975
Ethnicity - Asian -0.0402 0.0871
Ethnicity - Black -0.0901 0.0551
Ethnicity - Chinese 0.0019 0.2219
UKELD -0.0036 -0.0055
Age -0.0005 -0.0004
j - Interval 1 -0.2617 -0.1887
j - Interval 2 -0.2198 -0.1458
Table 5.4: Comparison of the estimated values of ^ 0:2769   ^ 0 found using the sensitivity
analysis from 4.3.2 with the observed values of ^ 0:2769 ^ 0 found using the values in Table
5.3.
1445.2 Simulations
To investigate the accuracy of the sensitivity analysis for the dierence in the parameters
from the independence and dependence models, over a range of parameter values, a simu-
lation study was conducted. The main aim is to establish whether the actual dierence in
the parameter estimates is generally overestimated or underestimated by the sensitivity
analysis. We also wish to assess the accuracy of the sensitivity analysis as a function of
dependence. This would give us some idea of when the use of this method is appropriate.
To keep the computation simple, we shall generate data from a piecewise exponential
distribution with no other covariates. The sensitivity analysis will be carried out on the
simulated data along with tting the dependent model so the accuracy of our method can
be assessed. This will be done for a wide range of the parameters ,  and , so we can
identify the situations where use of the sensitivity analysis is appropriate. The models
tted to the simulated dataset will assume the same distribution that the dataset was
simulated from. This allows us to assess the accuracy of the sensitivity analysis when we
have tted the correct model.
5.2.1 Simulation study set-up
The dierent combinations of these parameters used in the simulations are given in Table
5.5. Each of these combinations was combined with  values of -0.4, -0.3, -0.2, -0.1, 0.1,
0.2, 0.3 and 0.4. For each dierent combination of ,  and  we simulated 500 replicates.
In all the simulations, we assume n = 2000. For each scenario in Table 5.5, we simulate
observations from a 2-interval piecewise exponential model. We use e as the hazard of
failure in the second interval, and e+j1 as the hazard of failure in the rst interval. The
hazard of censoring in the second interval is e, with the hazard in the rst interval being
e+j2. An arbitrary cut-point for the 2-interval piecewise exponential model is chosen to
give approximately equal numbers of events in the two intervals. These are also given in
Table 5.5.
The dependent model will be tted and the sensitivity analysis will be applied to each
simulated data set. When tting the dependent model, the value of  will be xed. This is
because there is very little information about  in the data, even after identifying assump-
tions have been made, and consistent estimates of  cannot be obtained. This would make
it dicult to make meaningful comparisons between dierent parameter combinations.
Therefore we used a prole likelihood approach when estimating the other parameters in
the model. Similarly, the amount of dependence assumed in the sensitivity analysis is the
xed value of  used when tting the dependent model.
For each replication the parameter estimates from the dependent model, ^ 
(d)
 , were
145Part  j1  j2 Cut-point used
1 -2 -1 -3 -0.5 15
2 -4 -1 -3 -0.5 30
3 -6 -1 -3 -0.5 30
4 -2 -1 -4 -0.5 15
5 -4 -1 -4 -0.5 50
6 -6 -1 -4 -0.5 75
7 -2 -1 -5 -0.5 15
8 -4 -1 -5 -0.5 70
9 -6 -1 -5 -0.5 150
10 -8 -1 -5 -0.5 150
11 -2 -1 -6 -0.5 15
12 -4 -1 -6 -0.5 90
13 -6 -1 -6 -0.5 300
14 -8 -1 -6 -0.5 400
Table 5.5: Table showing the combinations of ,  and cut points used in the simulation
study. For each scenario,  values of -0.4, -0.3, -0.2, -0.1, 0.1, 0.2, 0.3 and 0.4 will be
investigated.
found along with the parameter estimates approximated by the sensitivity analysis, ^ 
(s)
 .
The value D = (^ 
(d)
   ^ 0)   (^ 
(s)
   ^ 0) is of interest. The element of D with the largest
magnitude is found as this corresponds to the largest discrepancy between the results of
the dependent model and the results of the sensitivity analysis. If this term is negative,
then the sensitivity analysis overestimates the change in the parameter estimates.
Generating from a piecewise exponential distribution
For the sake of simplicity, we shall consider only the piecewise exponential distribution
with 2 intervals in our simulations. Zhou (2001) gives an algorithm to transform standard
exponential random variables into piecewise exponential random variables,
[Generate Y  exp(1)] )
8
<
:
if [Y  a11] return Y=1
if [Y > a11] return a1 + (Y   a11)=2;
(5.6)
where a1, is the endpoint of the rst intervals and 1 and 2 are the rates in the rst
and second intervals respectively. As standard exponential random variables can be easily
generated using standard software packages, this algorithm is easy to implement.
For the failure time distribution, we will let the rates in the two intervals be e1 and
e2 respectively and simply apply the above algorithm. Simulating the observations from
the conditional distribution for the censored observations is a little tricky, due to the
146dependence on the failure time distribution. As dened earlier, the parameter for the
conditional distribution is  + i
 1=2
 B(t;). Under the structure we are using, i = 1
and B(t;) = 1   HT(t;). Under the piecewise exponential model, we can write the
cumulative hazard function as
HT(t;) =
j(t) X
j=1
tjej
where j(t) is the interval number in which the failure occurs and tj is the time experienced
in the jth interval. This means that the rates used to generate observations from the
censoring time distribution are
exp
8
<
:
1 + 
0
@1  
j(t) X
j=1
tjej
1
A
9
=
;
and exp
8
<
:
2 + 
0
@1  
j(t) X
j=1
tjej
1
A
9
=
;
:
5.2.2 Results
The mean values of the largest element of D were calculated along with a 95% condence
interval for the mean using the set-up described in Section 5.2.1. Table 5.6 gives these
results for the simulations. These results are also summarised graphically in Figure 5.2.
The plots in Figure 5.2 show the eect of  on the mean observed as  increases, at each
dierent level of .
The majority of the means observed in Table 5.6 are negative, which means that
generally the sensitivity analysis overestimates the change in the parameter estimates.
From the plots in Figure 5.2, it can be seen that generally we observe the larger means
when  is greater than 0.3, and  and  are similar in size or  > . The greater the
dierence between  and , the bigger the mean dierence we observe. As the size of
 relative to  increases, the hazard rate of censoring is also increasing relative to the
hazard rate for failure. So the simulated data sets would generally contain an increasing
proportion of censored observations. Therefore we observe the largest changes in the mean
of D when there is a relatively large proportion of censored observations in the data set.
Also as the magnitude of  increases, the size of the mean also increases, especially in the
situations with relatively large amounts of censoring.
Analysis of Variance
To establish the eects of the individual parameters on the simulation results, an analysis
of variance model that included all the main eects and interactions between ,  and 
was tted. The ANOVA nds that there is a signicant 3 factor interaction between , 
and , as we can see in Table 5.7. As  increases the mean observed generally decreases,
but the 3 factor interaction means that the values of  and  will aect the rate at which
147  =  2;  =  3  =  4;  =  3  =  6;  =  3
-0.4 -0.1492(-0.1514,-0.1470) -0.1636(-0.1655,-0.1618) -0.1410(-0.1428,-0.1393)
-0.3 -0.1006(-0.1021,-0.0991) -0.1239(-0.1253,-0.1226) -0.1120(-0.1131,-0.1108)
-0.2 -0.0574(-0.0582,-0.0565) -0.0807(-0.0816,-0.0798) -0.0767(-0.0774,-0.0760)
-0.1 -0.0234(-0.0238,-0.0230) -0.0387(-0.0391,-0.0383) -0.0385(-0.0388,-0.0382)
0.1 -0.0127(-0.0130,-0.0124) -0.0320(-0.0323,-0.0316) -0.0360(-0.0364,-0.0356)
0.2 -0.0162(-0.0167,-0.0157) -0.0544(-0.0555,-0.0533) -0.0597(-0.0610,-0.0584)
0.3 -0.0144(-0.0150,-0.0137) -0.0492(-0.0517,-0.0466) -0.0627(-0.0676,-0.0577)
0.4 -0.0140(-0.0144,-0.0135) -0.0009(-0.0048,0.0030) -0.1469(-0.1841,-0.1096)
  =  2;  =  4  =  4;  =  4  =  6;  =  4
-0.4 -0.0647(-0.0657,-0.0638) -0.1249(-0.1262,-0.1236) -0.1344(-0.1360,-0.1328)
-0.3 -0.0409(-0.0416,-0.0403) -0.0891(-0.0900,-0.0881) -0.1044(-0.1054,-0.1033)
-0.2 -0.0224(-0.0228,-0.0220) -0.0553(-0.0559,-0.0547) -0.0714(-0.0721,-0.0708)
-0.1 -0.0086(-0.0088,-0.0084) -0.0250(-0.0253,-0.0247) -0.0356(-0.0359,-0.0353)
0.1 -0.0045(-0.0046,-0.0043) -0.0196(-0.0198,-0.0193) -0.0329(-0.0333,-0.0326)
0.2 -0.0059(-0.0062,-0.0057) -0.0346(-0.0351,-0.0340) -0.0549(-0.0562,-0.0537)
0.3 -0.0059(-0.0062,-0.0056) -0.0408(-0.0420,-0.0397) -0.0579(-0.0609,-0.0548)
0.4 -0.0064(-0.0066,-0.0061) -0.0431(-0.0445,-0.0418) -0.0863(-0.0957,-0.0770)
  =  2;  =  5  =  4;  =  5  =  6;  =  5
-0.4 -0.0278(-0.0283,-0.0273) -0.0806(-0.0815,-0.0798) -0.1093(-0.1107,-0.1080)
-0.3 -0.0163(-0.0166,-0.0159) -0.0537(-0.0543,-0.0531) -0.0836(-0.0844,-0.0827)
-0.2 -0.0084(-0.0086,-0.0082) -0.0316(-0.0320,-0.0312) -0.0562(-0.0567,-0.0556)
-0.1 -0.0032(-0.0033,-0.0031) -0.0134(-0.0136,-0.0132) -0.0276(-0.0279,-0.0274)
0.1 -0.0017(-0.0018,-0.0016) -0.0094(-0.0095,-0.0092) -0.0250(-0.0253,-0.0246)
0.2 -0.0023(-0.0024,-0.0022) -0.0152(-0.0155,-0.0149) -0.0415(-0.0426,-0.0405)
0.3 -0.0027(-0.0029,-0.0025) -0.0183(-0.0187,-0.0178) -0.0506(-0.0526,-0.0487)
0.4 -0.0030(-0.0032,-0.0029) -0.0204(-0.0208,-0.0200) -0.0606(-0.0641,-0.0571)
  =  8;  =  5  =  2;  =  6  =  4;  =  6
-0.4 -0.0913(-0.0928,-0.0898) -0.0108(-0.0111,-0.0105) -0.0477(-0.0483,-0.0470)
-0.3 -0.0735(-0.0747,-0.0724) -0.0060(-0.0062,-0.0058) -0.0301(-0.0306,-0.0297)
-0.2 -0.0502(-0.0510,-0.0494) -0.0030(-0.0031,-0.0029) -0.0167(-0.0170,-0.0164)
-0.1 -0.0262(-0.0267,-0.0258) -0.0011(-0.0012,-0.0011) -0.0067(-0.0069,-0.0066)
0.1 -0.0226(-0.0231,-0.0221) -0.00060(-0.00065,-0.00056) -0.0040(-0.0041,-0.0038)
0.2 -0.0339(-0.0350,-0.0328) -0.00096(-0.00103,-0.00089) -0.0057(-0.0059,-0.0055)
0.3 -0.0579(-0.0655,-0.0502) -0.0012(-0.0013,-0.0011) -0.0062(-0.0065,-0.0060)
0.4 -0.2225(-0.2677,-0.1773) -0.0014(-0.0015,-0.0013) -0.0069(-0.0072,-0.0067)
  =  6;  =  6  =  8;  =  6
-0.4 -0.0966(-0.0976,-0.0956) -0.0907(-0.0923,-0.0891)
-0.3 -0.0704(-0.0711,-0.0697) -0.0732(-0.0746,-0.0719)
-0.2 -0.0442(-0.0446,-0.0438) -0.0518(-0.0526,-0.0509)
-0.1 -0.0203(-0.0205,-0.0201) -0.0266(-0.0270,-0.0262)
0.1 -0.0174(-0.0177,-0.0172) -0.0227(-0.0232,-0.0223)
0.2 -0.0329(-0.0336,-0.0323) -0.0358(-0.0369,-0.0347)
0.3 -0.0426(-0.0437,-0.0415) -0.0567(-0.0613,-0.0521)
0.4 -0.0508(-0.0521,-0.0494) -0.1441(-0.1558,-0.1325)
Table 5.6: The mean of largest element of D (with 95% condence intervals) for each
combination of parameters given in Table 5.5 and each value of .
148Figure 5.2: Eect of  on mean of largest element of D as  varies between -0.4 and 0.4
for the values of  considered in the simulation study.
149the mean decreases. There is a greater rate of decrease for larger values of  when 
is negative. This is because as  increases there is a greater decrease in the proportion
of censored observations in the simulated data sets with larger values of . Conversely,
for positive , the decrease in the proportion of censored observations as  increases is
greatest for the simulated data sets with smaller values of , so these values have the
greatest rate of decrease in the mean. The rate of decrease in the mean is also aected
by the magnitude of . For larger magnitudes of , the rate of decrease in the mean as
 increases is larger. This makes intuitive sense as the eect of censored observations on
the results of the sensitivity analysis increases as the magnitude of  increases.
Parameter DF Type I SS Mean Square F Value p
delta 8 48.4913 6.0614 1523.82 < 0:0001
theta 3 23.2965 7.7655 1952.22 < 0:0001
gamma 3 7.7221 2.5740 647.10 < 0:0001
delta*theta 24 19.2382 0.8016 201.52 < 0:0001
delta*gamma 24 8.7563 0.3648 91.72 < 0:0001
theta*gamma 7 0.6545 0.0935 23.51 < 0:0001
delta*theta*gamma 56 5.7415 0.1025 25.77 < 0:0001
Table 5.7: Signicance levels of parameters and interactions in analysis of variance
There are a handful of situations that are found to have means that are signicantly
dierent from most of the other means. These are when  =  6 and  =  3,  =  8 and
 =  5 and  =  8 and  =  6, all for  = 0:4. It is easy to identify these cases in Figure
5.2.
Further investigations revealed that in these cases, some of the data sets had large
outlying values that caused a large increase in the value of the sensitivity index, U. This
meant that the sensitivity analysis performed particularly badly for these data sets, result-
ing in an increased mean for D. This tells us that the accuracy of the sensitivity analysis
is aected by the size of the observations included in each interval. This was observed
in Sections 4.3.1 and 4.3.2 as the widest interval had the largest estimated changes in
the parameter estimates both when applying the sensitivity analysis for scalar parameters
and when including covariates. So the accuracy of the sensitivity analysis for piecewise
exponential models can be improved by dividing the time into a larger number of small
intervals.
The results of the simulation study carried out in this section suggest that the sensitiv-
ity analysis is not a good approximation of the change in parameter estimates when there
is heavy censoring and  becomes large. This could help to explain why the sensitivity
analysis overestimated the actual change in parameter estimates for the Liver Registra-
150tion dataset. In this dataset there is heavy censoring, with 71:7% of patients having a
potentially informatively censored time and a further 12:4% having a non-informatively
censored time. Also the dependent model tted suggests that  is around 0.3, although
with a wide condence interval because even after our assumptions to identify the joint
distribution of T and C we have little information about the dependence parameter.
However, even though some situations have been identied where the sensitivity anal-
ysis does not give a good approximation to the dependent model, the simulation study
in this section shows that there are many situations when the sensitivity analysis does
provide a reasonable approximation to the dependent model. This means that while the
sensitivity analysis was not as accurate as we would have hoped for the Liver Registration
data, it is still suitable for application in other situations.
5.3 Inclusion of Extra Terms in Approximations used in
Sensitivity Analysis
There are several Taylor expansions that are used in the derivation of the sensitivity
analysis described in Chapter 4. The accuracy of the sensitivity analysis may be improved
by including extra terms in any of these expansions. However, it is still necessary that
there is a closed form equation for the dierence in the parameter estimates. Because of
this restriction we found that it is possible to include extra terms in the approximation in
(4.3), but not those in used in (4.7).
Here, an equation for the sensitivity analysis is derived when using an additional
quadratic term in the approximation for the conditional density function of C. Hence
(4.3) is replaced by
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If this approximation of the joint density function is used in the likelihood in (4.1), then
151the likelihood becomes
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where
(yij;j) =
Z 1
yij
B(u;j)fT(u;j)du
ST(yij;j)
; and
(yij;j) =
Z 1
yij
B(u;j)2fT(u;j)du
ST(yij;j)
:
The method used to derive the sensitivity analysis equation is similar to that for the
sensitivity analysis for  in Section 4.2.3. This means that covariates will be included in
the sensitivity analysis. So  and  will be replaced by the parameter vectors  and 
respectively. However the linear predictor  = 0x To obtain an expression for ^    ^ 0,
Taylor expansions of the vector score functions
r0(0) =
@
@
`0(;;x) and r(^ ) =
@
@
`(;;x):
need to be used. As in Chapter 4, these expansions will only include the linear terms, so
that
r0(^ 0) ' r0()   (^ 0   )i(;x) = 0
r(^ ) ' r()   (^    )i(;x) = 0; (5.8)
where the (k;l)th element of the information matrix i(;x) is
@2
@k@l
`0(;;x):
The expressions in (5.8) can be rearranged to give
^    ^ 0 ' i(;x) 1(r()   r0()); (5.9)
152using the likelihood in (5.7) to obtain the kth component of r()   r0(), which is
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It is possible to apply the proportional hazards structure that was outlined in Section
4.2.2. As before, if this structure is assumed, i = 1, B(tj;;xj) = 1   HT(tj;;xj)
and (tj;;xj) =  HT(tj;;xj). The form of (tj;;xj) is 1 + HT(tj;;xj)2. Using
@
@kHT(tj;;xj) = xkHT(tj;;xj) and @
@HC(cj;j) = HC(cj;j), then the derivatives of
B(tj;;xj), B(tj;;xj)2, (tj;;xj) and (tj;;xj) are
@
@k
B(tj;;xj) =  xkHT(tj;;xj);
@
@k
B(tj;;xj)2 =  2xkHT(tj;;xj) + 2xkHT(tj;;xj)2;
@
@k
(tj;;xj) =  xkHT(tj;;xj) and
@
@k
(tj;;xj) = 2xkHT(tj;;xj)2:
It can also be shown that
@
@z(xj)SC(cj;z(xj))
SC(cj;z(xj))
=  HC(cj;z(xj));
@2
@z(xj)2SC(cj;z(xj))
SC(cj;z(xj))
= HC(cj;z(xj))(HC(cj;z(xj))   1);
@
@z(xj)fC(cj;z(xj))
fC(cj;z(xj))
= 1   HC(cj;z(xj)) and
@2
@z(xj)2fC(cj;z(xj))
fC(cj;z(xj))
= 1   3HC(cj;z(xj)) + HC(cj;z(xj))2:
If these terms are substituted into (5.10), then a simplied version of the kth component
153of r()   r0() is obtained, which is

n X
i=1
m X
j=1
xijk
n
HT(yij;;xij)HC(yij;ij)   Zij(1   Iij)HT(yij;;xij)
o
+2
n X
i=1
m X
j=1
xijk
n
(HT(yij;;xij)   Iij)HT(yij;;xij)HC(yij;ij)(HC(yij;ij)   1)
+ Zij(1   Iij)HT(yij;;xij)2(1   2HC(yij;ij))
o
: (5.11)
5.3.1 Application of sensitivity analysis that uses additional terms in
approximations to the Liver Registration data set
The sensitivity analysis using (5.9) is applied to the Liver Registration data set to see
if it gives an improvement on the sensitivity analysis presented in Chapter 4. Again,
it is assumed that the lifetime and censoring variables each have piecewise exponential
marginal distributions, each with three intervals with cut points at 40 and 165 days. Age,
recipient ethnicity, primary liver disease category and UKELD score at time of registration
were also included as covariates in the model for time to death. The model for time to
censoring only included an intercept term so that the results of this sensitivity analysis
can be compared to the observed values from the tted dependence model.
The hazards and associated functions for T and C with piecewise exponential marginal
distributions can be expressed as:
hT(tj;;xj) = e0xj hC(cj;j) = ej
HT(tj;;xj) = e0xjtj HC(cj;j) = ejcj
ST(tj;;xj) = exp( e0xjtj) SC(cj;j) = exp( ejcj) (5.12)
If the forms in (5.12) are substituted in (5.11), then the nal form of the kth component
of r()   r0() that shall be used in (5.9) is

n X
i=1
m X
j=1
xijke0xij 
eijy2
ij   Zij(1   Iij)yij
	
+ 2
(
n X
i=1
m X
j=1
xijke0xij
(e0xijyij   Iij)eijy2
ij(eijyij   1)
+ Zij(1   Iij)e0xijy2
ij(1   2eijyij)
	
)
; (5.13)
with the (k;l)th element of the information matrix i(;x) becoming
n X
i=1
m X
j=1
xijkxijle0xijyij:
154The rst term in (5.13) is the same as (4.30) in Section 4.2.3. So this sensitivity analysis
can be viewed as the original piecewise sensitivity analysis with a correction term. To see
if having this correction term in the sensitivity analysis improves its accuracy, the results
of the sensitivity analysis in Table 5.8 are compared to the values in Table 5.4.
Parameter ^ 0:2769   ^ 0
Intercept 0.6953
PLD - PBC -0.0757
PLD - PSC -0.0526
PLD - ALD -0.0489
PLD - AID -0.0709
PLD - HCV -0.0597
PLD - HBV -0.0805
PLD - Cancer -0.0641
PLD - Metabolic 0.0415
PLD - Other -0.0597
Ethnicity - White -0.0623
Ethnicity - Asian -0.0465
Ethnicity - Black -0.0944
Ethnicity - Chinese 0.0035
UKELD -0.0033
Age -0.0008
j - Interval 1 -0.3241
j - Interval 2 -0.2793
Table 5.8: The results of the sensitivity analysis that includes extra terms in the approx-
imations used, for  = 0:2769.
The piecewise sensitivity analysis that uses extra terms overestimates more of the
changes in the parameter estimates than the original sensitivity analysis. Also, any values
that were already overestimated by the original piecewise sensitivity analysis are overesti-
mated even more by the piecewise sensitivity analysis that uses extra terms, particularly
the values corresponding to the intercepts in each interval. Therefore, the sensitivity
analysis that uses extra terms is not an improvement on the original piecewise sensitivity
analysis.
1555.4 Summary
The aim of this chapter is to assess how accurate the sensitivity analysis is overall and to
identify any situations where it performs particularly badly.
We detail how to t the model that includes dependence before any simplifying as-
sumptions. Although it is possible to t this model, it is not simple and can be very time
consuming, especially if there are a large number of parameters. Also the dependence
assumption used can not be checked. This highlights why we need the sensitivity analysis
as we do not wish to t these complex models if it is not necessary. When this model was
tted to the Liver Registration data set, we found that the sensitivity analysis for w(x)
overestimated the change in parameter estimates. However, there were mixed results for
the sensitivity analysis for , although it did overestimate the change in the parameter
estimates corresponding to the intercepts in each interval. Overall the sensitivity analysis
for  was found to be more accurate than the sensitivity analysis for w(x).
To assess the general accuracy of the piecewise sensitivity analysis, a simulation study
was carried out across a range of parameter combinations, that correspond to a variety of
dierent situations. However, for simplicity, these simulations only consider models with
intercepts in each interval for both time to death and time to censoring. The sensitivity
analysis does tend to overestimate the change in these parameter estimates, although it is
worst when there are large outlying observations in the data set. The sensitivity analysis
also tends to overestimate the dierence in the parameter estimates corresponding to
the intercepts in each interval when a data set has a large amount of censoring and the
correlation coecient between T and C is assumed to be greater than 0.3.
A sensitivity analysis that uses an extra quadratic term in one of its Taylor expansions
was derived, as it was hoped this might be able to correct the overestimation seen when
there is heavy censoring in the data set. However, it was found for the Liver Registration
data set that this sensitivity analysis overestimated the change in the parameter estimates
even more than the original piecewise sensitivity analysis.
156Chapter 6
Comparing Waiting List and
Post-transplant Mortality in
Presence of Informative Censoring
We have reviewed the current methods for accounting for informative censoring in Chapters
2 and 3. We have also established that there is a change in parameter estimates in our
data set of interest when we assume informative censoring instead of non-informative
censoring that is large enough to be of concern. This was done using the sensitivity
analysis methodology developed in Chapters 4 and 5. So we will now consider a subject
of interest to NHSBT, which is whether patients are expected to receive a benet from
transplantation at all values of the UKELD score. We present a method that answers this
question by making use of one of the methods previously considered and apply it to the
Liver Registration data set. We also describe how this method can be extended to assess
whether patients receive a benet from alternative therapy transplants, such as using a
split liver or a liver from an extended criteria donor. However, this is not applied to the
Liver Registration data set.
It is important to be able to show that patients generally have an improvement in
their expected survival after transplantation. This becomes especially important when
we are considering some of the policies that have been adopted to increase the number
of donor livers available such as split livers or extended criteria donor livers. This can
be assessed using a concept known as survival benet, which uses the covariate-adjusted
hazard ratio for transplantation compared to not receiving a transplant, to quantify the
expected change in post-transplant mortality relative to waiting list mortality. If this ratio
is less than 1 then the expected survival of a patient after a transplant is greater then
their expected survival if they were to remain on the waiting list.
157Here we shall calculate the survival benet for dierent groups of UKELD scores to
see which patients get the most survival benet, or if there are any patients that do not
experience a signicant dierence between waiting and post-transplant mortality. This
shall be done using a method known as sequential stratication, which sets up experiments
to compare the survival of each transplanted patient with similar candidates who were on
the waiting list for at least the same amount of time as the transplanted patient. It
also uses weights similar to the inverse probability of censoring weights to account for
informative censoring.
Firstly, we will introduce the notation required for this method and discuss covariates
and the models necessary for the UKELD score before describing the method in more
detail. We will then describe the weight function that needs to be used to account for
the informative censoring in the data set. An estimating equation for this method is then
derived. Finally, we apply the method to our data set to produce estimates of the survival
benet for individuals in dierent UKELD groups.
6.1 Notation and Covariates
There are many dierent events that could be observed for each individual transplant
patient. Those include Di, time of death and Ci, time to censoring due to end of study or
lost to follow up. Ti will be used dene time to transplantation. The observed endpoint
for all individuals will be Yi = min(Di;Ci). Therefore a death indicator, i = I(Di < Ci),
will be necessary along with an at-risk indicator, Ri(t) = I(Yi  t). Ideally any patients
removed from the waiting list will be followed up after this removal. This was possible
in Schaubel et al.(2009b) using additional information from the Social Security Death
Master File. It is not possible for us to do something similar, as we have incomplete
death information for patients who are removed. However we do know whether they
were removed due to deteriorating condition or for other reasons. So if an individual was
removed because their condition had deteriorated, we assumed that they died on the date
of removal. Individuals that were removed for other reasons were censored at the time of
removal.
The counting process format will be used in this approach. This means that counting
processes for both death and transplantation are set up. These being ND
i (t) = I(Di 
t;i = 1) and NT
i (t) = I(Ti  min(t;Yi)) respectively. These remain at zero until
the patient either dies or receives a transplant, at which point they jump to one. The
increments of these processes are given by dND
i (t) = ND
i (t +dt) ND
i (t ) and dNT
i (t) =
NT
i (t  + dt)   NT
i (t ) respectively.
Counting processes for the deaths and transplantations in the entire sample can also
158be dened as ND(t) =
Pn
i=1 ND
i (t) and NT(t) =
Pn
i=1 NT
i (t). These count the number
of deaths or transplantations in the sample at or before time t. The increments in these
processes can also be found in a similar way to those outlined above.
There will also be the vector V(t) that contains the values of all the covariates identied
as being a signicant predictor of time to death for patients on the transplant waiting list
at time t. One of the major components of this vector will be the UKELD score. As this
score will change over time then will we need the recorded history,  V(t), of the vector
V(t).
6.2 Models for UKELD score
Ideally, we have measurements of the UKELD at several dierent times whilst the patient
remains on the waiting list. Unfortunately in the data set we have the UKELD score at
registration for all the patients that will be included in this analysis, and only a second
reading at time of transplantation for those who receive a transplant. So we have to choose
a method of modelling the UKELD scores at interim time points.
For the patients where we have two data points, we consider using linear interpolation
to compute the value of the UKELD score at intermediate time points. However, this
is probably not the best method to use as UKELD scores do not tend to vary linearly
with time. They tend to stay roughly constant until there is a fairly sudden deterioration
in the condition of the patient. But we do not have enough UKELD values to capture
this behaviour, so the two choices we have are linear interpolation or carrying forward the
UKELD values recorded at the time of registration on the waiting list.
Some of the patients with recorded UKELD values at the time of transplant have
UKELD values at time of transplant that are lower than their recorded values at time of
registration. If we use linear interpolation for these patients, then we would have decreasing
values of UKELD at the intermediate times. This would suggest that the patient's liver
function is improving over time, which would make it unlikely that they would be given
a liver transplant. There is obviously something happening to these patients that the
recorded values of UKELD we have for them does not capture, therefore it would be
better to assume that their UKELD values remain constant at the value recorded at time
of registration.
UKELD Model 1 For patients with UKELD values at time of transplant that are
larger then those at time of registration, we use linear interpolation to nd intermediate
values. For patients who are not transplanted, or have a value of UKELD at transplant
that is lower than that at time of registration, we assume that the UKELD value remains
159constant at the value recorded at time of registration.
UKELD Model 2 For this model, we assume that the UKELD scores remain constant
at the value recorded at time of registration for all patients.
More information on how a patient's UKELD score changes over time is now being
collected, so in future applications of this method, these values can be used instead of
either of the models we have presented here.
6.3 Sequential Stratication Method
The sequential stratication method allows the comparison of waiting list mortality and
post-transplant mortality for liver transplant patients, from which the survival benet
of transplantation can be derived. There are nT ordered times to transplantation from
registration on the list, tj where j = 1:::nT. At each of these transplant times an
\experiment" is initiated that compares the mortality of the patient being transplanted
with the mortality of similar patients who were still on the waiting list at time tj. In
Schaubel et al.(2009b), similar patients were considered to be those in the same geographic
region and the same MELD category, who are still at risk. For the NHSBT data that will
be analysed, geographic region does not have the same eect on survival as in the United
States so there will be no need to condition on this. Also the UKELD score will be used
instead of the MELD score.
Schaubel et al. (2009b) classify patients who are still at risk as those who are alive,
untransplanted and active on the waiting list at time tj. This means that min(Ti;Yi) > tj.
So, the patient's time to transplantation or some other endpoint from time of registration
is greater than tj. This is what we shall refer to as patients being matched by time from
registration. We also consider the case where patients are matched by date of transplant,
where patients are only considered to be at risk if they are alive and untransplanted and
active on the list on the date of transplant j. Figure 6.1 illustrates some of the dierences
between these two methods of deciding whether a patient should be included in control
group. The dashed arrows in these plots show how long the patients have been on the
waiting list before the time of the jth transplant.
When matching by time from registration, each individual has spent the same amount
of time on the waiting list prior to being entered into the experiment. This means time
from registration can be used in the models that we t. It is not as simple as that when
matching by date of transplant. As we can see from the right hand plot in Figure 6.1,
individuals will have been active on the waiting list for dierent lengths of time. This
means that to be able to make meaningful comparisons between the individuals in an
160Figure 6.1: Plots showing possible dierences between patients included in control groups
when matching by time from registration to transplant and by date of transplant.
experiment we need to measure from a time dierent from time of registration. We use
time from the date of the jth transplant and include previous time spent on the waiting
list as a covariate in our model.
Therefore we need to dene some new variables to be used when tting a model that
matches by date. These include DATETi;DATEDi andDATECi, which are the date of
transplant, date of death and date of censoring, respectively, for patient i. From these we
dene DATEYi, which is the earliest date out of DATETi;DATEDi andDATECi. We also
require DATEAi which is the date that the ith patient becomes active on the waiting list.
A variable is also needed that gives the amount of time patient i spent on the waiting list
before the date of the jth transplant. We dene this to be pij.
To show whether a patient is included in a particular experiment when matching by
time from registration, an experiment entry indicator will be dened as,
eij = Ifmin(Ti;Yi)  tj;ui(tj) = ujg
for the ith patient with respect to the jth experiment. Here uj is the UKELD score for the
patient undergoing the jth transplant and ui(tj) is the UKELD score for the ith patient
at time tj.
To show whether a patient is included in a particular experiment when matching by
date, the experiment entry indicator will be dened as,
eij = IfDATETj 2 [DATEAi;DATEYi];ui(tj) = ujg
161for the ith patient with respect to the jth experiment.
We will treat patients who are subsequently transplanted or removed from the waiting
list in the same way for both methods. Patients will be censored from an experiment if
they were to receive a transplant. This is because they will have triggered an experiment
of their own and will no longer be contributing to mortality on the waiting list. Ideally
we would follow up removals after their time of removal. However this information is
not available to us, we only know whether they were removed because their condition
had deteriorated or not. Therefore we will assume that any that were removed due to
deteriorating condition would have died shortly after, so we assume they died on the date
of removal. For individuals who were removed for other reasons, we will censor them on
the date of removal, as we have have no further information about their expected survival.
Considering each individual experiment, there will be an \experimental" group and a
\control" group. The patient j, who received the transplant that triggered the experiment
will be the only observation in the experimental group. We can dene the contributions
towards the model for each type of matching method using the standard counting process
format of (start, stop, event indicator).
When matching by time from registration, the patient in the experimental group will
give a contribution of (tj;Yj = min(Dj;Cj);j). The individuals in the corresponding
control group will contribute (tj;min(Yi;Ti);iI(Di < Ti)).
We can also dene the contributions when matching by date, after restarting the time
scale at the date of transplant. For the individual in the experimental group, this will be
(0;Yj  pjj;j), where pjj is the amount of time the individual in the experimental group
spends on the waiting list before their transplant. Similarly, the patients in the control
group will contribute (0;min(Ti   pij;Yi   pij);iI(Di < Ti)), where pij is the amount of
time the ith individual spends on the waiting list before the jth transplant.
The model that corresponds to this proposed method of sequential stratication when
nding the survival benet for dierent groups of UKELD scores is
D
ij(t;0) = D
0j(t)exp

T
0 Zij
	
; (6.1)
where 0 = (T
1 ;T
2 )T and Zij = (ZT
ij1;ZT
ij2). Here the parameter vector of interest is
1 = (1;:::;p)T, while Zij1 is the p  1 covariate vector with kth component IfTi =
tjgIfuj 2 UKELDkg, where UKELDk is the kth of the p groups of UKELD scores. The
estimates of the vector 1 will give the UKELD-category-specic hazard ratios of post-
transplant mortality versus wait-list mortality. The vector Zij2 contains any additional
adjustment covariates.
It is possible to generalise the above model to any situation. If we have a covariate
X for which we wish to calculate the survival benet of the patients at each level of the
162covariate, then we could still use the model in (6.1). However, Zij1 would become the p1
covariate vector with kth component IfTi = tjgIfxj 2 Xkg where Xk is the kth group of
the covariate of interest. The experiment entry indicators would be redened as
eij = Ifmin(Ti;Yi)  tj;xi(tj) = xjg and
eij = IfDATETj 2 [DATEAi;DATEYi];xi(tj) = xjg;
when matching by time from registration and date of transplant respectively, with xi(tj)
being the value of the covariate X for the ith patient at time tj.
6.3.1 Calculating the survival benet of alternative transplant therapies
If we want to nd the survival benet of an alternative therapy, such as using a split
liver or a liver from an extended criteria donor, relative to a standard transplant, then
we need to set up the model to be used in the sequential stratication method slightly
dierently from that given previously. Instead of an experiment being generated by every
transplant observed, only the alternative therapy transplants will initiate an experiment.
This would then allow us to estimate the ratio of the hazard function of the alternative
therapy relative to that of remaining on the waiting list and possibly receiving a standard
transplant in the future.
We would still be able to write the model used as
D
ij(t;0) = D
0j(t)exp

T
0 Zij
	
;
but with 0 = (AT;T
0 ) and Zij = (Zij1;Zij2) where AT is the parameter of interest and
Zij1 = IfTAT
i = tjg, where TAT
i is the time that an alternative therapy transplant, such
as a transplant using a split liver or an organ from an extended criteria donor, occurs for
the ith patient. To be included as a control for an experiment, a patient would need to be
on the waiting list at the time of transplant, so the experiment entry indicators would be
eij = Ifmin(Ti;Yi)  tjg and
eij = IfDATETj 2 [DATEAi;DATEYi]g;
when matching by time from registration and date of transplant respectively. If necessary,
additional constraints could be placed on the patients included as controls for a exper-
iment so that only patients comparable to the patient who initiates the experiment are
considered.
6.4 Estimating the Weight Function
The contributions of all subjects will need to be weighted to adjust for the bias introduced
by the dependent censoring of transplanted patients. This will be done using weights that
163are similar to inverse probability of censoring weights, which are described in detail in
Section 3.1. The probability of remaining untransplanted from time tj to time t will be
given by an estimate of
Gij(t) = exp
(
 
Z t
tj
dT
i (s)
)
; t > tj;
which can be expressed as the ratio
Gi(t)
Gi(tj) where
Gi(t) = exp

 
Z t
0
dT
i (s)

;
is the survival function for time to transplantation. The inverse of Gij(t) is used in the
weight function and this is equivalent to using the unstabilised weights dened in Section
3.1. However the probability of remaining untransplanted starts from time tj instead of
time 0. This is why the inverse of Gij(t) has Gi(tj) as the numerator rather than 1.
Liver transplantation will be assumed to follow the proportional hazards model,
T
i (tj0) = T
0 (t)exp

T
0 Vi(t)
	
; (6.2)
where T
0 (t) is the baseline transplant hazard. This model implies that the transplant
hazard for an individual only depends on the current values of vector of covariates. This
is realistic as waiting list priority will be given to those who seem sickest at a particular
time, as indicated by current covariate values, not their historic values.
The Cox proportional hazards model will be used to estimate the parameter vector
0. The covariates that will be included in this model are all the covariates that are to
be included in the model for time to death.
We will use a Kaplan-Meier estimate that has been extended to include the covariates
used in the model for liver transplantation given in (6.2) as an estimate for Gij(t). It is
not clear whether Schaubel et al (2009b) use this estimate. It is possible that they may
have used ^ Si(t) =
n
^ S0(t)
oexp(^ 0Vi(t))
to nd the estimates of the survival functions used
in Gij(t). However, this should not be used when we have time-dependent covariates in
the model.
Although we do not know which estimate for Gij(t) was used by Schaubel et al.
(2009b), in a dierent paper (Zhang and Schaubel (2010)) that used similar weights,
the estimate ^ Si(t) =
n
^ S0(t)
oexp(^ 0Vi(t))
was used with time-dependent covariates. So, it
is likely that this may have been used in Schaubel et al. (2009b) as well.
Now using this model we can calculate estimates of the weighted risk set indicators,
^ Wij(t;0) = Rij(t) ^ Gij(t) I(Ti>tj);
164where
Rij(s) = Ri(s)fI(Ti = tj) + I(Ti > tj)I(Ti > s)g
which is the risk set indicator for the jth experiment and ^ 0 is the vector of parameter
estimates from the Cox model for transplantation. This modies the ordinary risk set at
time s to include only those who were at risk when the experiment was initiated and have
not since crossed over into the transplanted set.
6.5 Deriving an Estimating Equation
It is now necessary to derive an equation that can be used to obtain estimates for the
parameters of interest. The approach used here will be slightly dierent from that outlined
in Schaubel et al(2009b), but it is equally valid when using a counting process format for
the data.
The prole likelihood for our transplantation data will be given by
NT Y
j=1
n Y
i=1
Y
ttj
(
eijWij(t;0)expfTZijg
P
i eijWij(t;0)expfTZijg
)eijWij(t;0)dNi(t)
:
From this we can easily obtain the log prole likelihood, which is given by
`(;0) =
NT X
j=1
n X
i=1
Z 
tj
eijWij(t;0)
"
log(eijWij(t)) + TZij
  log
 
X
i
eijWij(t)expfTZijg
!#
dNi(t)
where  = maxfX1;:::;Xng. The estimating equation can be obtained using the score
function which can be found by dierentiating the log prole likelihood with respect to .
This gives
U(;0) =
NT X
j=1
n X
i=1
Z 
tj
eijWij(s;0)
"
Zij  
P
i eijWij(s;0)Zij exp(TZij)
P
i eijWij(s;0)exp(TZij)
#
dNi(s);
which can be written more compactly if we let
S
(d)
j (s;;0) = n 1
n X
i=1
eijWij(s;0)Z
d
ij expfTZijg for d = 0;1;2
where z
0 = 1 and z
1 = z for any vector, z and
Ej(s;;0) = S
(1)
j (s;;0)=S
(0)
j (s;;0):
165In the nal estimating equation, an estimate of the weight function is needed, which was
discussed in Section 6.4. Thus the nal form of the necessary estimating equation is
U(; ^ 0) =
NT X
j=1
n X
i=1
Z 
tj
eij ^ Wij(s; ^ 0)fZij   Ej(s;; ^ 0)gdND
i (s): (6.3)
This is the form of the score equation for a weighted, stratied proportional hazards
model, that can be tted using standard statistical software packages, such as PROC
PHREG in SAS. The only thing to note is that, as we are using weighted data, we should
use the robust sandwich estimate of the covariance matrix to nd the standard errors of
the parameter estimates. This will give standard errors that tend to be slightly more
conservative than those found using the inverse of the information matrix.
6.6 Results
The sequential stratication method is now applied to the Liver Registration data set
so that estimates of 1 to 5 can be found. These are the parameters for the covariate
vector Zij1, which was dened in Section 6.3, which contains the indicators of whether the
observations are equal to the jth transplant time and which UKELD group they belong
to. However the values that are interest are exp(^ 1) to exp(^ 5). They are the ratios of
the estimated hazard functions for patients who create experiments (those that receive
transplants) to control patients (those that remain on the waiting list). If they have a
value of less than 1 then those who receive transplants have a lower hazard of death. We
can then use these values to determine the groups of UKELD scores in which the patients
have the greatest survival benet.
We did not include UKELD score as a covariate in the models because it had been
used to match similar patients in the sequential stratication method. We split UKELD
score into 5 groups when doing this. The boundaries for these groups were chosen by
examining the 20%, 40%, 60% and 80% quantiles of the distribution of UKELD score
and using similar values to these so that the groups contain roughly the same number of
patients.
We included other covariates in these models: age at registration, primary liver disease
category, ethnicity, serum sodium at time of registration and INR at time of registration.
We also included previous time spent on the waiting list in the model where we matched
patients by date. We do not present the parameter estimates for these covariates.
Tables 6.1 and 6.2 contain the hazard ratios for post-transplant mortality in contrast
to mortality on the waiting list for 5 dierent levels of UKELD score when matching by
time from registration. Also given are the 95% condence intervals and p-values. The
same results when matching by date can be seen in Tables 6.3 and 6.4.
166k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.265 (0.177,0.398) < 0:0001
2 50:5  u < 53:5 0.150 (0.103,0.218) < 0:0001
3 53:5  u < 56:5 0.211 (0.146,0.305) < 0:0001
4 56:5  u < 60 0.121 (0.085,0.171) < 0:0001
5 u  60 0.169 (0.129,0.222) < 0:0001
Table 6.1: UKELD category specic hazard ratios (post-transplant versus wait-list) when
controls are matched using time from registration with UKELD model 1
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.276 (0.195,0.393) < 0:0001
2 50:5  u < 53:5 0.171 (0.120,0.244) < 0:0001
3 53:5  u < 56:5 0.194 (0.138,0.273) < 0:0001
4 56:5  u < 60 0.146 (0.104,0.205) < 0:0001
5 u  60 0.150 (0.108,0.209) < 0:0001
Table 6.2: UKELD category specic hazard ratios (post-transplant versus wait-list) when
controls are matched using time from registration with UKELD model 2
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.346 (0.230,0.519) < 0:0001
2 50:5  u < 53:5 0.171 (0.115,0.256) < 0:0001
3 53:5  u < 56:5 0.228 (0.157,0.331) < 0:0001
4 56:5  u < 60 0.127 (0.088,0.182) < 0:0001
5 u  60 0.206 (0.153,0.277) < 0:0001
Table 6.3: UKELD category specic hazard ratios (post-transplant versus wait-list) when
controls are matched using date of transplant with UKELD model 1
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.322 (0.221,0.468) < 0:0001
2 50:5  u < 53:5 0.193 (0.134,0.277) < 0:0001
3 53:5  u < 56:5 0.184 (0.125,0.270) < 0:0001
4 56:5  u < 60 0.156 (0.108,0.224) < 0:0001
5 u  60 0.134 (0.091,0.196) < 0:0001
Table 6.4: UKELD category specic hazard ratios (post-transplant versus wait-list) when
controls are matched using date of transplant with UKELD model 2
167Tables 6.1 to 6.4 show that generally UKELD groups 4 and 5 have the lowest hazard
ratios, although occasionally group 2 has a fairly low hazard ratio. This means they
have the greatest dierence between waiting list and post-transplant mortality, with post-
transplant survival expected to be much greater than waiting list survival. In terms of
survival benet, this means that the patients in UKELD groups 4 and 5 generally have
the highest survival benet from liver transplantation, under these models. Also, UKELD
group 1 always has the highest hazard ratio, which means the patients with the lowest
UKELD scores have the lowest survival benet.
These results make intuitive sense as UKELD score is a good predictor of mortality,
we know that as the UKELD score increases, the expected survival on the waiting list
decreases. So the contrast between waiting list and post-transplant mortality should in-
crease as long as post-transplant mortality does not also decrease rapidly as UKELD score
increases.
The results also suggest that the transplants being carried out on patients with high
UKELD scores are not futile, as they can expect a signicant improvement in their survival
after transplant. However, we should be aware that the data we are considering are
observational data. So, any patients with high UKELD scores that receive liver transplants
have been deemed as suitable for transplant by a surgeon. Therefore the result we see
here may be a consequence of this selection bias in our data.
In addition to these tted models, we also produced bootstrap condence intervals
to assess the robustness of the results from these models. We carried out B bootstrap
replications, each time sampling from our dataset with replacement and then applying the
sequential stratication method to the new dataset. The distributions of the bootstrap
estimates for exp(1) to exp(5) were then examined and the 2.5 and 97.5 percentiles of
the distributions were used to nd 95% condence intervals for these parameter estimates.
Tables 6.5 and 6.6 give the bootstrap condence intervals when matching by time from
registration using UKELD model 1 and UKELD model 2 respectively. The bootstrap
condence intervals for the same models, but matching by date instead, can be seen in
Tables 6.7 and 6.8. The histograms of the bootstrap estimates for exp(1) to exp(5)
for each of these models were examined to ensure that the estimates were approximately
normally distributed. The histograms were roughly bell shaped, with the majority being
roughly symmetric, although there was occasionally some skewness, particularly in the
distributions of the bootstrap estimates for UKELD group 1.
There is considerable overlap between the bootstrap condence intervals in each of
these tables. However, the intervals for exp(^ 1) do tend to be much wider than those for
the other four parameters. These results suggest that a UKELD score of greater than
50.5 is all that is needed for patients to receive a signicant benet from transplantation.
168Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.126,0.946)
exp(^ 2) (0.057,0.370)
exp(^ 3) (0.088,0.404)
exp(^ 4) (0.056,0.208)
exp(^ 5) (0.085,0.301)
Table 6.5: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by time from registration. The UKELD model being used here is UKELD model
1.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.137,0.959)
exp(^ 2) (0.070,0.413)
exp(^ 3) (0.087,0.371)
exp(^ 4) (0.070,0.246)
exp(^ 5) (0.073,0.271)
Table 6.6: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by time from registration. The UKELD model being used here is UKELD model
2.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.151,0.976)
exp(^ 2) (0.086,0.354)
exp(^ 3) (0.118,0.423)
exp(^ 4) (0.055,0.214)
exp(^ 5) (0.096,0.319)
Table 6.7: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by date. The UKELD model being used here is UKELD model 1.
169Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.159,0.975)
exp(^ 2) (0.097,0.390)
exp(^ 3) (0.100,0.331)
exp(^ 4) (0.076,0.278)
exp(^ 5) (0.064,0.220)
Table 6.8: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by date. The UKELD model being used here is UKELD model 2.
However, dierent numbers of intervals and boundaries for these intervals need to be
investigated before we can be certain of this.
When the condence intervals in Tables 6.5 to 6.8 are compared to those in Tables 6.1
to 6.4, we see that the bootstrap condence intervals are always wider than the those from
the tted models. However, for the nal two UKELD groups, the bootstrap condence
intervals tend to be fairly close to the condence intervals from the tted models. This
suggests that the results for these two groups are fairly robust to changes in the individuals
included in the data set.
Figure 6.2 gives a graphical representation of all the results for the models considered
so far. For each UKELD group we show the hazard ratios and condence intervals from
the tted models using each of the UKELD models, alongside the bootstrap condence
intervals for the same models. This allows easy comparison of the results from each of the
models much more easily. The horizontal line on the plots corresponds to a hazard ratio
of value 1. If a condence interval crosses this line then the dierence between waiting list
and post-transplant mortality is not considered to be signicant.
Generally, we see that the hazard ratios and the upper limits of the condence intervals
tend to decrease as the UKELD score increases. However, under UKELD model 1 there
is a slight increase in the hazard ratios and 95% condence intervals for UKELD group 5
compared to UKELD group 4. This increase in the 95% condence interval means there
is more uncertainty about the estimate of the hazard ratio for UKELD group 5.
From the plots, we see that the bootstrap condence intervals for UKELD group 1
are much wider than those for any of the other groups. They are also close to including
a hazard ratio of 1, suggesting that dierence between waiting list and post-transplant
mortality is only just signicant.
It is also much easier to see just how much overlap there is between the condence
intervals, particularly between UKELD groups 2 and 3 and UKELD groups 4 and 5.
For this particular data set, the results suggest that there is very little dierence be-
170tween using time from registration to match controls and using date of transplant to match
the control patients. However, if the survival benet of a fairly new alternative transplant
therapy is being calculated, where we could expect to see a noticeable improvement in the
survival of patients over time, then matching control patients by date of transplant may
give more realistic results.
Figure 6.2: Plots showing the hazard ratios and 95% condence intervals of post-transplant
mortality versus waiting list mortality from both the model and bootstrap when matching
control patients by time from registration and when matching control patients by date
1716.7 Using Additional Criteria when Matching Control Pa-
tients
So far we have included as controls for the experiments any patients who were still on the
waiting list either at the time of transplantation or on the date of the transplant. However,
in reality, only patients who are deemed suitable for the donor organ would be considered
for transplant. Thus we should incorporate some of these additional criteria into our
model, so that we only use patients that are comparable to the experiment generating
patient as controls.
One of the most important criteria when deciding if a patient is suitable for a transplant
is whether he is blood group compatible with the donor of the organ. If the donor has
blood group O, then any patient can have the organ. If the donor has blood group A,
then the organ can only be given to a patient with blood group A or AB. If the donor has
blood group B, then the organ can only be given to a patient with blood group B or AB.
If the donor has blood group AB, then only patients who also have blood group AB can
receive the organ.
If we only include patients who are blood group compatible when matching by time
from registration, then the experiment entry indicator would be
eij = Ifmin(Ti;Yi)  tj;ui(tj) = uj;rbgi = AorAB if dbgj = A;
rbgi = B orAB if dbgj = B;rbgi = AB if dbgj = ABg
for the ith patient with respect to the jth experiment. Here rbgi is the blood group of the
ith potential recipient and dbgj is the blood group of the donor of the organ that is used
in the jth transplant. Similarly the experiment entry indicator when matching controls
by date of transplant and blood group would become
eij = IfDATETj 2 [DATEAi;DATEYi];ui(tj) = uj;rbgi = AorAB
if dbgj = A;rbgi = B orAB if dbgj = B;rbgi = AB if dbgj = ABg
for the ith patient with respect to the jth experiment.
As blood group compatibility is so important when choosing a recipient for a donor
organ, it should be included in the nal model that we use to nd the survival benet for
the dierent groups of UKELD scores.
Another criterion that is considered when selecting recipients for a donor organ is
the dierence between the weight of the recipient and the weight of the donor. If this
dierence is too large, then the donor organ could be the wrong size. Therefore patients
are usually only considered if their weight is within 10kg of the weight of the donor.
However, this is not strictly adhered to, as we found by looking at the dierences in
172weights for the patients who were transplanted. So it is not as important to include this in
the model as the previous criterion. For this reason we will incorporate it in a model that
already considers blood group compatible patients, and compare the results to a model
that incorporates only blood group compatibility.
If we include patients who are both blood group and weight compatible when matching
by time from registration, then the experiment entry indicator would be
eij = Ifmin(Ti;Yi)  tj;ui(tj) = uj;rbgi = AorAB if dbgj = A;rbgi = B
orAB if dbgj = B;rbgi = AB if dbgj = AB;jdwj = rwij  10kgg
for the ith patient with respect to the jth experiment. Here rwi is the weight of the ith
patient and dwj is the weight of the donor of the organ that is used in the jth transplant.
Similarly the experiment entry indicator when matching controls by date of transplant,
blood group and weight would become
eij = IfDATETj 2 [DATEAi;DATEYi];ui(tj) = uj;rbgi = AorAB if dbgj = A;
rbgi = B orAB if dbgj = B;rbgi = AB if dbgj = AB;jdwj = rwij  10kgg
for the ith patient with respect to the jth experiment.
6.7.1 Results
Here we apply the sequential stratication method to our data set but also incorporate
some of the additional criteria described in the previous section. Firstly, we consider
models that match by time from registration and blood group for both UKELD models.
The results for these models are given in Tables 6.9 and 6.10. Then models that match
by time from registration, blood group and weight are presented, again using each of the
UKELD models considered. Tables 6.11 and 6.12 contain the results for these models.
The decreasing patterns in the hazard ratios and the limits of the condence intervals
are even more evident in these tables than in previous results. Again those in UKELD
groups 4 and 5 have the largest survival benet and those in group 1 tend to have the
lowest survival benet.
We have also produced 95% condence intervals based on the percentiles of the dis-
tribution of the bootstrap estimates for exp(1) to exp(5). The aim here is to produce
some more robust condence intervals for the hazard ratios that are of interest. These are
given in Tables 6.13 to 6.16.
As seen previously, the bootstrap condence intervals are always wider than those from
the tted model. There is also much overlap between the bootstrap condence intervals
given in each table. However, the condence intervals do tend to get tighter for each
successive UKELD group and the upper limit of the condence interval tends to decrease.
173k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.264 (0.173,0.402) < 0:0001
2 50:5  u < 53:5 0.234 (0.154,0.354) < 0:0001
3 53:5  u < 56:5 0.194 (0.132,0.287) < 0:0001
4 56:5  u < 60 0.132 (0.093,0.189) < 0:0001
5 u  60 0.113 (0.085,0.152) < 0:0001
Table 6.9: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 1, when controls are matched using time from registration and blood group.
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.259 (0.179,0.376) < 0:0001
2 50:5  u < 53:5 0.278 (0.189,0.407) < 0:0001
3 53:5  u < 56:5 0.191 (0.135,0.270) < 0:0001
4 56:5  u < 60 0.162 (0.115,0.227) < 0:0001
5 u  60 0.104 (0.072,0.149) < 0:0001
Table 6.10: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 2, when controls are matched using time from registration and blood group.
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.358 (0.234,0.548) < 0:0001
2 50:5  u < 53:5 0.276 (0.178,0.428) < 0:0001
3 53:5  u < 56:5 0.178 (0.117,0.271) < 0:0001
4 56:5  u < 60 0.139 (0.097,0.200) < 0:0001
5 u  60 0.109 (0.079,0.150) < 0:0001
Table 6.11: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 1, when controls are matched using time from registration, blood group
and weight.
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.353 (0.240,0.518) < 0:0001
2 50:5  u < 53:5 0.349 (0.233,0.523) < 0:0001
3 53:5  u < 56:5 0.182 (0.126,0.263) < 0:0001
4 56:5  u < 60 0.160 (0.113,0.227) < 0:0001
5 u  60 0.107 (0.073,0.157) < 0:0001
Table 6.12: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 2, when controls are matched using time from registration, blood group
and weight.
174There are two bootstrap condence intervals for UKELD group 1 that suggest the
estimated hazard ratio is not as signicant as was suggested under the tted model. In
Table 6.15, the condence interval for UKELD group 1 includes the value 1, which suggests
there is no signicant dierence between waiting list and post-transplant mortality here.
In Table 6.16, the condence interval for UKELD group 1 does not include the value 1,
but the upper limit of the interval is close to it, which suggests the estimated hazard ratio
here is only just signicant.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.119,0.816)
exp(^ 2) (0.087,0.542)
exp(^ 3) (0.085,0.373)
exp(^ 4) (0.061,0.251)
exp(^ 5) (0.056,0.253)
Table 6.13: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by time from registration and blood group. The UKELD model being used here
is UKELD model 1.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.121,0.794)
exp(^ 2) (0.116,0.600)
exp(^ 3) (0.081,0.358)
exp(^ 4) (0.079,0.300)
exp(^ 5) (0.046,0.238)
Table 6.14: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by time from registration and blood group. The UKELD model being used here
is UKELD model 2.
Figure 6.3 gives a graphical representation of all the results for models that match
controls by time from registration and use additional criteria when matching. For each
UKELD group we show the hazard ratios and condence intervals from the tted models
using each of the UKELD models, alongside the bootstrap condence intervals for the
same models. As before, the horizontal line on the plots corresponds to a hazard ratio of
value 1.
These plots provide a summary of all the results in Tables 6.9 to 6.16, they can be used
to interpret the results of models that match controls by time from registration and use
175Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.154,1.046)
exp(^ 2) (0.107,0.623)
exp(^ 3) (0.065,0.359)
exp(^ 4) (0.064,0.258)
exp(^ 5) (0.053,0.261)
Table 6.15: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by time from registration, blood group and weight. The UKELD model being
used here is UKELD model 1.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.158,0.949)
exp(^ 2) (0.142,0.756)
exp(^ 3) (0.072,0.347)
exp(^ 4) (0.073,0.291)
exp(^ 5) (0.046,0.256)
Table 6.16: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by time from registration, blood group and weight. The UKELD model being
used here is UKELD model 2.
176at least one of the additional criteria when matching. We see that the downward trend in
the hazard ratios and the upper limits of the condence intervals is more pronounced here
than in Figure 6.2. We can also see that there is a lot of overlap between the condence
intervals, particularly between groups 1 and 2 and groups 3 and 4.
In the plot for models that match controls using time from registration and blood
group, we see that the bootstrap condence intervals for UKELD group 1 are not as
wide as those in Figure 6.2. This would be the model that is recommended for use as it
incorporates what is considered to be the most important additional criteria without the
size of the control groups appearing to be too greatly reduced. It does not matter which of
the UKELD models is used as the results seem to be fairly robust to the choice of UKELD
model.
From the plot for models that match controls by time from registration, blood group
and weight, we can see that the bootstrap condence interval for UKELD group 1 using
UKELD model 1 suggests the dierence between waiting list and post-transplant mortality
is not signicant. It is also possible to see that for UKELD groups 1 and 2 there is much
more uncertainty in the estimates. This could be due to a reduction in the size of the
control groups caused by using the weight matching criterion.
We now apply the sequential stratication method with the additional criteria to mod-
els that use date of transplant to match control patients. Firstly, we considered models
that matched by date and blood group for both UKELD models. The results for these
models are given in Tables 6.17 and 6.18. Then models that matched by date, blood group
and weight are presented, again using each of the UKELD models considered. Tables 6.19
and 6.20 contain the results for these models.
The patterns that we see in the results in Tables 6.17 to 6.20 are not as clear as those
in the results for matching controls by time from registration. UKELD groups 4 and 5 still
tend to have the lowest hazard ratios and therefore the greatest survival benet, although
this is not always the case. For example, in Table 6.18 the hazard ratio for UKELD group
3 is lower than that for UKELD group 4. The groups with the lower UKELD scores still
have the higher hazard ratios and so the lower values of survival benet. However, here it
is often UKELD group 2 that has the highest hazard ratio rather than UKELD group 1.
However, there is a substantial overlap in all of the condence intervals.
Again we have produced bootstrap condence intervals for these models, and they are
given in Tables 6.21 to 6.24. The condence intervals in these tables are all wider than those
for the tted model, as expected from previous results. As before, there is considerable
overlap between the condence intervals shown in each table. But the condence intervals
do get tighter and have lower upper limits for the models that use UKELD model 2.
For the models that use UKELD model 1, there seems to be more uncertainty about the
177Figure 6.3: Plots showing the hazard ratios and 95% condence intervals of post-transplant
mortality versus waiting list mortality from both the model and bootstrap when matching
control patients by time from registration and using additional criteria
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.288 (0.190,0.437) < 0:0001
2 50:5  u < 53:5 0.272 (0.171,0.432) < 0:0001
3 53:5  u < 56:5 0.186 (0.119,0.291) < 0:0001
4 56:5  u < 60 0.154 (0.105,0.228) < 0:0001
5 u  60 0.157 (0.113,0.218) < 0:0001
Table 6.17: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 1, when controls are matched using date of transplant and blood group
178k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.264 (0.178,0.390) < 0:0001
2 50:5  u < 53:5 0.274 (0.179,0.419) < 0:0001
3 53:5  u < 56:5 0.191 (0.129,0.283) < 0:0001
4 56:5  u < 60 0.208 (0.142,0.305) < 0:0001
5 u  60 0.113 (0.074,0.173) < 0:0001
Table 6.18: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 2, when controls are matched using date of transplant and blood group
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.343 (0.213,0.554) < 0:0001
2 50:5  u < 53:5 0.392 (0.240,0.637) < 0:0001
3 53:5  u < 56:5 0.278 (0.178,0.436) < 0:0001
4 56:5  u < 60 0.154 (0.102,0.232) < 0:0001
5 u  60 0.176 (0.125,0.249) < 0:0001
Table 6.19: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 1, when controls are matched using date of transplant, blood group and
weight
k UKELD Scores expf^ kg 95% Condence Interval P-value
1 u < 50:5 0.322 (0.207,0.500) < 0:0001
2 50:5  u < 53:5 0.383 (0.248,0.591) < 0:0001
3 53:5  u < 56:5 0.223 (0.150,0.331) < 0:0001
4 56:5  u < 60 0.217 (0.146,0.321) < 0:0001
5 u  60 0.157 (0.104,0.237) < 0:0001
Table 6.20: UKELD category specic hazard ratios (post-transplant versus wait-list) using
UKELD model 2, when controls are matched using date of transplant, blood group and
weight
179hazard ratio for UKELD group 5, than that for UKELD group 4.
Most of the condence intervals here suggest that there is not a signicant dierence
between waiting list and post-transplant mortality for UKELD group 1. The condence
interval for UKELD group 1 in Table 6.22 suggests that it is only just signicant. The
condence intervals for this group are so wide here which suggests that the control groups
are too small to make precise inferences about the hazard ratio.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.114,1.039)
exp(^ 2) (0.102,0.624)
exp(^ 3) (0.071,0.410)
exp(^ 4) (0.059,0.299)
exp(^ 5) (0.070,0.343)
Table 6.21: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by date and blood group. The UKELD model being used here is UKELD model
1.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.115,0.950)
exp(^ 2) (0.109,0.620)
exp(^ 3) (0.074,0.391)
exp(^ 4) (0.085,0.395)
exp(^ 5) (0.045,0.275)
Table 6.22: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by date and blood group. The UKELD model being used here is UKELD model
2.
Figure 6.4 gives a graphical representation of all the results for models that match
controls by date of transplant and use at least one of the additional criteria when matching.
As before, we show the hazard ratios and condence intervals from the tted models using
each of the UKELD models, alongside the bootstrap condence intervals for the same
models, for each UKELD group.
Figure 6.4 provides a summary of the results in Tables 6.17 to 6.24 and can be used
to interpret the results of models that match controls by date of transplant and also use
at least one of the additional criteria when matching. We see that generally there is still
180Parameter Bootstrap 95% Condence Interval
exp(^ 1) (0.113,1.511)
exp(^ 2) (0.116,0.986)
exp(^ 3) (0.100,0.614)
exp(^ 4) (0.056,0.310)
exp(^ 5) (0.066,0.381)
Table 6.23: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by date, blood group and weight. The UKELD model being used here is UKELD
model 1.
Hazard Ratio Bootstrap 95% Condence Interval
exp(^ 1) (0.133,1.382)
exp(^ 2) (0.122,0.893)
exp(^ 3) (0.078,0.471)
exp(^ 4) (0.083,0.423)
exp(^ 5) (0.052,0.360)
Table 6.24: Table showing 95% condence intervals for the UKELD group specic hazard
ratios based on percentiles of the distribution of bootstrap estimates when B=1,000 and
matching by date, blood group and weight. The UKELD model being used here is UKELD
model 2.
181a decreasing trend in the hazard ratios and the upper limits of the condence intervals,
although it is not as clear to see as in Figure 6.3.
In the plot for models that match control patients by date and blood group, the
bootstrap condence interval for UKELD group 1 using UKELD model 1 suggests that
there is not a signicant dierence between the waiting list and post-transplant mortality.
The dierence is only barely signicant if we consider the bootstrap condence interval
for this UKELD group using UKELD model 2. We can also see that there is much overlap
between the condence intervals for UKELD groups 1 and 2 and UKELD groups 3 and 4.
In the plot for models that match control patients by date, blood group and weight,
both the bootstrap condence intervals for UKELD group 1 suggest that there is no sig-
nicant dierence between waiting list and post-transplant mortality. Also the bootstrap
condence interval for UKELD group 2 under UKELD model 1 suggests that the dierence
here is only just signicant. It is likely that the additional criteria that have been applied
here have made the control groups too small, which is why we see so much uncertainty in
the estimated hazard ratios.
Figure 6.4: Plots showing the hazard ratios and 95% condence intervals of post-transplant
mortality versus waiting list mortality from both the model and bootstrap when matching
control patients by date and using additional criteria
1826.8 Summary and Recommendations
In this chapter, we describe the sequential stratication method which creates a stratum
each time a patient is transplanted and compares his/her survival to those of similar
candidates who were active on the waiting list at the time. This method was presented in
Schaubel (2009b), although we have made a few alterations to the method.
We use this to derive the survival benet for dierent UKELD score groups using
covariate-adjusted hazard ratios for transplantation compared to not receiving a trans-
plant. We found that the groups with the highest UKELD scores have the lowest hazard
ratios and so have the greatest survival benet.
We present two methods for selecting the patients that are used as comparisons for the
experimental patient. The rst is the one used in Schaubel (2009b), where the comparison
patients are those that have been on the waiting list for at least the same amount of time
as the experimental patient. We have developed the second method, where the patients
used for comparison are those that are registered as active on the waiting list on the date
of the transplant of the experimental patient.
Here, the results of the two methods are similar, suggesting that it does not matter
which one is used. However, if there is likely to be a change in the expected survival of
patients receiving a particular therapy over time, then using patients that are registered
as active on the date of transplant for comparison may give more realistic results.
We also describe how the same method could be used to compare the hazard function
for an alternative transplantation therapy, such as a split liver or a liver from an extended
criteria donor, with the hazard function of remaining on the waiting list and possibly
receiving a standard transplant at a later date.
We also considered using additional criteria when choosing patients to be included
in the comparative group, which were blood group compatibility and a suitable weight
relative to the weight of the donor. The results of these models showed the same trends as
the results of the models without these additional criteria, so that those with the highest
UKELD scores have the greatest survival benet from liver transplantation.
However, we recommend using a model that ensures patients that are included in the
comparative group are also blood group compatible, as this makes our model more realistic
and there is also less uncertainty about the estimates produced by this model.
When applying the method outlined in this chapter, we must be aware that we are
using observational data and therefore there may be bias in our results because of this.
One particular example is selection bias. All of the patients in the data set have been
chosen by clinicians for transplantation, which means they were considered suitable for
the particular organ and well enough to undergo the procedure. Therefore the results from
183the sequential stratication method may not be representative of all patients in the group,
particularly for those with high UKELD scores as they are the most sick on the list.
184Chapter 7
Discussion and Future Work
The aim of this thesis is to develop suitable methodologies for analysing data from patients
on the waiting list for a liver transplant, where patients who are censored due to trans-
plantation are suspected to be informatively censored. These methodologies should allow
the survival function to be estimated as well as any signicant covariates to be identied.
Ultimately, they should be able to be developed into methods that can calculate other
values that are of interest to NHSBT, such as survival benet.
A detailed discussion of how this thesis meets these aims is given in Section 7.1. A
summary of the main strengths and weaknesses is given in Section 7.2. Many of the
methods discussed in Chapters 2 and 3 and the method developed in Chapter 4 can be
applied to other situations instead of the liver transplantation setting considered in this
thesis. Therefore, Section 7.3 gives recommendations on how to analyse general data
with potentially informative censoring. We also explain in Section 7.4 how the methods
developed in this thesis are of use to NHSBT, which provided the funding for this project.
Finally, extensions of the methods developed and possible future work are discussed in
Section 7.5.
7.1 Discussion
Estimators that can be used to give bounds on the estimated survival function are re-
viewed in Chapter 2. All these estimators are applied to the Liver Registration data set,
but it is found that they give bounds that are too wide to be of use. Slud and Rubinstein
(1983) and Klein and Moeschberger (1988) suggest restricting the values that the depen-
dence parameters can take to provide tighter bounds on the estimated survival function.
However, even these bounds are too wide to be useful.
Even though the bounds on the estimated survival function are not useful, these estima-
tors can still be used to estimate the survival function if a suitable value of the dependence
185parameter is specied. As we cannot identify the amount of dependence between T and
C from the observed data, then this approach is not recommended. These estimators also
do not allow all covariates to be incorporated, which is another reason why we would not
recommend their use in practice. However, we will still discuss the properties of these es-
timators so that we can identify which is most suitable for use in the liver transplantation
setting.
We would not recommend use of either the estimator in Fisher and Kanarek (1974)
or the estimator in Slud and Rubinstein (1983), as it is not easy to specify an amount of
dependence between T and C that can be interpreted easily using standard measures of
dependence. All the other estimators considered in Chapter 2 use Kendall's  to specify
the amount of dependence between T and C. Use of the Fisher-Kanarek estimator is
also not recommended due to some strange behaviour that can be observed when the last
observation is censored.
We recommend that the copula-graphic estimator is used instead of the self-consistent
estimator, when using an estimator with an assumed copula, as it is less computationally
intensive. Also, it is found in a simulation study in Zheng and Klein (1994) that the
self-consistent estimator has a signicantly larger bias than the copula-graphic estimator.
It is not known how the other estimators in Chapter 2 compare to the copula-graphic
estimator. However, as these methods cannot easily be used in practice due to the wide
bounds found and the diculties with incorporating covariates, it would not be particularly
useful to identify the preferred estimator of those in Chapter 2.
The literature review is continued in Chapter 3, where methods that can incorporate
covariates and are generally of more use practically are considered. These methods can
be split into two categories: estimators that use models of the censoring process and
sensitivity analyses.
The most widely used approaches in the literature are estimators that use a regression
model for time to censoring. These estimators are known as inverse probability of censoring
weighted (IPCW) estimators. These estimators are weighted versions of the standard
methods, with the weights being the inverse of the probability of the individual remaining
uncensored under the chosen regression model for time to censoring. This allows us to nd
the KM estimate of the survival function or the parameter estimates for the Cox model
in the absence of any censoring. The models for time to censoring that are considered
are Cox's proportional hazards model, Weibull proportional hazards model and Aalen's
additive hazard model. We feel that Cox's proportional hazards model is the best model
to use as it can easily incorporate time-dependent covariates and can also be tted easily
using standard software.
For IPCW estimators to be unbiased, the assumption of sequential ignorability of
186censoring needs to hold. Consequently, if all the prognostic factors for both T and C are
adjusted for in the model for censoring, then C is independent of T. This assumption
is more restrictive than some of the other assumptions used in the methods discussed in
Chapter 3. The assumption that is used in Siannis (2004), Siannis et al. (2005) and
Siannis (2011) can be related to the semi-parametric model in Scharfstein and Robins
(2002), which has the assumption of sequential ignorability of censoring as a special case.
However, the assumption of sequential ignorability of censoring is an intuitive choice
as it seems likely that dependence between T and C would be due to shared prognostic
factors. But it is possible that some of these prognostic factors are unmeasured and
there would be residual dependence between T and C that is not explained by the shared
factors included in the model for time to censoring. If there is residual dependence then
the IPCW estimates would be biased. Although if the most signicant shared prognostic
factors are included in the model for time to censoring, then this bias should be fairly small.
Scharfstein and Robins (2002) and Rotnitzky et al. (2007) develop a sensitivity analysis
that can be used to see how sensitive an estimator that assumes sequential ignorability
of censoring is to diering amounts of residual dependence. Unfortunately, this method
cannot be used on IPCW estimators as they used a dierent estimator that assumes
sequential ignorability of censoring.
Despite this, the sensitivity analysis from Rotnitzky et al. (2007) is still applied to the
Liver Registration data set. It is found that the bounds on the estimator that are derived
are too wide to be of use practically. The method is also so computationally intensive that
it is not easy to include many covariates or factors with many levels.
The other sensitivity analyses presented in Chapter 3 assess the sensitivity of the
results from standard methods to the assumption of informative censoring. Sensitivity
analyses for both parametric survival models and the Cox proportional hazards model are
included.
The sensitivity analyses for parametric survival models are computationally simpler
but cannot be applied to every data set as they require the marginal distributions of T
and C to be one of the standard parametric survival distributions, such as the exponential
of the Weibull. The sensitivity analysis in Siannis (2004) and Siannis et al. (2005) is our
preferred sensitivity analysis for parametric survival models as it gives values that seem
more feasible than the sensitivity analysis in Zhang and Heitjan (2006). However, the
sensitivity analysis in Siannis (2004) and Siannis et al. (2005) does use several simplifying
approximations which may aect the accuracy of the method.
The sensitivity analysis in Siannis (2011) uses a similar assumption about the depen-
dence between T and C as Siannis (2004) and Siannis et al. (2005) and some of the same
simplifying approximations but for the Cox proportional hazards model. It is more com-
187putationally intensive as it requires the estimation of the baseline hazard functions but
can be applied to a greater number of data sets.
The sensitivity analysis in Huang and Zhang (2008) is also for the Cox proportional
hazards model but uses the same assumption as Zheng and Klein (1994), where the joint
distribution of T and C is specied using a copula function. This is much more computa-
tionally intensive than Siannis (2011) and also requires additional untestable assumptions.
This is because we have to specify the copula family to be used as well as the amount
of dependence between T and C. It is for these reasons that the sensitivity analysis in
Siannis (2011) is our preferred sensitivity analysis for the Cox proportional hazards model.
All of the estimators and methods described in the literature review in Chapters 2 and
3 rely on untestable assumptions to make the joint distribution of T and C identiable.
This means that we are unable to say which of the methods has the most realistic model
for the liver transplantation setting. So any recommendations about which methods to
use when analysing data are based on the properties of the methods and the intuitiveness
of the assumption made about the dependence between T and C.
There are two main conclusions that can be drawn from the literature review: sensi-
tivity analyses are useful for assessing the sensitivity of standard results to the assumption
of informative censoring and IPCW estimators are the preferred estimators when carrying
out analyses on a data set where we know the standard methods are sensitive to infor-
mative censoring. These conclusions have inuenced the work in Chapters 4 and 6. In
Chapter 4, we develop a new sensitivity analysis that overcomes some of the weaknesses
of the sensitivity analyses discussed in Chapter 3. In Chapter 6, we use weights similar to
those used for IPCW estimators to adjust for the informative censoring in the data set.
As discussed in Chapter 3, when applying a sensitivity analysis to the data set, we have
to choose between using parametric models or Cox proportional hazards models for the
marginal distributions of T and C. Using parametric models allows us to use a sensitivity
that is simpler to apply but these models are not suitable for all data sets. Conversely,
proportional hazards models are more exible and so can be used for a wider range of data
sets but the sensitivity analysis that has to be used is more computationally intensive. The
new sensitivity methodology that we derive in Chapter 4 is a compromise between the two
types of sensitivity analysis considered previously. We use piecewise exponential models
for the marginal distributions of both T and C, which are more exible than standard
parametric survival models but allow us to retain the computationally simplicity of the
sensitivity analysis.
There is only one drawback to using piecewise exponential survival models for the
marginal distributions of T and C. To specify the distribution, suitable cut points for the
intervals need to be specied. However, there is no preferred method for doing this in the
188literature.
The sensitivity analysis in Chapter 4 is derived rst for scalar parameters in each
interval and is then extended to include covariates as well. There are two possible ways
of incorporating covariates into the sensitivity analysis, using either a linear predictor
or considering a vector of parameters. The sensitivity analysis for a linear predictor is
simpler but the sensitivity analysis for a vector of parameters is more useful as the change
in individual parameter estimates can be assessed. These two methods also give very
dierent values of the estimated changes in parameter estimates, therefore the model that
accounts for informative censoring is tted to the Liver Registration data set to assess
which is the more accurate method. The sensitivity analysis is used to approximate the
parameter estimates for this model as it is time consuming to t this model. It is found
that the results from the sensitivity analysis for the vector of parameters are closest to
those from this tted model. Therefore this is our preferred method of incorporating
covariates into the sensitivity analysis.
Another issue with this sensitivity analysis is that only small values of the parameter
specifying the dependence between T and C can be used due to the approximations that
are required to obtain the form of the sensitivity analysis equation. It is also useful to
know how these approximations aect the accuracy of the sensitivity analysis. This is
why a simulation study is conducted in Chapter 5. The simulation study uses a range of
dierent parameter combinations so that the general applicability of the sensitivity analysis
can be assessed. For simplicity, only models with scalar parameters in each interval are
considered in the simulation study. Also, we only assess the accuracy of the sensitivity
analysis when the piecewise parametric models are correctly specied. It is found that
the sensitivity analysis tends to overestimate the change in the parameter estimates, but
it is least accurate when there is a large amount of censoring in the data set or any
individuals with particularly large observation times. Both of these are observed in the
Liver Registration data set, so the sensitivity analysis should be more accurate in other
applications than it is for the situation under consideration in this thesis. As expected, the
sensitivity analysis also becomes less accurate as the value of the dependence parameter
is increased.
The results of the simulation study are used in an attempt to improve the accuracy
of the sensitivity analysis derived in Chapter 4. It is possible that including more terms
in some of the approximations may improve the accuracy of the sensitivity analysis so a
separate sensitivity analysis that uses a quadratic term in one of its Taylor expansions is
also developed. However, it is found that for the Liver Registration data set this sensitivity
analysis is not more accurate than the original sensitivity analysis.
Finally, in Chapter 6, a method that is particularly useful to NHSBT is considered.
189The sequential stratication method allows the survival benet of groups of patients on
the waiting list for a liver transplant to be calculated. This is achieved by comparing
the survival of each transplanted patient in the data set with the survival of suitable
control patients. We amend an existing method so that the method used to match control
patients is more realistic and the method is suitable for UK data rather than the US data
for which it had originally been designed. The original method matched control patients
by the length of time spent on the waiting list and we revised the method so that patients
who were on the waiting list on the date of a transplant were used as control patients.
However, it is found that the results for the Liver Registration data set are robust to the
method of matching control patients used. We also consider using only patients that are
blood group compatible with the donor organ as control patients and recommend using this
criterion when applying the sequential stratication method to UK data. An additional
criterion that can be used is to ensure that control patients have a suitable weight relative
to the weight of the donor. However, it was found that this made the groups of control
patients for each transplant too small so we recommend that this is not used.
The sequential stratication method can also be used to calculate the survival benet
of alternative transplantation therapies, such a split liver or a liver from an extended
criteria donor. However, we only discuss this briey and do not apply this to the Liver
Registration data set.
As the survival benet of the groups of patients on the waiting list is found using
observational data, then we need to be aware that there may be bias in the results as a
consequence of this. One particular example is selection bias. Any patients in the data
set who were transplanted had been selected by clinicians as suitable for transplantation.
Therefore, the results for each group of patients may not be applicable for every patient
in that group.
7.2 Summary of strengths and weaknesses
There has not previously been a comprehensive review of the most recent literature on
informative censoring, which we have carried out in Chapter 3. This is useful even if we
are considering only the liver transplant setting as many of the ndings also apply more
general settings.
The main strength of the sensitivity analysis method derived in Chapter 4 is that it can
be applied to a wide range of datasets whilst still being computationally simple due to the
exibility of piecewise exponential models. However, there are a couple of drawbacks for
this method. The rst is that it can only be applied for fairly small values of dependence
between T and C due to the approximations necessary to derive the sensitivity analysis
190equation. Secondly, we have to t a piecewise exponetial model to the data and there is
no preferred method for identifying the correct cut points to use.
Another strength of the thesis is that a simulation study has been carried out for the
sensitivity analysis developed in Chapter 4 to assess its accuracy in a range of situations.
This has not been done for the sensitivity analysis in Siannis et al. (2005) and Siannis
(2004), which our method is based on. It is found that the sensitivity analysis using scalar
parameters performed worse when there is a large amount of censoring or particularly large
observation values, both of which are present in the liver transplantation setting. But the
simulation study also demonstrates the general applicability of the sensitivity analysis as
it was shown that it is fairly accurate for a wide range of parameter combinations.
The survival benet methodology described in Chapter 6 has not been applied to UK
data before. Some modications of the method are also made to make it more suitable for
this data. However, the drawback of this survival benet methodology is that it is only
suitable for the transplantation setting and cannot be applied in more general settings.
7.3 Suggestions for general data with potentially informa-
tive censoring
A owchart summarising the process that we recommend should be followed if there is
potentially informative censoring in a dataset is given in Figure 7.1.
We can see that in Figure 7.1, the rst decision to be made is whether there is a
convincing argument for potentially informative censoring in the data set. Unfortunately,
due to the identiability issues described in Section 1.1.2, it is not possible to develop a
test to establish whether there is informative censoring in a data set. Therefore, the best
alternative is to see whether there is a good argument for informative censoring and then
conduct a sensitivity analysis to establish whether the assumption of informative censoring
aects the results of the standard models.
When applying a sensitivity analysis to assess the sensitivity of the results from stan-
dard models to the assumption of informative censoring, we recommend using the sen-
sitivity analysis we developed in Chapter 4. This is because it is exible enough to be
applied to most data sets whilst still being computationally simple. To establish whether
the results of the standard models are sensitive to informative censoring for the application
being considered, then the change in values of interest should be investigated. The values
of interest that are used will depend on the application being considered. For example,
in the liver transplantation setting the individual survival functions are assessed as ulti-
mately we will be calculating survival benet which is aected by changes in individual
survival. It is not possible to develop a test of whether the changes in the values of interest
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Figure 7.1: Flowchart showing the process to be followed if there is potentially informative
censoring in a data set.
192are signicantly large. Therefore, the decision of whether the changes are considered to
be large will again depend on the particular application that is being considered and is
subjective.
If it is determined using the sensitivity analysis that the change in the values of interest
are indeed considered large, then the analyses for this data should be carried out using
IPCW versions of the required estimators. If the changes in the values of interest are
found to be fairly small, then the standard methods of analysis can be used.
7.4 Summary of value of work to NHSBT
Chapters 2 and 3 provide a comprehensive review of the informative censoring methods in
the literature for the liver transplantation setting. We identify the most suitable estimators
and sensitivity analyses to be used in this setting. The results of this literature review
are also applicable to the analysis of patients on the waiting list for transplants for other
organs, with the exception of those waiting for a kidney transplant.
In Chapters 4 and 5, we develop an improved sensitivity analysis and establish its
general applicability. Its exibility and computational simplicity mean that it can be
easily applied to any data set in the transplantation setting where there is potentially
informative censoring.
The survival benet methodology derived in Chapter 6 is particularly useful for NHSBT
as it allows the survival benet of groups of patients on the waiting list to be calculated.
Modications were made to the method presented in Schaubel et al. (2009b) to ensure that
it is suitable for UK data, rather than the US data for which it was originally developed.
It can also be easily amended to give the survival benet of patients that receive new or
alternative transplant therapies. This is useful to NHSBT as they have introduced the use
of split livers and extended criteria donor to increase the number of donor livers available.
7.5 Extensions and Future Work
When developing the sensitivity analysis in Chapter 4, only piecewise exponential models
are considered. One possible extension of this work is to make it suitable for use with
piecewise Weibull models.
The simulation study for this sensitivity analysis that is carried out in Chapter 5
could also be extended. We only consider the accuracy of the sensitivity analysis when
the piecewise parametric models for the marginal distributions are correctly specied.
However, it is likely that we will not identify the exact piecewise parametric distribution
present in a data set, so it would be useful to investigate the robustness of the sensitivity
193analysis to the misspecication of the models for the marginal distributions.
There is also more work that could be done on the survival benet methodology derived
in Chapter 6. The method could be applied to the transplantation of other organs as it
is likely that there will be the same issues with informative censoring. We could also look
into calculating the survival benet of alternative therapies, mentioned briey in Section
6.3.1, in more detail and develop programs to implement this.
Finally, we observe a large amount of missing data in our data set so another area
of possible future work is to develop an multiple imputation method for large medical
databases. This would prevent us from having to disregard large numbers of observations
due to missing data.
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